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ABSTRACT 
Synapses are recognized as being highly plastic in structure and function, 
strongly influenced by their own histories of impulse traffic and by signals from 
nearby cells. Synaptic contacts are fundamental for the development, 
homeostasis and remodeling of complex neural circuits. Synapses are highly 
varied in their molecular composition. Understand this diversity is important 
because it sheds light on the way they function. In particular, this may be useful 
for understanding the mechanisms at the basis of synaptic dysfunctions 
associated with neurodevelopmental disorders, such as Autism Spectrum 
Disorders (ASD) in order to develop properly targeted therapeutic tools.  
During the first part of my Phd course I characterized the functional role of 
gephyrin at inhibitory synapses (paper N. 1). Gephyrin is a scaffold protein 
essential for stabilizing glycine and GABAA receptors at inhibitory synapses. 
Using recombinant intrabodies against gephyrin (scFv-gephyrin) I tested the 
hypothesis that this protein exerts a trans-synaptic action on GABA and 
glutamate release. Pair recordings from interconnected hippocampal cells in 
culture revealed a reduced probability of GABA release in scFv-gephyrin-
transfected neurons compared with controls. This effect was associated with a 
significant decrease in VGAT, the vesicular GABA transporter, and in neuroligin 2 
(NL2), a protein that, interacting with the neurexins, ensures the cross-talk 
between the post- and presynaptic sites. I also found that, hampering gephyrin 
function produced a significant reduction in VGLUT, the vesicular glutamate 
transporter, an effect accompanied by a significant decrease in frequency of 
miniature excitatory postsynaptic currents. Over-expressing NLG2 in gephyrin-
deprived neurons rescued GABAergic but not glutamatergic innervation, 
suggesting that the observed changes in the latter were not due to a homeostatic 
compensatory mechanism. These results suggest a key role of gephyrin in 
regulating trans-synaptic signaling at both inhibitory and excitatory synapses. 
Several lines of evidence suggest that proteins involved in synaptic function are 
altered in ASDs. In particular, in a small percentage of cases, ASDs have been 
found to be associated with single mutations in genes encoding for cell adhesion 
molecules of the neuroligin-neurexin families. One of these involves the 
postsynaptic cell adhesion molecule neuroligin (NL) 3. In the second part of my 
PhD, I used transgenic mice carrying the human R451C mutation of Nlgn3, to 
study GABAergic and glutamatergic signaling in the hippocampus early in 
postnatal life (paper N. 2). I performed whole cell recordings from CA3 
pyramidal neurons in hippocampal slices from NL3 R451C knock-in mice and I 
found an enhanced frequency of Giant Depolarizing Potentials, as compared to 
controls. This effect was probably dependent on an increased GABAergic drive to 
principal cells as demonstrated by the enhanced frequency of miniature GABAA-
mediated (GPSCs) postsynaptic currents, but not AMPA-mediated postsynaptic 
currents (EPSCs). The increase in frequency of mGPSCs suggest a presynaptic 
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type of action. This was further supported by the experiments with the fast-off 
GABAA receptor antagonist TPMPA that, as expected for an enhanced GABA 
transient in the cleft, showed a reduced blocking effect on miniature events. 
Although an increased number of available postsynaptic GABAA receptors, if 
these are not saturated by the content of a single GABA containing vesicle may 
account for these results, this was not the case since a similar number of receptor 
channels was revealed with peak-scaled non-stationary fluctuation analysis in 
both WT and NL3R451C knock-in mice, indicating that the observed effects were 
not postsynaptic in origin. Presynaptic changes in GABA release can be 
attributed to modifications in the probability of GABA release, in the number of 
release sites or in the content of GABA in single synaptic vesicles. Changes in 
probability of GABA release seem unlikely considering that we examined 
miniature events generated by the release of a single quantum. Our data do not 
allow distinguishing between the other two possibilities (changes in the number 
of release sites or in vesicle GABA content). However, in agreement with 
previous data from Südhof group showing an enhancement of the presynaptic 
GABAergic marker VGAT (but not VGlut1) in the hippocampus of NL3R451C KI 
mice (Tabuchi et al., 2007), it is likely that an increased GABAergic innervation 
may contribute to the enhancement of GABA release.  
In additional experiments I found that changes in frequency of miniature 
GABAergic events were associated with an acceleration of mGPSCs decay 
possibly of postsynaptic origin. The increased frequency of mEPSCs detected in 
adult, but not young NL3 R451C mice may represent a late form of compensatory 
homeostatic correction to counter the excessive GABAA-mediated inhibition. 
Therefore, it is reasonable to assume that alterations in the excitatory/inhibitory 
balance, crucial for the refinement of neuronal circuits early in postnatal 
development, accounts for the behavioral deficits observed in ASDs patients. 
Although also in the present case, a modification of gephyrin expression in 
R451C NL 3 knock-in mice was associated with changes in GABAergic 
innervations suggesting the involvement of a trans-synaptic signal, the role of 
NL3 mutation in this effect remains to be elucidated. 
Finally, I contribute in writing a review article (paper N. 3) that gives an up dated 
picture of alterations of GABAergic signaling present in different forms of Autism 
Spectrum Disorders. 
 
 
 
 
*** 
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INTRODUCTION 
 
Structural organization of synapses 
 
Synapses are specialized intercellular junctions between neurons or between 
neurons and other excitable cells where signals are propagated from one cell to 
another with high spatial precision and speed. Synapses can be divided in 
electrical or chemicals depending whether transmission occurs through direct 
propagation of the electrical stimulus or via a chemical intermediate. A general 
feature of a synapse is a close apposition of specialized regions of the plasma 
membranes of the two participating cells to form the synaptic interface. On the 
presynaptic side a cluster of neurotransmitter-filled synaptic vesicles is 
associated with the presynaptic plasma membrane.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
On the postsynaptic membrane an accumulation of neurotransmitter receptors is 
marked by a thickening of the membrane and by the presence of a sub-
membraneous electron-dense scaffold. In the majority of the cases, the 
presynaptic compartment is localized in the out-pocketing of an axonal branch 
Fig. 1 Summary of axonal function and reaction sequence and timing of synaptic 
transmission. (A) A pyramidal neuron is schematized with its different compartments. Four 
major functions of the axon are illustrated (i.e., spike initiation, spike propagation, excitation-
release coupling, and integration). A spike initiates in the axon initial segment (AIS) and 
propagate towards the terminal where the neurotransmitter is released. In addition, electrical 
signals generated in the somatodendritic compartment are integrated along the axon to 
influence spike duration and neurotransmitter release. (B) Time constants of reaction 
sequences taken from the calyx of Held (left) and corresponding traces (right).  (A, modified 
from Debanne 2011; B, modified from Sudhof, 2004) 
A B 
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and the postsynaptic compartment is localized at the surface of the cell body or 
dendrite. Morphological studies of central nervous system (CNS) synapses had 
led to their classification into two major groups, type I and type II (Grey, 1959) 
or asymmetric and symmetric respectively (Colonnier, 1968). Type I synapses, 
which involve dendritic spines and shafts, are formed by axon terminals that 
contain round vesicles. These synapses have a synaptic cleft of ~ 20nm and a 
prominent density on the cytoplasmic face of the postsynaptic membrane. Type 
II synapses involve neuronal perikarya and dendritic shafts. Respect to type I, 
type II synapses have a narrower synaptic cleft (~ 12nm), and a less prominent 
density beneath the postsynaptic membrane. In addition, the vesicles are 
smaller. It is widely accepted that terminals with larger vesicles (belonging to 
asymmetric synapses) are excitatory while with smaller vesicles (belonging to 
symmetric synapses) are inhibitory.  
 
Spikes are generated in the axon initial segment 
 
Communication in neurons occurs mainly through action potentials. Variations 
in potential arising from somato-dendritic integration of multiple inputs, 
culminate into the axon initial segment (AIS) where a supra-threshold resultant 
will trigger the action potential. Relative to their somato-dendritic compartment, 
the AIS bears a higher density of sodium (Na+) channels (20- to 1.000-fold 
higher). These comprise three different isoforms: Nav1.1, Nav1.2 and Nav1.6, 
which are differently expressed in various neurons. For instance, Nav1.1 
channels prevail in GABAergic interneurons (Ogiwara et al., 2007). Interestingly, 
sodium channels localized in the distal part of AIS display the lowest threshold 
for action potential generation and this account for spike initiation and back 
propagation.  
The duration of the action potentials is determined by potassium channels which 
are highly expressed in the AIS. Among these, Kv1.1 and Kv1.2 are frequently 
associated with excitatory and inhibitory synapses and carry currents that are 
10-fold larger than those measured at the soma (Kole et al., 2007). Kv2.2 
channels have been involved in regulation of interspike intervals during 
repetitive firing (Johnston et al., 2008). Kv7 channels (7.2 and 7.3), responsible 
for the M-current are involved in the control of the resting membrane potential 
and action potential threshold (Pan et al., 2001; Shah et al., 2008; Yue and Yaari, 
2006). Calcium channels are also present in the AIS where they regulate spike-
timing, burst-firing, and action potential threshold (Bender and Trussell, 2009). 
Using calcium imaging, pharmacological tools, and immunochemistry, a recent 
study has reported the presence of P/Q-type (Cav2.1) and N-type (Cav2.2) 
Ca2+ channels in the AIS of L5 neocortical pyramidal neurons (Yu et al., 2010). 
These channels determine pyramidal cell excitability through the activation of 
calcium-activated BK channels. 
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After initiation the spike will propagate towards the axons terminal where the 
neurotransmitter is released. Action potentials invade also the soma and 
dendrites (Fig. 1, left), providing a retrograde signal that would affect synapses 
impinging on the soma and dendrites. The efficacy of this back-propagation 
depends on the presence of active conductances along the dendritic tree. Back-
propagating action potentials which occur also in vivo (Svoboda et al., 1999; 
Buzsaki and Kandel, 1998) act as coincident detectors for enhancing synaptic 
efficacy. The depolarization provided by the spike can relieve the Mg2+ block of 
NMDA channels leading to calcium influx and second messenger activation. 
 
Mechanisms of neurotransmitter release 
Synaptic transmission involves a sequence of complex and coordinated events; 
once the action potential invades the presynaptic terminal, Ca2+enters through 
voltage-gated Ca2+ channels, thus increasing intracellular Ca2+ concentration. 
Ca2+ binds to presynaptic Ca2+ sensors, which will result in the exocytosis of  
synaptic vesicles and finally neurotransmitter release. Once released, the 
neurotransmitter diffuses across the synaptic cleft and binds to postsynaptic 
receptors. In this way, a voltage change in the presynaptic neuron is converted 
into a chemical signal (which gives rise to an electrical response in the 
postsynaptic cell). Remarkably, these biophysical and biochemical events are 
extremely fast as the whole process occurs in less than one millisecond (Borst & 
Sakmann, 1996). 
Ca2+ entering in mammalian central neurons is mediated mainly by CaV2.1 and 
CaV2.2 channels (Dunlap et al., 1995; Olivera et al., 1994). CaV2.2 channels 
(responsible for the N-type Ca2+ currents), are most important at synapses 
formed by neurons of the peripheral nervous system. However, in some central 
synapses, including a subset of inhibitory interneurons of the hippocampus 
(Poncer et al., 1997), CaV2.2 channels have been found to be involved in 
neurotransmitter release. CaV2.1 channels, which mediate P/Q-type 
Ca2+currents, have a major role at most synapses formed by neurons of the 
mammalian central nervous system. Ca2+ binds to the Ca2+ sensor, 
synaptotagmin, inducing a conformational change of the SNARE complex from a 
trans to a cis state (Sudhof, 2004), resulting in vesicles exocytosis and 
neurotransmitter release. Neurotransmitter release is proportional to the third 
or fourth power of Ca2+ entry (Augustine et al., 1987; Dodge and Rahamimoff, 
1967; Katz and Miledi, 1970; Zucker and Regehr, 2002). Thus, a 2-fold change in 
presynaptic Ca2+ current will cause an 8- to 16-fold change in transmitter 
release. In the majority of synapses, neurotransmitter is released in a fast and 
synchronous (phasic) manner resulting in large postsynaptic currents (Llinas et 
al., 1981; Sabatini and Regehr, 1996). However, examples of slow and 
asynchronous (tonic) neurotransmitter release resulting from residual Ca2+ 
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remaining in the terminal after an action potential, have been described in the 
literature (Hagler and Goda, 2001; Lu and Trussell, 2000; Atluri and Regehr, 
1998; Barrett and Stevens, 1972; Goda and Stevens, 1994; Hubbard, 1963; 
Rahamimoff and Yaari, 1973; Heft and Jonas, 2005).  
 
 
 
 
 
 
 
 
 
 
Phasic and tonic transmission depend both on Ca2+. Phasic transmission play a 
key role in the synchronization of the activity of principal cell ensembles and in 
the generation of high-frequency oscillatory activity in interneuron networks 
(Cobb et al., 1995; Buzsáki & Draguhn, 2004); tonic transmission may set the 
gain or offset of the input-output relations of postsynaptic target cells (Mitchell 
and Silver, 2003). 
Quantal synaptic transmission  
 
Pioneering studies from Katz and colleagues have shown that, at the frog 
neuromuscular junction, synaptic transmission is quantized, i.e. presynaptic 
action potentials give rise to postsynaptic signals that, from trial to trial display 
Fig. 2 The synaptic vesicle cycle. Synaptic vesicles are filled with neurotransmitters by 
mechanisms involving active transport (step1) and thus form the clusters of vesicles that 
represent the reserve pool (step2). Filled vesicles are docked at the active zone (step3) 
where they undergo a priming reaction (step4) that makes them competent for Ca2+ 
triggered fusion-pore opening (step5). Synaptic vesicles following fusion-pore opening 
undergo endocytosis and recycle via several routes: local reuse (step 6), fast recycling 
without an endosomal intermediate (step 7) or clathrin-mediated endocytosis (step8) with 
recycling via endosomes (step 9). Red arrows indicated steps in exocytosis while yellow 
arrows indicate step in endocytosis and recycling. (modified from Sudhof 2004) 
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fluctuations in amplitude among discrete levels (Katz, 1969). These discrete 
levels occur at integral multiples (0, 1, 2…) of an underlying unit, the “quantum”. 
The quantal hypothesis first enunciated by del Castillo and Katz (1954) was a 
major conceptual advance in the understanding of synaptic mechanisms. Thus 
according to the quantal theory, neurotransmitter is packaged in discrete 
quantities (quanta) that are released in an all-or-none manner. As release occurs 
at specific sites, synaptic efficacy E can be described using three quantal 
parameters:  
 
E= N*Pr*Q. 
 
where N is the number of functional release sites, Pr the probability of release of 
a single site and (Q) is the quantal size, i.e. the amplitude of the response to a 
single quantum. Changes in one or more of these parameters are responsible for 
modifications in synaptic strength. Assuming that each site acts independently, 
binomial and Poisson statistics can be used to model the stochastic behavior of 
synaptic transmission, to estimate quantal parameters, and to identify the site of 
changes in synaptic efficacy. 
Quantal analysis was applied first to central synapses by Kuno (1964). However, 
it should be stressed that this model of synaptic transmission has received only 
partial support from studies in the CNS (for review see Redman and Faber, 
2003). The more general finding is that, although synaptic transmission is 
stochastic and can even fail on occasions (i.e. a presynaptic action potential does 
not generate a postsynaptic response) postsynaptic responses tend to cluster at 
preferred amplitudes (Raastad, 1995). Quantal analysis resulted particularly 
useful to extract information on the mechanisms regulating changes in synaptic 
strength. Application of quantal analysis to central neurons relies on few 
assumptions, some of them found to be reasonably robust. For example if 
transmission failures reflect cases where the presynaptic action potential did not 
trigger exocytosis, it may be possible to use failures frequency as an indirect 
measure of the state of presynaptic terminals. Despite the differences in quantal 
neurotransmission between the CNS and neuromuscular junction, measuring the 
trial to trial fluctuations in the amplitudes of postsynaptic currents or potentials 
yields a powerful insight in the loci of alterations in synaptic strength.  
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Short-term synaptic plasticity 
 
Synapses are not static transmitter devices, on the contrary they display a plastic 
behavior. Short-term synaptic plasticity is referred to changes in the synaptic 
efficacy that usually occurs on a timescale of milliseconds to minutes. Short-term 
plasticity is important for information processing and plays a key role in a 
multitude of computational processes in the brain (Abbott and Regehr, 2004; 
Katz and Miledi, 1968; Zucker and Regehr, 2002). Short-term plasticity typically 
reﬂects a presynaptic change in neurotransmitter release (Del Castillo and Katz, 
1954; Katz and Miledi, 1968; Zucker and Regehr, 2002) however it is important 
to note that also postsynaptic mechanisms may contribute to short-term 
plasticity (see below). Short-term plasticity can result in synaptic enhancement 
(through three processes: facilitation, augmentation and post-tetanic 
potentiation) or in synaptic depression (Zucker and Regehr, 2002). Although the 
molecular mechanisms responsible for the various types of short-term plasticity 
Fig. 3 Quantal transmitter release. A, recordings of EPP from a neuromuscular junction 
superfused with low calcium Ringer containing solution. Superimposed traces represent 
responses to stimulation of a presynaptic motor neuron (arrows). Note the step-like 
fluctuations in EPP amplitude recorded from the same junction. B, quantitative analysis of 
EPP amplitude fluctuations. The upper graph plots the distribution of amplitudes of minis, 
which can be described by a Gaussian function. The lower graph illustrates the pronounced 
trial-to-trial fluctuations in EPP amplitude, including ‘failures” (leftmost histobar) where no 
EPPs were elicited. Smooth curve represents the predictions of a Poisson series, assuming 
that EPPs represent multiple release of mini-like quanta. The number of quanta in each EPP 
is indicated by the roman numbers on the abscissa. (modified from Fatt & Katz, 1952) 
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are not yet fully understood, it is well established that they are all Ca2+ 
dependent (Katz and Miledi, 1968; Zucker and Regehr, 2002). 
According to Katz and Miledi (1968), the residual Ca2+ remaining in the synapse 
after an action potential acts to enhance synaptic transmission. This hypothesis 
has been supported by a series of more recent experiments in which introducing   
the slow Ca2+ chelator EGTA into the presynaptic terminal reduces synaptic 
facilitation (Atluri and Regehr, 1996; Habets and Borst, 2005; Hochner et al., 
1991; Korogod et al., 2005; Regehr et al., 1994; Van der Kloot and Molgo, 1993). 
This effect can be partially explained assuming that, the residual Ca2+ binds to 
the Ca2+ sensor synaptotagmin (Sudhof, 2004) to increases exocytosis and 
neurotransmitter release (Katz and Miledi, 1968). However, the scenario seems 
to be more complicated as more recent data indicate that residual Ca2+acts not 
only on calcium sensors but also on Ca2+ -binding proteins (Blatow et al., 2003; 
Felmy et al., 2003; Muller et al., 2007; Sippy et al., 2003; Tsujimoto et al., 2002). 
Augmentation and PTP require longer trains of stimuli than facilitation and are 
deﬁned by their longer decay time constants (augmentation: from 5 to 10 s; PTP: 
from 30 s to minutes) (Zucker and Regehr, 2002), but they may represent 
overlapping physiological processes. Augmentation is caused by an increase in 
the probability of vesicle release rather than an increase in the size of the readily 
releasable pool of vesicles (Stevens and Wesseling, 1999). The rate of Ca2+ 
clearance from the synapse can determine whether augmentation or PTP occurs 
(Korogod et al., 2005; Zucker and Regehr, 2002). Residual Ca2+ that accumulates 
during the long stimuli that induce augmentation and PTP is eliminated from the 
synapse by the Ca2+-ATPase and by the Na+/Ca2+exchanger. Long trains of action 
potentials increase intracellular Ca2+and Na+ concentrations and slow the rate of 
Ca2+ clearance by the Na+/Ca2+ exchanger or even drive it in reverse. Residual 
Ca2+driving PTP can also result from the slow efﬂux of Ca2+ from mitochondrial 
or endoplasmic reticulum where it accumulates during tetanic stimulation (Lin 
et al., 1998; Narita et al., 2000; Tang and Zucker, 1997). 
Synaptic depression reduces the synaptic strength during repeated stimuli, 
delivered as closely paired stimuli (paired-pulse depression) or trains of stimuli. 
Depletion of the pool of readily releasable vesicles seem the main explanation for 
synaptic depression (Zucker and Regehr, 2002). However, in some 
circumstances vesicle depletion does not fully account for rapid synaptic 
depression (Sullivan, 2007; Xu and Wu, 2005). Decreased release probability 
caused by a reduced Ca2+ entry (Forsythe et al., 1998; Xu and Wu, 2005), or 
changes occurring downstream to Ca2+ entry (Wu and Borst, 1999) have been 
proposed. Therefore, like facilitation, augmentation, and PTP, multiple 
mechanisms contribute to synaptic depression, and their relative roles are still 
under debate. 
Postsynaptic mechanisms also contribute to short-term plasticity. In fact, 
postsynaptic receptors saturations can prevent an increase in synaptic strength 
also if the neurotransmitter release is enhanced (Foster et al., 2000; 2005). A 
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similar situation is represented by receptor desensitization following repetitive 
activation of presynaptic terminals (Jones and Westbrook, 1996; Overstreet et 
al., 2000). On the contrary, relief of the polyamine block in Ca2+ permeable 
AMPARs induces facilitation in some cortical synapses (Rozov and Burnashev, 
1999). 
 
The neurotransmitter concentration profile at active synapses 
 
Once released from the presynaptic terminal, the neurotransmitter reaches a 
peak concentration and then decays rapidly. The synaptic agonist transient (1-5 
mM) is thought to undergo extremely fast clearance (time constant of ∼ 100 μs) 
(Clements, 1996). Such a brief transmitter transient is even faster than receptor 
opening, implying that synaptic receptor activation occurs in conditions of non-
equilibrium. 
Understanding the temporal and concentration profile of neurotransmitters 
released during synaptic transmission, is a fundamental aspect towards the 
comprehension of neuronal communication. In the brain, the spatial and 
temporal properties of synaptic inputs are important determinants for specific 
neuronal functions including signal integration, network oscillations and 
selection of neuronal ensembles (Freund and Katona, 2007; Klausberger and 
Somogyi, 2008). Generally, it is thought that the major determinants of kinetic 
properties of post-synaptic currents (PSCs) commonly rely on the gating 
properties of post-synaptic receptors as exemplified for glutamatergic NMDAR-
and AMPAR-mediated EPSCs with slow and fast decay, respectively (Lester and 
Jahr, 1992). Similarly, GABAergic synapses are characterized by a marked kinetic 
diversity that is commonly ascribed to the variety of post-synaptic GABAA 
receptors (GABAAR) isoforms (Cherubini and Conti, 2001; Eyre et al., 2012). For 
instance, GABAA receptors containing α1 or α3 subunits (along with β and γ2 
subunits) have been demonstrated to underlie fast and slow IPSCs kinetics, 
respectively (Gingrich et al., 1995; Mozrzymas et al., 2003). However it is 
important to note that the kinetics of synaptic currents can be in some cases, 
different from predictions made exclusively on the basis of  the gating properties 
of post-synaptic receptors. Several experimental works have demonstrated that 
at excitatory and inhibitory synapses the profile of neurotransmitter 
concentration in the synaptic cleft may exert a significant role in determining the 
amplitude and kinetics of synaptic currents.  
During the last decade, many efforts have been dedicated to estimate the 
neurotransmitter profile at active synapses. However, several difficulties 
(synapses size and geometry, experimental inaccessibility of the synaptic cleft, 
quantal properties of neurotransmitter release etc.) lead only to a rough 
approximation of neurotransmitter behavior in the synaptic cleft. In this section I 
will provide a short description of the main methods employed for the 
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estimation of synaptic agonist time course (for an extensive review see Clements, 
1996; Scimemi and Beato, 2009; Barberis et al., 2011). 
 
 Low affinity competitive agonist 
 
Clements and colleagues (1992) introduced the method of low affinity 
competitive antagonist to estimate the time course of neurotransmitter in the 
cleft. In the presence of a quickly dissociate competitive antagonist, the amount 
of synaptic currents block, strongly depends on the strength of the pre-synaptic 
neurotransmitter release, because, antagonists and agonist compete for the same 
binding site. For an efficient displacement of competitive antagonist by synaptic 
agonist a fundamental prerequisite is that the dissociation time constant of the 
antagonist is comparable with the duration time of the neurotransmitter 
transient in synaptic cleft. Different low affinity antagonists have been used to 
estimate the time course of the main neurotransmitters in the CNS (Overstreet et 
al., 2003; Clements et al., 1992; Beato, 2008). Despite the low affinity antagonist 
method is widely used, it is important to remember that it has some limitations; 
the most notable is that for a given concentration of antagonist, the same amount 
of inhibition of the control response can be observed both with a short pulse of 
high agonist concentration or a long pulse of low agonist concentration 
(Diamond, 2001). 
 
 Mathematical simulation 
 
Mathematical models of a typical synaptic connection incorporating the 
geometry of the synaptic cleft, the extra-synaptic space, the binding of 
transmitter to receptors and uptake sites allow to obtain    prediction on  the 
profile of the neurotransmitter in the synaptic cleft. In particular, complex 3D 
reconstruction of synaptic structures together with Monte Carlo simulations 
have been used to explore the role of morphological and kinetics variable on 
synaptic currents (Wahl et al., 1996; Kruk et al., 1997). Despite the utility of 
these approaches, their predictive power is affected by some uncertainties 
associated with the parameters that are used (difference in synapse structure, 
size, number and distributions of receptors within a cell population).  
 
 Modifiers of gating 
 
Compounds affecting the agonist binding to post-synaptic receptors resulted 
particularly useful in providing information about the agonist transient (Barberis 
et al., 2011). This method is based on the consideration that even minimal up or 
down regulation of the agonist binding rate has a marked effect on the amplitude 
and time course of currents obtained after a short exposure to synaptically 
released neurotransmitter. To this purpose several compounds have been used 
(dextran, benzodiazepine, zinc, chlorpromazine). This method seems to provide 
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more qualitative than quantitative details especially when it is used to analyze 
synaptic currents (Barberis et al., 2011). 
 
The postsynaptic organization of synapses 
 
The presence of ion channels and neurotransmitter receptors stabilized by 
scaffold proteins, allow the postsynaptic side to receive the neurotransmitter 
signal released from the presynaptic terminal and transduce it into electrical and 
biochemical changes. Excitatory and inhibitory postsynaptic specializations are 
quite different both in the structural and molecular organization. Excitatory 
synapses occur mainly on tiny protrusion called dendritic spine (Bourne & 
Harris, 2008) while inhibitory synapses are formed mainly on the shaft of 
dendrites or, on cell bodies and axon initial segment (Wierengart, 2008). 
The molecular and structural diversity of the synapses contribute in a 
fundamental way to the development of specific connectivity patterns and to the 
functional properties of neuronal networks. In this section I will discuss the main 
structural and molecular features of both excitatory and inhibitory synapses. 
 
Excitatory synapses 
 
The postsynaptic density  
 
Excitatory synapses are characterized by morphological and functional 
specialization of the postsynaptic membrane called postsynaptic density (PSD). 
The PSD contains the glutamate receptors and several associated signaling and 
structural molecules (Sheng, 2011). It is now widely accepted that the PSD exerts 
a fundamental role allowing the correct apposition of pre- and postsynaptic 
membranes to cluster postsynaptic receptors and to link active postsynaptic 
receptors to biochemical events in the postsynaptic neuron. The PSD was first 
observed in electron microscopy as an electron-dense thick portion of the 
postsynaptic membrane (Siekevitz, 1985). The PSD is highly heterogeneous with 
a diameter ranging from 200-800 nm (mean 300-400 nm) and thickness of 30-
60 nm (Carlin et al., 1980). The structure and composition of PSDs is 
developmentally regulated (Petralia et al., 2005; Swulius et al. 2010) and 
generally, the expression level of many PSD proteins increase during 
development, reaching their peaks at ~ 2-4 week after birth and correlates with 
the formation and maturation of synapses within the brain. 
As already stated, the PSD is endowed with a large number of scaffolding 
proteins that can be present in different splice isoforms. Synaptic scaffolding 
proteins contain multiple domains for protein-protein interaction. A hallmark of 
PSD scaffold proteins is a ~ 90 aminoacid motif, the PDZ domain that is 
fundamental for the interaction with binding partners (Funke et al., 2004). 
20 
 
Probably, the best studied protein of the excitatory synapses is PSD-95. PSD-95 
together with its family members (PSD-93, SAP97 and SAP 102) is a very 
versatile protein exerting a major role in several synaptic functions. 
 
• Interaction and localization of synaptic proteins: PSD-95 stabilizes interacting 
membrane proteins at synapses by suppressing their lateral diffusion and/or 
internalization (Bats et al., 2007; Roche et al., 2001). PSD-95 binds to the C-
terminal tail of many postsynaptic adhesion molecules including neuroligins 
(NLs),  synaptic adhesion like molecules (SALMs) and leucine-rich repeat trans-
membrane neuronal proteins (LRRTM)  (Irie et al., 1997; Craig and Kang, 2007; 
Sudhof, 2008; Brose, 2009.) In addition PSD-95 participates in the assembly of 
NMDA receptor-associated protein complex and in the recruitment of signaling 
proteins able to modulate the function of glutamate receptors (Bhattacharyya et 
al., 2009). PSD-95 recruits AMPA receptors to the synapse thus participating to 
receptor trafficking (Chen et al., 200; Schnell et al., 2002; Nicoll et al., 2006; Bats 
et al., 2007). PSD-95 binds directly to the carboxy-terminal tails of the NR2 
subunits of NMDA receptors (Kornau et al., 1997). The simultaneous interaction 
with adhesion molecules, glutamate receptors and signaling proteins confer to 
the PSD-95 family proteins a central role in the morphological and functional 
maturation of synapses and their maintenance. 
 
• Regulation of synaptic strength and plasticity: overexpression of PSD-95 in cell 
cultures enhances AMPA receptor mediated excitatory synaptic transmission (El-
Husseini et al., 2000); in brain slices, the overexpression of PSD-95 increases the 
frequency of mEPSCs, enhances AMPA but not NMDA receptor mediated EPSCs 
(Stein et al., 2003; Ehrlich and Malinow, 2004). On the contrary, knocking down 
PSD-95 with RNAi  has a relatively modest effect on NMDA receptor-mediated 
transmission (Elias et al., 2006; Futai et al., 2007). Transgenic mice with targeted 
truncation of PSD-95 exhibit normal excitatory synaptic structure and function 
(Migaud et al., 1998), while mice deficient of both PSD-95 and PSD-93 show a 
strong reduction in the frequency of AMPA receptor –mediated synaptic currents 
(Elias et al., 2006). In PSD-95 null mice and in mice with targeted PSD-95 
truncation LTP is enhanced (Beique et al., 2006; Migaud et al., 1998). Beyond 
PSD-95 others important proteins of the PSD are represented by the Shank 
family, the Homer family and the GKAP family. 
The Shank family is composed by large proteins (~ 200 kDa) with multiple 
interacting domains that undergo differential splicing. Shank proteins (Shank 1-
3) exert a crucial role in dendritic spine differentiation and synaptic 
transmission (Sala et al., 2001). The Homer family of scaffolding proteins (Homer  
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1-3) are associated with Shank and group I metabotropic glutamate receptors 
(mGluR1 and mGluR5). 
The GKAP family of scaffolding proteins (GKAP/SAPAP1-4) interacts with the C-
terminal GK-like domain of PSD-95 family proteins (Kim et al., 2004).The 
carboxyl terminus of GKAP, interacts with the PDZ domain of Shank, which binds 
to Homer forming an interacting scaffold in the deeper part of PSD. In addition 
AMPA receptor binding scaffolds GRIP and PICK1 (present in the PSD) 
participate in AMPA receptor trafficking (Shepherd and Huganir, 2007).  
In addition, the PSD contains a huge variety of cytoplasmic signaling molecules 
such as kinases (CaMKIIα) and phosphatases (e.g. serine/threonine protein 
phosphatase I and protein tyrosine phosphatases) (Sheng and Hoogenraad 
2007).  
 
Glutamate receptors 
 
The vast majority of excitation in the central nervous system is mediated by 
glutamate, a ubiquitous amino acid (Watkins and Jane 2006). In neurons, 
glutamate is packed within synaptic vesicles by dedicated vesicular transporters 
(VGluTs) and following presynaptic activity is released in the synaptic cleft. Once 
Fig. 4  Structural organization of excitatory synapse. The postsynaptic density is endowed  of 
membrane receptors and ion channels, scaffold and adaptor proteins, signaling proteins, cell-
adhesion molecules and components of the cytoskeleton. Glutamate receptors, such as NMDARs 
and AMPARs are located at the postsynaptic membrane, with the NMDARs at the centre and the 
AMPARs more peripheral. The PDZ-domain-containing scaffold proteins PSD95 and the Src-
homology domain 3 (SH3) and multiple ankyrin repeat domains (Shank) family form a two-
layer protein network below the postsynaptic membrane, which is bridged by guanylate kinase-
associated protein (GKAP). The presynaptic and postsynaptic membranes are connected by cell-
adhesion molecules. (modified from Feng & Zhang, 2009) 
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released, glutamate acts on several structurally and pharmacologically different 
types of receptors: the ionotropic and the metabotropic receptors. 
 
Ionotropic glutamate receptors (iGluRs) 
 
Because iGluRs form ion channels permeable to cations, and the equilibrium 
potential for glutamate is close to 0 mV, positive to the resting membrane 
potential, activation of iGluRs results in membrane depolarization. Besides 
mediating the basic excitatory synaptic responses, iGluRs are also central in the 
induction and maintenance of synaptic plasticity. Mammalian iGluRs are encoded 
by a total of 18 genes that assemble into four major families: AMPA, kainate, 
NMDA, and delta receptors (Hollmann et al. 1989; Seeburg, 1993; Nakanishi and 
Masu, 1994; Dingledine et al., 1999). iGluRs are tetrameric protein complexes 
made up of four subunits surrounding an ion channel pore. Each iGluR subunit 
shows a characteristic modular organization consisting in: (1) a large 
extracellular domain(~ 380 aminoacids); (2) an agonist binding domain (~300 
aminoacids); (3) a transmembrane domain formed by three membrane 
spanning-segment (M1, M2, M4) and a membrane reentrant loop (M2); (4) a 
cytoplasmic carboxy-terminal domain whose residues interact with numerous 
intracellular scaffolding and trafficking proteins. 
 
AMPA receptors are encoded by four different genes (GluA1-4, also known as 
GluR1-4); AMPAR subunits can form both homo- and heteromers. The latter 
constitute the majority of native AMPARs (Jonas and Burnashev, 1995; 
Rossmann et al., 2011). Each AMPA receptor subunit may exist in the flip or flop 
version, dependent on alternative splicing of two exons encoding a 38-aa 
segment of the extracellular loop between M3 and M4.Flip forms desensitize 
with a slower kinetics compared to flop forms. Flip subunits are mainly 
expressed early in development. In addition, the mRNA encoding for the GluR2 
subunit can undergo editing mechanisms. Post-transcriptional modifications 
cause the substitution of glutamine (Q), located in position 586 on the 
transmembrane segment M2, with arginine (R) on the same position. The 
presence of an arginine is responsible for the electrostatic interaction that makes 
the receptor Ca2+ impermeable. This editing mechanism seems to be 
developmentally regulated. Infact, the edited and non- edited forms of the GluR2 
subunit coexist during the first postnatal days while in the adult the edited form 
is predominant. Calcium impermeable AMPARS receptors show a strong 
rectification at depolarizing potentials; this phenomenon is due to the presence 
in the cytoplasma of polyamines such as spermine and spermidine that, at 
positive potentials, enter through the channel pore causing its block. The 
majority of AMPA receptors expressed by excitatory neurons include one or two 
GluR2 subunits: in this case the receptors are Ca2+ impermeable; However, AMPA 
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receptors expressed by astrocytes and several interneurons lack the GluR2 
subunits and therefore are calcium permeable. 
 
Ionotropic Glutamate receptors (iGluRs) 
 
AMPARs KainateRs NMDARs DeltaRs 
GluA1 
GluA2 
GluA3 
GluA4 
 
GluK1 
GluK2 
GluK3 
GluK4 
GluK5 
 
GluN1 
GluN2 (A,B,C,D) 
GluN3 (A,B) 
 
GluD1 
GluD2 
 
 
Table 1. The four families of iGluR subunits. Each subunit is encoded by a distinct gene. There is 
no known mixing of subunits between families. 
 
 
NMDA receptors are encoded by seven genes (GluN1; GluN2A-D; GluN3A-B, also 
known as NR1; NR2A-D; NR3A-B). NMDARs are obligatory heteromers 
associating two GluN1 subunits with either two GluN2 subunits (which can be of 
different types) or a combination of GluN2 and GluN3 subunits (Cull-Candy and 
Leszkiewicz, 2004; Ulbrich and Isacoff, 2007; Paoletti, 2011). The NMDA sub-unit 
composition is developmentally regulated as NR2B subunit expressed in the 
cortex and in the hippocampus during the first postnatal week is substituted 
with NR2A in the adult ; this substitution results in faster decay currents. 
NMDARsare characterized by a high affinity for glutamate, Ca2+permeabilityanda 
slow gating kinetics. At resting potentials, physiological concentrations of Mg2+ 
(Mcbain and Mayer, 1994) block the NMDA receptors. The receptors are 
activated only when glutamate release is paired with postsynaptic depolarization 
(i.e. activation of AMPA receptors). These properties make them ideally suited 
for their role as a coincidence detectors underlying Hebbian processes in 
synaptic plasticity such as learning, chronic pain, drug tolerance and dependence 
(Collingridge and Singer, 1990; Bear and Malenka, 1994; Trujillo and Akil, 1995; 
Collingridge and Bliss, 1995; Dickenson, 1997). 
 
Kainate receptors are encoded by five different genes (GluK1-5, also known as 
GluR5-7, KA1-2). They are distributed throughout the brain but, unlike AMPA 
receptors (AMPARs) and NMDA receptors (NMDARs), they are mainly expressed 
on nerve terminals (both excitatory and inhibitory) where they regulate 
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transmitter release. More peculiarly, they link to metabotropic signaling 
pathways in addition to operating as conventional ionotropic receptors 
(Contractor et al., 2011). 
In KAR, only GluK1–GluK3 subunits can function as homomers; GluK4 and GluK5 
form functional receptors only when co-expressed with GluK1–GluK3 
(Contractor et al., 2011). 
 
 
 
 
 
 
 
 
 
Metabotropic glutamate receptors 
 
mGluRs are members of the G-protein-coupled receptor (GPCR) superfamily, the 
most abundant receptor gene family in the human genome. GPCRs are 
membrane-bound proteins that are activated by extracellular ligands such as 
light, peptides, and neurotransmitters, and transduce intracellular signals via 
interactions with G proteins. The resulting change in conformation of the GPCR 
induced by ligand binding activates the G protein, which is composed of a 
heterotrimeric complex of α, β, and γ subunits. In their inactive state, G proteins 
are bound to guanosine 5- diphosphate (GDP); activation of the G protein causes 
the exchange of guanosine 5-triphosphate (GTP) for GDP within the α subunit. 
Activated G-protein subunits then modulate the function of various effector 
molecules such as enzymes, ion channels, and transcription factors. Inactivation 
of the G protein occurs when the bound GTP is hydrolyzed to GDP, resulting in 
reassembly of the heterotrimer. 
GPCRs consist of an extracellular N-terminal domain, seven transmembrane-
spanning domains, and an intracellular C-terminus. mGluRs are classified into 
three groups based on sequences homology, G-protein coupling, and ligand 
selectivity.  
Fig. 5  Structural organization of AMPARs. AMPARs are displayed as heteromers composed 
by four subunits. The site of binding of agonist and antagonist are illustrated (modified from 
http://chrisparsons.de/Chris/ampa.htm) 
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Group I includes mGluRs 1 and 5. These receptors are generally localized on the 
postsynaptic membranes outside the synaptic cleft (Baude et al., 1993). They are 
coupled via G proteins to phospholipase C and, they are active during high-
frequency activation of afferent fibers when, glutamate overflows the synapse; 
their activation leads to an increase in both inositol triphosphate and 
diacilglycerol (Fagni et al., 2000). 
Group II (which includes mGluRs 2 and 3) are localized on presynaptic nerve 
terminals where they exert a key role in down regulating glutamate release. 
Group II receptors are activated only when glutamate overflows the synapse. 
Group III (which includes mGluRs, 4, 6, 7, 8) are localized on presynaptic 
terminals, very close or even within the active zones (Shigemoto et al., 1996, 
1997). The distinction between group II and III receptors can be done 
pharmacologically: while group III are blocked by L-AP4, group II by DCG IV.  
 
Inhibitory synapses 
 
 Postsynaptic organization  
 
The major scaffold protein of the inhibitory PSD (both GABAergic and 
glycinergic) is the multi-domain, 93 kDa protein gephyrin (Kneussel and Betz, 
2000; Fritschy et al., 2008). Originally co-purified with glycine receptors (GlyR; 
Pfeiffer et al., 1982), gephyrin has been later found to be associated also with 
GABAergic synapses (Sassoè-Pognetto et al., 1995; Sassoè-Pognetto and Fritschy, 
2000). This molecule is composed by three domains: the E and G domains 
connected by a linker region. Gephyrin lacks the PDZ domains but forms 
aggregates (dimers of trimers) by spontaneous oligomerization giving rise to an 
hexagonal structure known as “lattice”. The precise mechanisms by which 
gephyrin forms postsynaptic scaffolds is not yet known in the molecular details 
(Fritschy et al., 2008; Tretter et al., 2012). Gephyrin binds a cytoplasmic loop of 
the GlyR β subunit (Meyer et al., 1995) and is essential for postsynaptic 
clustering of GlyRs (Kirsch et al., 1993; Feng et al., 1998) and GABAARs (Essrich 
et al., 1998; Yu et al., 2007).  
The clustering of gephyrin and GABAARs is to some extent mutually dependent, 
since deletion of GABAARs disrupts gephyrin clusters (Essrich et al., 1998; 
Schweizer et al., 2003; Li et al., 2005; Kralic et al., 2006; Studer et al., 2006) and  
removal of gephyrin by knocking down its gene results in a massive loss of post-
synaptic GABAAR aggregates (Kneussel et al., 1999, 2001; Fischer et al., 2000; 
Lévi et al., 2004). The mechanisms by which gephyrin contributes to GABAARs 
clusterization are not fully elucidated. However, there is a general consensus that 
this molecule decreases the lateral mobility of GABAA receptors in the plasma 
membrane (Jacob et al., 2005; Thomas et al., 2005). 
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 Recently, several interactions have been demonstrated to occur between 
gephyrin and GABAARs subunits. Alldred et collegues (2005) have identified the 
fourth trans-membrane domain of the GABAAR γ2 subunit as essential for 
mediating postsynaptic GABAARs clustering , whereas the major γ2 cytoplasmic 
loop is required for the recruitment of gephyrin into GABAAR clusters. Direct 
interactions between gephyrin and the GABAAR α2 and α3 subunits have 
emerged only recently (Tretter and Moss, 2008; Saiepour et al., 2010). The 
relevance of the numerous gephyrin isoforms generated by alternative splicing is 
not completely understood (Paarmann et al., 2006; Fritschy et al., 2008). 
Gephyrin function may depend on post-translational modifications. To this 
purpose recent studies indicate that phosphorylation of gephyrin at specific 
residues (particularly enriched in the linker region) participate in anchoring 
GlyRs and GABAARs at postsynaptic sites (Zita et al., 2007; Charrier et al., 2010; 
Tyagarajan et al., 2011). A still unresolved issue is whether gephyrin equally 
contributes to the clustering of all major subtypes of synaptic GABAARs. The 
analysis of spinal cord sections, retina organotypic cultures, and cultured 
hippocampal neurons derived from gephyrin null mice lead to the idea that this 
protein mediates the postsynaptic accumulation of GABAARs containing the α2 or 
the α3 subunits, and suggested the existence of additional clustering mechanisms 
(Fischer et al., 2000; Kneussel et al., 2001; Lévi et al., 2004). However, in the 
brain gephyrin colocalizes with all major types of postsynaptic GABAARs 
containing either the α1, α2, or α3 subunits (Sassoè-Pognetto et al., 2000), 
indicating that its function is not restricted to α2 and α3-containingsynapses. 
Despite the enormous progress made in the understanding gephyrin function, 
this protein still remains an “enigmatic” organizer of the inhibitor synapse 
(Tretter et al., 2012). 
Another central molecule of the inhibitory synapse is collybistin (CB). Three 
main CB variants, CB 1–3, differing in the C-terminal region have been found in 
the rat. CB is formed by three major functional domains: an N-terminal SH3 
domain, encoded by a spliced exon (SH3), a DH (or GEF) domain and a PH 
domain. CB seems to have a strong role in inhibitory synapses maintenance as 
several loss-of-function mutations in the collybistin gene ARGEF9 are associated 
with severe forms of X-linked mental retardation and hyperekplexia (Kalscheuer 
et al., 2009). In recombinant expression systems, CB is essential for cell-surface 
translocation of gephyrin (Kins et al., 2000). Based on data from recombinant 
systems, this interaction was suggested to be responsible for a conformational 
change relieving the auto-inhibition of the DH domain, thus facilitating cell-
surface translocation of gephyrin and GABAARs. 
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Ionotropic GABAA receptors 
 
Ionotropic GABAA receptors (GABAARs) are members of the superfamily of 
hetero pentameric ligand-gated ion channels that also include the nicotinic 
acetylcholine receptors, glycine receptors, and 5-HT3 receptors (reviewed in 
Unwin, 1989). In the adult GABAARs mediate fast inhibitory neurotransmission 
thus exerting a fundamental role in regulating neuronal excitability. The receptor 
subunits share a common ancestral structure that includes an extracellular N-
terminal domain, four trans-membrane domains (TM1-4), and an extended 
cytoplasmic loop region between TM3 and TM4 that mediates interactions with 
trafﬁcking and signaling factors (Figure 6). GABAAR subunits are encoded by 19 
different genes that have been grouped into eight subclasses based on sequence 
homology (α 1-6, β 1-3, γ 1-3, δ, ε, θ, π, ρ 1-3). Alternative splicing contributes to 
additional receptor diversity. This molecular heterogeneity give rise to different 
type of GABAARs. Receptors with different subunit compositions exhibit different 
pharmacology and channel gating properties, are differentially expressed during 
development and in the adult brain, accumulate at different neuronal cell 
surfaces, and are subject to differential regulation by extracellular cues. 
Fig. 6 Structural organizationof the inhibitory synape. Gephyrin the major scaffold 
molecule of the inhibitory synapse, forms an hexagonal structure known as “lattice” that is 
needed to anchor GABA and Gly receptors. Collybistin is required for the post-synaptic 
clustering of gephyrin at GABAergic synapses while at glycinergic synapses gephyrin and 
Glyrs are targeted to the postsynapses independently of collybistin. Neuroligin2 binds to 
collybistin on the postsynaptic site and with neurexins on the presynaptic site ensuring a 
correct cross-talk between the two synaptic elements. Interactions of gephyrin with 
elements of the cytoskeleton is essential for its trafficking toward the membrane. 
Abbreviation: DHL, dynein heavy chains; DLC ½, dynein light chain1/2; KIF 5A, B, C, kinesin 
family protein 5 A, B, C; Mena, microfilament adaptors of the mammalian enabled; NRX, 
neurexins; PI3P, phosphatidylinositol-3-phosphate; VASP, vasodilator stimulated 
phosphoprotein (modified from Poulopoulos et al., 2009) 
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GABAA receptors are localized at both synaptic and extrasynaptic sites. The first 
mediate fast synaptic inhibition while the second tonic inhibition. GABAA 
receptors facing the presynaptic releasing sites have a low affinity for GABA 
(they are exposed for a very short period of time to high GABA concentrations) 
while GABAA receptors localized away from the synapses have a high affinity for 
GABA (they are exposed for a long period of time to very low GABA 
concentrations) and in comparison with synaptic receptors desensitize less. 
Because of their high affinity and low desensitization rate, extrasynaptic 
receptors are persistently able to sense low concentrations of GABA. 
Activation of extrasynaptic GABAA receptors by GABA escaping from the cleft 
generates a persistent (tonic) GABAA-mediated conductance (Farrant and 
Nusser, 2005). Tonic GABAergic signaling in mature neurons was first identified 
in granule cells of the cerebellar cortex (Kaneda et al., 1995; Brickley et al., 1996) 
where, application of GABAARs antagonists was found to reduce the current 
required to keep the cell at a fixed potential (the ‘holding current’). This was 
accompanied by a decrease in the background noise, consistent with the block of 
stochastic ion channels openings. To date, similar GABA-mediated tonic 
conductance has been demonstrated in several brain structures including the 
hippocampus and the cortex. Tonic inhibition regulates a numbers of 
physiological processes such as signals integration, network excitability and 
information processing. Therefore, it is not surprisingly that alterations in tonic 
GABAAR-mediated conductance are implicated in different pathological states 
(Brickley and Mody, 2012). 
 
 
Regulation of GABAAR assembly 
 
Despite the high number of GABAARs would predict a large heterogeneity of 
receptor subtypes, basic rules of assembly (Luscher et al., 2011) and the 
differential distribution of subunit types among brain region and neuronal 
population restricts the overall number of receptor subtypes. 
At synapses, GABAARs are composed mainly of two α1, α2, or α3 subunits 
together with two β2 or β3 subunits and a single γ2 subunit. Compared to other 
GABAAR subtypes discussed below these receptors exhibit low affinity for GABA 
and thus are optimized to respond selectively to relatively high concentrations of 
GABA released into the synaptic cleft (300 μM, Perrais and Ropert, 1999). The γ2 
subunit is essential for postsynaptic clustering of GABAARs (Essrich et al., 1998). 
However, the γ3 subunit can substitute for the γ2 subunit and contribute to 
postsynaptic GABAARs in the developing postnatal brain (Baer et al., 1999). 
Freeze-fracture replica immunogold labeling indicates that α2, α3 and β3 
subunit-containing receptors are 50–130 times more concentrated at synapses 
than at extrasynaptic sites (Kasugai et al., 2010). Not all γ2-containing receptors 
are concentrated at synapses. In particular, α5βγ2 receptors are found almost 
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exclusively at extrasynaptic sites (Brunig et al., 2002; Crestani et al., 2002; 
Serwanski et al., 2006) where they  contribute to tonic GABAA-mediated 
inhibition (Caraiscos et al., 2004; Glykys et al., 2008).The most prominent 
population of non-synaptic GABAARs mediating tonic inhibition consists in α4βδ 
receptors in the forebrain and α6βδ receptors in the cerebellum. In addition, 
Fig. 7 Structural organization of the GABAAR. (A) The binding of GABA ito GABA binding 
sites at the interface between α  and β subunits open the receptor associated chloride (Cl-) 
channel. The benzodiazepine binding site is located at the interface between α and ϒ2 
subunits. Barbiturates, ethanol and neurosteroids bind to sites in the membrane-spanning 
regions of the subunits. (B) Topography of GABAA R subunit ; The extracellular N-terminal 
domain is responsible for the binding of the neurotransmitter; four transmembrane domains 
forming the ion channel; the intracellular loop between transmembrane domain 3 and 4 
forms the motif for regulatory phosphorylation sites and for intracellular factors anchoring 
the receptor in the right position (modified from Uusi-Oukari& Korpi, 2010). (C) Several types 
of receptors are involved in generating tonic conductance; different sub-units are denoted by 
different color (modified from Glykys & Mody, 2007). (D) The shift of the holding current 
following the application of GABAAR antagonist picrotoxin reveals the magnitude of tonic 
conductance (modified from Walker & Kullmann, 2012) 
 
 
A B 
D C 
30 
 
α1βδ receptors underlie tonic inhibition of hippocampal interneurons (Glykys et 
al., 2007). Lastly, GABAARs also are present on axons, including the axon initial 
segment of pyramidal cells (Nusser et al., 1996; Brunig et al., 2002; Szabadics et 
al., 2006), mossy fiber terminals of hippocampal granule cells (Ruiz et al., 2003; 
Jang et al., 2006; Alle and Geiger, 2007), axon terminals of retinal bipolar 
neurons (Shields et al., 2000) and cerebellar parallel fibers (Stell et al., 2007). 
Axonal GABAARs are thought to modulate action potential conductance and 
neurotransmitter release (Kullmann et al., 2005).  
 
Retrograde messengers and trans-synaptic signaling 
 
It is well known that under physiological conditions, postsynaptic neurons can 
release from their cell bodies and/or dendrites substances that act as trans-
synaptic retrograde messengers to modulate transmitter release. A retrograde 
messenger can be defined as a substance released ‘‘on request’’ from the 
postsynaptic neuron and acting on presynaptic terminals, where is able to 
modify synaptic transmission.  
To be defined as a retrograde messenger, a given molecule should fulfill the 
following criteria:  
 
 The synthesis and release of the retrograde messenger must be in the 
postsynaptic neuron. 
 
 Abolishing the synthesis and/or release of the messenger from the 
postsynaptic neuron must abolish the retrograde signaling. 
 
  Disrupting presynaptic targets must abolish retrograde signaling  
 
As outlined in the examples below, several molecules with completely different 
chemical properties and different mechanisms of synthesis, release and way of 
action have been proposed as retrograde messengers.  
 
 
Messengers derived from lipids 
 
Some signaling molecules are synthesized from lipid precursors. Usually the 
synthesis and release of these lipophilic molecules are dependent on 
postsynaptic calcium rise, although the complete pathway is formed by different 
regulatory steps. The release of such molecules does not require vesicle fusion. 
After leaving the postsynaptic cell, these molecules activate receptors on the 
surface of presynaptic terminals. The endocannabinoid signaling system 
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provides an example of lipophilic retrograde messengers (Freund et al., 2003; 
Llano et al., 1991; Pitler and Alger, 1992). 
 
Messengers derived from gases 
 
Different types of gases have been classified as retrograde messengers in the 
central nervous system. Probably the best characterized is the nitric oxide (NO); 
NO is synthesized on request, as for its particular nature cannot be stored. 
Calcium influx through NMDA receptors activates nitric oxide synthase (NOS), 
which synthesizes NO from L-arginine (Boehningand,  2003; Garthwaite, 2008).  
 
 
Messenger derived from growth factors 
 
Different growth factors can be synthesized by neurons especially during period 
of intense synaptogenesis; growth factors can act also as retrograde messenger. 
For example, BDNF, released from the postsynaptic neuron during 
depolarization can acts on presynaptic TrkB receptors to regulate synaptic 
strength. (Du and Poo, 2004;  Zhang and Poo, 2002). Other secreted proteins that 
may act as retrograde messengers include growth factors such as NGF, NT-3, and 
NT-4. 
 
Trans-synaptic modulation by cell-adhesion molecules 
 
Every synapse shows unique features about its structure and function; this 
diversity is present even among synapses formed onto a single neuron. Several 
evidences have shown that, despite the huge heterogeneity, postsynaptic and 
presynaptic structures and functions are well coordinated at the level of the 
individual synapse. This specificity  emerges  from the  assembly of specific 
molecules on both sides of the synaptic cleft; however, what kinds of molecules 
are involved in these processes, which side of the synapse ‘instructs’ the other 
and which kind of mechanisms are involved, are questions only partially 
addressed. 
In this section I will discuss the evidence for trans-synaptic modulation of the 
neurotransmitter release by cell-adhesion molecules of the neuroligins family. 
 
The neurexin-neuroligin complex 
 
Neurexins (Nrxs) and neuroligins (NLs) are transmembrane proteins localized 
on the pre- and post- synaptic sites, respectively. Their structural organization 
consists of an extracellular domain necessary for trans-synaptic interactions, a 
trans-membrane domain and an intracellular domain that allow neurexin and 
neuroligin to interact with different proteins present on their respective synaptic 
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sites. The extracellular sequences of NLs are composed of a single domain that is 
homologous to acetylcholinesterase; this domain allows neuroligins to form 
dimers. Mammals express four NLs genes (NL1-4). In humans the Nlgn3 and 
Nlgn4 genes are localized in the X-chromosome. The Nlgn4 gene is 
complemented on the Y-chromosome by a similar Nlgn5 gene. The different NL 
isoforms show a conserved aminoacidic sequence, but different patterns of 
cellular localization. NL1 seems to be localized exclusively at excitatory synapse, 
NL2 and NL4 at inhibitory synapses and NL3 both at excitatory and inhibitory 
synapses. 
The NRXs protein family consists of three known members, Nrxs1–3. Nrxs are 
localized on the presynaptic site (but see Zhang et al., 2010 for a potential 
postsynaptic role). Their distribution to excitatory and inhibitory synapses 
appears to be regulated by complex alternative splicing mechanisms. 
Initial evidence that neuroligins had a role in synapses function and maturation 
was provided by Scheiffele et al., (2000) who demonstrated that NLs expressed 
in non-neuronal cells can induce in co-cultured neurons presynaptic 
specializations. In similar experiments it was demonstrated that also NRXs, when 
expressed in a non-neuronal cell, can induce formation of postsynaptic 
specializations in co-cultured neurons (Graf et al., 2004). In addition, 
overexpression of NLs in neurons causes an increase in synapse numbers (Chih 
et al., 2006). Altogether, these studies suggest that, at least in cell cultures, NLs 
and Nrxns have a powerful synaptogenic effect. However, this scenario has been 
complicated by the analysis of knockout (KO) mice showing that NLs and α-
Nrxns are essentials for synaptic function but not synapse formation (Missler et 
al., 2003; Varoqueaux et al., 2006). 
Different papers have highlighted the role of NLs as trans-synaptic signals. Thus, 
affecting postsynaptic NLs function may alters neurotransmitter release from 
presynaptic terminals (this effect has been described also for other synaptic 
proteins; see Gottmann 2006 for a review). In agreement with an increase in 
presynaptic release probability, most studies found an increase in frequency but 
not amplitude of miniature events (Prange et al., 2004; Levinson et al., 2005). 
Transfecting cultured neurons with a dominant-negative form NL1, lacking the 
C-terminal sequence for PSD-95 binding led to a reduction in the frequency of 
AMPAR-mediated mEPSCs, again supporting a trans-synaptic regulation of 
presynaptic release probability (Nam and Chen, 2005). In contrast, by over-
expressing NL1 an increase of mEPSCs frequency and glutamate release was 
found (Stan et al., 2006). In 2007 Futai and colleagues provided evidence that 
NL1 regulates neurotransmitter release. They convincingly demonstrated in 
organotypic hippocampal slices that the scaffolding protein PSD-95 and 
neuroligin1 are able to modulate the release probability in a retrograde way, 
resulting in altered presynaptic short-term plasticity. This effect seems to be 
mediated by the presynaptic β-neurexin. These results indicate that trans-
synaptic protein-protein interactions can functionally link postsynaptic and 
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presynaptic function. In a recent study from our laboratory, that will be the 
object of this thesis, we demonstrated that hampering gephyrin function with 
selective intrabodies alters the probability of GABA release at inhibitory 
synapses, an effect mediated by NL2 since it can be rescued by over expressing 
this protein in gephyrin-deprived neurons (Varley et al., 2011). Thus, at 
GABAergic synapses, NL2 appears to act in a way similar to that of NL 1 at 
excitatory synapses (Graf et al., 2004; Varoqueaux et al., 2004). Deletion of NL2 
decreases the frequency and amplitude of miniature GABAergic currents in CA1 
hippocampal pyramidal cells and in the spinal cord.  This reduction was 
accompanied by an increase in failures rate, again suggesting a presynaptic effect  
(Poulopoulos et al., 2009). Based on these evidences, it is plausible to assume 
that NLs regulate via trans-synaptic signaling the probability of neurotransmitter 
release at both excitatory and inhibitory synapses. However, how the NL-NRX 
complex controls vesicle exocytosis and recycling is not completely understood. 
 
 
 
 
 
 
 
The hippocampus 
 
One of the reasons for the interest in the hippocampus is that since the early 
1950s, this structure was recognized to play a fundamental role in some forms of 
learning and memory. In 1957, Scoville and Milner described the case of a patient 
known by his initials as H.M., who underwent bilateral removal of the 
hippocampus for the treatment of an intractable form of epilepsy. HM, probably 
Fig. 8 model of the neuroligin1/β-neurexin assembly at central synapse. The 
neurexin/neuroligin complex is tethered to pre- and post-synaptic membranes. The protein-
protein interactions span and maintain the physical space of the synaptic cleft ensuring a 
functional and reliable synaptic transmission (modified from Comoletti et al., 2007) 
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the most studied neuropsychological subject in memory research suffered a 
permanent loss of the ability to encode new information into long term 
memories. This anterograde form of memory impairment has been seen in other 
patients with bilateral damage of the hippocampus. This and subsequent studies 
have suggested that the deep structures of the temporal lobe, including the 
hippocampus (Amaral and Witter, 1989), are involved in the storage of long-
term memory traces (Milner et al., 1998; Eichenbaum et al., 1999; Kim and 
Baxter, 2001; Burgess et al., 2002). Evidence has been provided that the 
hippocampus is involved in storing and processing spatial information. Studies 
on rodents have demonstrated that some neurons in the hippocampus possess 
spatial firing fields. These cells, called “place cells” (Muller, 1996), fire when the 
animal finds itself in a particular location in the space regardless the direction of 
navigation. Place cells have been also seen in humans involved in finding their 
way around a virtual reality town (Ekstrom et al., 2003).  The discovery of place 
cells led to the idea that the hippocampus may represent a “cognitive map”. 
Recent evidence has cast doubt on this perspective, indicating that the 
hippocampus may be crucial for more fundamental processes within navigation. 
Thus, studies on animals have shown that the intact hippocampus is required for 
simple spatial memory tasks (for instance, finding the way back to a hidden goal) 
(Kwok and Buckley, 2006).  
 
Hippocampal anatomy 
 
The hippocampus is an elongated structure located on the medial wall of the 
lateral ventricle, whose longitudinal axis forms a semicircle around the thalamus. 
The hippocampus proper and its neighbouring cortical regions, the dentate gyrus 
(DG), subiculum and enthorinal cortex, are collectively termed “hippocampal 
formation”. The hippocampus proper is divided into stratum oriens, stratum 
pyramidale, stratum radiatum and stratum lacunosum-moleculare. In their 
classical works, Ramon y Cajal and Lorente de No’ grouped excitatory neurons in 
four regions called CA1-CA4. In general, CA4 is considered the part of the CA3 
closed to the dentate gyrus. The CA2 region represents the small portion 
between the CA3 and the CA1. This part is often ignored but it could have an 
important role in epilepsy because of the large amount of recurrent collaterals 
(Shepherd, 1998; Whitner et al., 2009). All pyramidal neurons are endowed with  
basal dendrites that arborise and form the stratum oriens and apical dendrites 
that are radially oriented in the stratum radiatum and lacunosum-moleculare. In 
the DG, granule cells represent the principal neurons, while the area between DG 
and the CA3 region is called the hilus (Figure 9). The main inputs to the 
hippocampus come from the enthorinal cortex, the septum and the contralateral 
hippocampus, whereas a unique unidirectional progression of excitatory 
pathways links each region of the hippocampus, creating a sort of trisynaptic 
circuit. The perforant path, originating from the enthorinal cortex passes through 
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the subicular complex and terminates mainly in the dentate gyrus, making 
synapses on granule cells. Then the distinctive unmyelinated axons of the 
granule cells (the mossy fibers) project to the hilus and to the stratum lucidum of 
the CA3 region. Here they make synapses en passant on CA3 pyramidal neurons 
showing the large, presynaptic varicosities typical of mossy fibres-CA3 contacts. 
These presynaptic expansions form a unique synaptic complex with equally 
intricate postsynaptic processes called thorny excrescences and may contain tens 
of releasing sites (Jonas et al., 1993). Information is therefore transferred, 
through Schaffer collaterals, from CA3 to CA1 pyramidal neurons, which send 
their axons to the subiculum and the deep layers of the enthorinal cortex. Thus, 
information entering the enthorinal cortex from a particular cortical area, 
crosses the entire hippocampus and returns to the cortical area from which it 
was originated. The transformations that take place during this process are 
presumably essential for information storage (Shepherd, 1998).  
 
     
 
 
 
 
 
 
 
 
 
 
 
Fig. 9 The hippocampus. The mossy cells in the hilar region (h) of the hippocampus are 
immunostained green for the calcium binding protein calretinin. Principal cell bodies are stained 
in blue labeling the pyramidal layer (sp) in areas CA1 and CA3 and the granule cell layer (g) of 
the dentate gyrus.. (modified from Foster et al., 2006). 
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Local Circuits of the hippocampus 
 
Hippocampal neurons are divided into two major classes: principal cells and 
interneurons. Although considerably less abundant (< 10%) than principal 
neurons, recent technical and conceptual progress have indicated an astonishing 
variety of interneuron classes endowed with different morphological and 
functional properties (Freund and Buzsaki, 1996; PING 2008). The interaction 
between GABAergic interneurons and glutamatergic principal cells are 
reciprocal: interneurons inhibit principal cells and are excited by them. The 
connectivity between these two neuronal classes is quite high: individual 
interneurons can inhibit > 50% of principal cells located within ~ 100 µm and 
receive excitatory input from a large fraction of them (Ali et al., 1999; Fino and 
Yuste, 2011; Glichfeld et al., 2008) 
 
 All hippocampal subfields receive an abundance of extrinsic afferentsthat, can be 
grouped into three broad classes: 
 
1) Glutamatergic inputs originating from the enthorinal cortex and/or other 
ipsilateral and controlateral hippocampal subregions. 
 
2) The septo-hippocampal GABAergic projection. 
 
Fig. 10 laminar structure of the hippocampus. The hippocampus proper is divided into 
stratum oriens (s.o.), stratum pyramidale (s.p.), stratum radiatum (s.r.) and stratum lacunosum-
moleculare (s.l.-m). filled circles represent interneurons. The major inputs to the hippocampus 
are represented on the right (modified from Freund and Buzsaki, 1996). 
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3) Different pathways from the brainstem and forebrain nuclei releasing 
neurotransmitters often referred to as “neuromodulators” such as 
acethylcoline, dopamine, noradrenaline etc… 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Glutamatergic afferent pathways show a high degree of laminar selectivity. 
Enthorinal afferents target the distal apical dendrites of granule and pyramidal 
cells, whereas commissural/associational fibers innervate the proximal 
dendrites of granule cells and the apical and basal dendrites of pyramidal 
neurons in the strata radiatum and oriens of the CA3 and CA1 subfields. This 
laminar specificity of inputs can have powerful effects on shaping any 
consequent output from the target population.  
 
A. Feedforward inhibition 
input 
output 
output 
 
B. Feedback inhibition 
output 
input 
 
 
 
C. Recurrent excitation 
input 
 
D. Mutual inhibition 
output 
input 
Fig. 11 Local circuit of the hippocampus.A. Feedforward inhibition. Axon collateral from 
excitatory afferent fibers contact local interneurons. B. feedback inhibition. Axon collaterals 
from local principal cells contact local interneurons, interneuron populations in A and B are 
not always mutually exclusive. C. Recurrent excitation. Axon collaterals from local principal 
cells also contact other local principal cells. D. mutual inhibition. Some interneurons subtypes 
contact other interneurons as well as principal cells and some interneurons contact other 
interneurons exclusively. Red circles, excitatory synapses; green circles, inhibitory synapses 
(modified from Buhl and Whittington, 2007)  
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These excitatory afferent inputs diverge on both principal cells and interneurons 
(Buzsaki, 1984).When cortical principal cells make excitatory synaptic contacts 
on local interneuron that in turn form inhibitory synaptic contacts on the 
principal cell population feed-back inhibition arises. On the contrary, when long-
range afferent inputs diverge onto both principal cells and local interneurons 
feed-forward inhibition is generated. Feed-forward inhibition serves to impose a 
temporal framework on a target area on the basis of the input received. The 
extra delay associated with an additional synapse in the circuit ensures that the 
feed-forward inhibitory synaptic event does not impinge on the initial, direct 
extrinsic synaptic event in principal neurons. Some interneurons receive input 
only from extrinsic afferents and can therefore participate only in feed-forward 
inhibition as for example cells associated with the perforant path in the 
molecular layer of the dentate gurus and neurogliaform cells in area CA1 (Han et 
al., 1993; Vida et al., 1998). Feed-forward inhibition can account for most of the 
input from extrinsic sources. For example, the mossy fiber axons in area CA3 
make about 10 times as many contact with CA3 interneurons as with the far 
more numerous CA3 principal cells (Acsady et al., 1998). 
If principal neurons fire, a number of interneurons receive synaptic excitation. 
The strength of excitatory synaptic innervation is such that there is a high 
probability that the target interneuron will fire an action potential. As 
consequence, interneurons target local principal cells, thus providing a feedback 
inhibitory circuit. In area CA1, excitatory neurons have a strong preference for 
interneurons as targets (Gulyas et al., 1998). Many interneurons can be involved 
in both forms of inhibition thus providing a functional link between afferent 
input patterns and any resulting output from the target area. 
In addition to circuits involving both principal excitatory neurons and inhibitory 
interneurons, there are many examples of interneuron-interneuron synaptic 
interactions. There is evidence of a broad heterogeneity of interneuron-
interneuron connections, with single presynaptic interneurons innervating other 
interneurons with different postsynaptic target (dendritic and perisomatic 
compartments of pyramidal cells) (Tamas et al., 1998). On the contrary of feed-
forward and feed-back inhibition, this mutual inhibition can be relatively weak. 
For example, CA1 basket cells have a higher probability to form synapses with 
principal cells than with other basket cells; some classes of interneurons appear 
to target exclusively other interneurons (Freund and Buzsaky, 1996). This 
recurrent pathway provides a mechanism by which rhythmic patterns of activity 
can be generated in interneuron circuits and projected onto principal cells, 
generating in such a way an oscillatory activity (Whittington et al., 1995). 
Recurrent connections are not limited to interneurons. In fact, also recurrent 
excitation is present in hippocampal local circuits. In the hippocampus there are 
probably few, if any, neurons without local axon collaterals synapsing on 
neighboring cells. In general, principal neurons recurrently excite other local (or 
neighboring) principal neurons as well as interneurons. The recurrent 
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connections between pyramidal neurons are particularly abundant in the CA3 
region and are responsible for making this region quite unstable. These 
connections are responsible for generating in particular conditions epileptiform 
activity, characterized by spontaneous, synchronized and rhythmic firing in a 
large number of neurons (Miles and Wong, 1986; Traub and Miles, 1991) 
The hippocampus is characterized by a high degree of neuronal 
interconnectivity. This is due to a multitude of converging inputs and diverging 
outputs. 
 
Synaptic dysfunctions in neurodevelopmental disorders associated with 
Autism  
 
Combined genetic and neurobiological approaches have provided evidence that 
synaptic mutations increase the risk of Autism Spectrum Disorders (ASDs). ASDs 
comprise a complex and heterogeneous group of pathological conditions 
including autism, Rett and Asperger syndromes, and pervasive developmental 
disorders-otherwise non specified, characterized by impaired social interactions, 
deficits in verbal and non-verbal communication, and a limited interest in the 
surrounding environment associated with stereotyped and repetitive behaviors 
(APA, 2000). The incidence of these disorders varies between 10 and 20 per 
10000 children. In approximately 70% of the cases, ASDs are associated with 
intellectual disability and in 25% of the cases with seizures (Tuchman and Rapin, 
2002). Clinical signs start appearing at the age of 3 years, but prospective studies 
of infants at risk have demonstrated that deficits in social responsiveness, 
communication, and play could be present already at the age of 6–12 months. 
Genetic factors are thought to account for 80% of autism cases. This hypothesis 
is strengthen by the fact that ASDs are the most heritable neurodevelopmental 
disorders of early childhood. Since autism is a spectrum of disorders, it is 
conceivable that in most cases different genes act in combination in different 
individuals (Garber, 2007). Despite the etiopathology of autism is still not yet 
very well understood, in recent years, several important discoveries have 
pointed out that  alterations  of synaptic functions could be implicated in the 
etiopathogenesis of autism, leading to the concept that ASDs (but also others 
brain disorders such as schizophrenia, ) can be considered “synaptopathies”. 
The most common single-gene mutations associated to ASDs occur in the fragile 
X syndrome (FMR1), in the tuberous sclerosis (TSC1, TSC2),  in the Angelman 
syndrome (UBE3A), in the Rett syndrome (MECP2), and in Phelan-McDermid 
syndrome SHANK3  (for review see Pizzarelli and Cherubini, 2011). Rare 
mutations in the neuroligins (NL2, 3, 4) and neurexins (Nrxs1) genes have also 
been found to be associated with autism (Jamain et al., 2003). Some of these 
mutations have been introduced in mice in order to create mice model of ASDs. 
Despite the difficulties to re-create autistic features in mice (Nestler and Hyman, 
2010), these models are particularly useful because allow to study cellular 
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function along with synaptic activity and ultimately with behavior, Moreover it is 
possible to use these models to implement pharmacological strategies to rescue 
behavioral phenotypes reminiscent of those found in autistic patients. 
In the following paragraph I will dicuss evidences that link neuroligins to ASDs. 
 
 
Disorders due to dysfunction of neuroligins and neurexins 
 
Single mutations of the X-linked Nlgn 3 and Nlgn 4 genes encoding for the 
adhesion molecules NL3 and NL4 were among the ﬁrst to be identiﬁed in ASD 
patients (Jamain et al., 2003). One of these, a missense mutation causing the  
R451C substitution (arg451→cys451) within the extracellular domain of NL3 
was detected in two male siblings, One exhibited an autistic behavior associated 
with severe intellectual disabilities (ID) and seizures; his brother resulted 
affected by the Asperger syndrome. Typical of many X-linked disorders, their 
mother, a carrier, did not manifest any autistic symptom (Jamain et al., 2003). 
Similarly to NL3, the ﬁrst identiﬁed NL4 mutation occurred in a male with 
autism, in his brother with Asperger syndrome, and in the asymptomatic carrier 
mother (Jamain et al., 2003). Other truncating mutations were identiﬁed in all 
affected members of a large family with X-linked ID (Laumonnier et al., 2004) 
and in two male siblings; one with autism, ID, and a motor tics, and another with 
Tourette syndrome exhibiting attention deﬁcit, hyperactivity, cognitive defects, 
and (Lawson Yuen et al., 2008). A de novo single-base substitution near the 
promoter region of NL4 has beenfound in one male with autism and ID (Daoud et 
al., 2009). Thus, mutations in NL3 and NL4 cause a wide range of social and 
cognitive abnormalities ranging from Asperger syndrome to severe cognitive 
impairement and tics. Also mutations in the neuroligin binding partners 
neurexins have been associated with autism; the ﬁrst involving neurexin1 was 
identiﬁed in two individuals with ASD and balanced chromosomal abnormalities 
(Kim et al., 2008). Stop mutations (S979X) in Nrx1 have been reported in a 
patient with autistic behaviors, severe ID, hyper-breathing, and some 
dysmorphic features (Zweier et al., 2009). 
 
Pathophysiology 
 
Loss of NL 3 in mice causes some features that are typically seen in ASD patients. 
Nlgn3-null mice display impaired ultrasound vocalization and altered social 
memory, possibly owing to olfactory deﬁciency. The animals, however, 
performed as well as wild types on direct social interactions and did not have 
learning deﬁcits or stereotypies (Radyushkin et al., 2009). A recent study from 
NL3 knock-out mice has revealed disrupted hetero-synaptic competition and 
altered metabotropic glutamate receptor-dependent synaptic plasticity in the 
cerebellum (Baudouin et al., 2012). Interestingly, in this case it was possible to 
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rescue the observed deficits by re-expressing NL 3 in juvenile animals, 
highlighting the possibility of reverting neuronal circuit alterations after 
completion of development (Baudouin et al., 2012). 
Mice carrying a knock-in allele with the R451C substitution displayed impaired 
social interactions associated with enhanced spatial learning (Tabuchi et al., 
2007). These modifications were associated at the cellular level, with increased 
levels of the vesicular GABA transporter without apparent changes in the 
number of GABAergic synapses.  In another animal model, a single amino-acid 
substitution (R704C) found in the neuroligin 4 gene and associated with autism 
(Yan et al., 2005) has been introduced into mouse neuroligin-3 by homologous 
recombination. Electrophysiological and morphological studies have revealed 
that the neuroligin-3 R704C mutation does not significantly alter synapse 
formation, but is responsible of a major and selective impairment of AMPA (but 
not GABA or NMDA) receptor-mediated synaptic transmission in pyramidal 
neurons of the hippocampus (Etherton et al., 2011). As for NL3, deletion of a NL4 
in mice caused impaired social interactions and decreased ultrasonic 
vocalization, consistent with human studies illustrating that loss-of-function 
mutations cause ASDs and ID (Jamain et al., 2008). Mice lacking a-neurexins 
isoforms show a decreased presynaptic Ca2+ currents, especially N-type Ca2+ 
currents (Missler et al., 2003).These data illustrate that the both neurexins and 
their binding partners neuroligins, are essential for proper synapse assembly 
and function and, strength the concept that a synaptic dysfunction can be the 
cause of ASD. 
 
Aim of the work 
  
Compelling evidence indicates that cell adhesion molecules, once thought to 
function as the static backbones of synapses, can actually be dynamic regulators 
of synaptic plasticity that contribute to memory formation. Recently, an array of 
cell adhesion molecules, have been found to be engaged in a wide range of forms 
of synaptic plasticity (Dalva et al., 2007). These proteins all share two important 
features: first, they form homophilic or heterophilic protein-protein interactions 
spanning and maintaining the physical space of the synaptic cleft, and second, 
they interact with intracellular signaling partners on both sides of the synapses. 
Thus, these classes of adhesion molecules are well equipped to couple the 
functional and structural dynamics of synapses.  
During my PhD course I combined electrophysiological recordings with 
molecular biology and immunocytochemistry to verify the hypothesis that 
gephyrin, the major scaffold molecule at inhibitory synapses, can 
transynaptically regulate synaptic strength. Selective intrabodies against 
gephyrin (scFv-gephyrin) developed in our laboratory (Zacchi et al., 2008) were 
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used to impair gephyrin function in cultured hippocampal neurons. When 
expressed in cultured rat hippocampal neurons as a fusion protein containing a 
nuclear localization signal, scFv-gephyrin were able to remove endogenous 
gephyrin from GABAA receptor clusters. Immunocytochemical experiments 
revealed a significant reduction in the number of synaptic gamma2-subunit 
containing GABAAreceptors and a significant decrease in the density of the 
GABAergic presynaptic marker, the vesicular GABA transporter (VGAT). These 
effects were associated with a slow down of the onset kinetics, a reduction in the 
amplitude and in the frequency of miniature inhibitory postsynaptic currents 
(Marchionni et al., 2009). The quantitative analysis of current responses to 
ultrafast application of GABA indicated that changes in onset kinetics resulted 
from modifications in the microscopic gating of GABAA receptors and in 
particular from a reduced entry into the desensitized state. In addition, 
hampering gephyrin function with scFv induced a significant reduction of GABAA 
receptor-mediated tonic conductance. The decrease in tonic conductance and in 
the frequency of miniature events suggest a reduced probability of GABA release 
probably secondary to the transynaptic action of gephyrin, Therefore, I first 
performed pair recordings from interconnected hippocampal cells in culture (the 
target cell expressing scFv) and found indeed a reduced probability of GABA 
release into scFv-gephyrin-transfected neurons as compared to controls. This 
effect was associated with a significant decrease in VGAT, the vesicular GABA 
transporter, and in NLG2, a protein that, interacting with neurexins, ensures the 
cross-talk between the post- and presynaptic sites. We were able to rescue these 
effects by over-expressing NLG 2 in gephyrin-deprived neurons.  
Since a dysfunction of synaptic proteins of the NLs-Nrxn families may account for 
some forms of ASD, in another set of experiments I took advantage of knock-in 
mice carrying the R451C mutation of the Nlgn3 gene (found in two Swedish 
brothers) to examine whether this mutation affects GABAergic and glutamatergic 
signaling in the hippocampus at early developmental stages. I found that an 
increased GABAergic innervation was responsible for the increase in frequency 
of network-driven GDPs, a hallmark of developmental networks, thought to play 
a crucial role in synapse formation and stabilization, The increased GABAergic 
but not glutamatergic innervations may affect in a developmental regulated way 
the excitatory/inhibitory balance, crucial for the refinement of neuronal circuits.. 
Although also in the present case, a modification of gephyrin clusters in R451C 
NL 3 knock-in mice was associated with changes in GABAergic innervations 
suggesting the involvement of a trans-synaptic signal, the role of NL3 mutation in 
this effect remains to be elucidated. 
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Materials and Methods 
 
Ethical approval 
 
All experiments were performed in accordance with the European Community 
Council Directive of November 24, 1986 (86/609EEC) and were approved by the 
local authority veterinary service and by SISSA ethical committee. All efforts 
were made to minimize animal suffering and to reduce the number of animal 
used. 
 
Animals.  
 
NL3R451C mice (Tabuchi et al., 2007) were purchased from Jackson Laboratories 
(Maine, USA). Experiments were performed on off-spring male derived from 
heterozygous mating. Electrophysiological experiments were performed and 
analyzed blind before genotyping. This was carried out on tail biopsy DNA by 
PCR using a standard protocol. At least three mice for each genotype were used 
in a given experiment.   
Neuronal and Cell Cultures 
Primary cell cultures were prepared as described previously (Andjus et al., 
1997). Briefly, 2–4-day-old (P2–P4) Wistar rats were decapitated after being 
anesthetized with an intraperitoneal injection of urethane (2 mg/kg). 
Hippocampi were dissected free, sliced, and digested with trypsin, mechanically 
triturated, centrifuged twice at 40 × g, plated in Petri dishes, and cultured for up 
to 14 days. Experiments were performed on cells cultured for at least 7 days. For 
paired recording experiments, neurons were plated at low density (∼40,000 
cells/ml). HEK-293 cells were maintained in DMEM supplemented with 10% 
fetal calf serum, penicillin (100 units/ml), and streptomycin (100 mg/ml) and 
transiently transfected with various plasmid constructs using the standard 
calcium phosphate method. Cells were collected 24–48 h after transfection.  
Construction of Plasmid Vectors, scFv-Gephyrin 
Complementary DNAs encoding full-length FLAG-tagged gephyrin have been 
described previously (Zita et al., 2007). The N-terminal truncated gephyrin 
polypeptide (amino acids 2–188) fused to GFP is described by Maas et al. (Maas 
et al., 2006). It acts as a dominant negative protein due to its lack of dimerization 
motif and is able to deplete endogenous gephyrin clusters in neurites within 24 h 
of expression. The murine HA-tagged NLG1 and HA-tagged NLG2 were 
constructed as reported elsewhere (Scheiffele et al., 2006; Chih et al., 2006) HA-
tagged NLG2Y770A point mutant was kindly provided by Dr. Varoqueaux 
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(Poulopoulos A., 2009). NLG2-GFP was constructed by using PCR-based 
mutagenesis. A PvuI restriction site was introduced 10 amino acids downstream 
of the sequence encoding for the transmembrane domain of NLG2-HA. This 
restriction site was then used to clone the EGFP coding sequence amplified using 
oligonucleotides containing PvuI consensus sites. The last 94 amino acids of the 
cytoplasmic domains of both NLGs were inserted into pGEX4T1 vector for 
bacterial expressions as glutathione S-transferase (GST)-NLGs 94-amino acid 
fusion proteins. All PCR-amplified products were fully sequenced to exclude the 
possibility of second site mutations. The technique for isolating scFv-gephyrin 
has already been reported (Zacchi et al., 2008).  
Neuronal Transfection and Immunocytochemistry 
Hippocampal neurons in culture were transfected with EGFP alone or co-
transfected with EGFP and scFv-gephyrin using the calcium phosphate 
transfection method. For each Petri dish, 3 μg of DNA was transfected in total. 
Reliable co-transfection was ensured by routinely transfecting 0.9 μg of EGFP 
and 2.1 μg of scFv-gephyrin and identified by the increased EGFP signal around 
the nucleus. For the rescue experiments, scFv-gephyrin and the full-length HA-
tagged NLG2 (NLG2-HA), NLG2Y770A (NLG2Y770A-HA), and NLG1 (NLG1-HA) 
were co-transfected at a ratio of 1:2. Neurons were transfected at 7 days in vitro 
and used for immunostaining 48 h later. All steps were carried out at room 
temperature. After fixation with 4% paraformaldehyde in PBS for 10 min, 
neurons were quenched in 0.1 m glycine in PBS for 5 min and permeabilized 
with 0.1% Triton X-100 in PBS for 2 min. For the rescue experiments, cells were 
fixed with precooled 4% paraformaldehyde in PBS for 5 min at 4 °C then 5 min at 
room temperature. They were then blocked in 0.2% BSA/1% FCS or 10% FCS in 
PBS for 30 min. After incubation with primary antibodies for 1 h, cells were 
incubated with Alexa Fluorophore-conjugated secondary antibodies (1:400) for 
45 min. In the case of double-immunostaining, cells were incubated with 
biotinylated secondary antibodies (1:100, 45 min) followed by streptavidin-
conjugated fluorophores (1:100, 30 min). The coverslips were washed in PBS, 
rinsed in water, and mounted with VectaShield (Vector Laboratories).  
The antibodies used were as follows: mouse monoclonal anti-VGAT (1:200, 
Synaptic Systems), mouse monoclonal anti-VGLUT1 (1:200, Synaptic Systems), 
rabbit polyclonal anti-NGL2 (1:200, Synaptic Systems), biotinylated goat anti-
mouse IgG (Vector Laboratories). All secondary antibodies were obtained from 
Invitrogen.  
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In Vitro Binding, Immunoprecipitation, and Western Blot Analysis 
Transfections were performed with the calcium phosphate method. GST 
pulldown assays were performed as described previously (Zita et al., 2007). For 
NLGs and gephyrin co-immunoprecipitation, HEK 293 cells overexpressing 
NLG1-HA/NLG2-HA and gephyrin-FLAG were lysed in 50 mm Tris-HCl, pH 7.5, 
100 mm NaCl, 0.1% Tween 20, 10% glycerol, 10 mm EDTA, 2 mm MgCl2, and 
protease inhibitor mixture and immunoprecipitated by the anti-FLAG antibody. 
Analysis of NLG1/NLG2-gephyrin interactions was performed on postnuclear 
homogenates from neonatal rat brains using the following lysis buffer: 50 mm-
Tris HCl, pH 7.5, 150 mm NaCl, 0.5% CHAPS, 1 mm EDTA, 10% glycerol, and 
protease inhibitor mixture. After a 2-h incubation with monoclonal anti-gephyrin 
antibody, an immunoprecipitation experiment was performed according to 
standard procedures. Primary antibodies were revealed by HRP-conjugated 
secondary antibodies (Sigma) followed by ECL (Amersham Biosciences). The 
following primary antibodies were used: mouse monoclonal anti-FLAG M2 
(Sigma), mouse monoclonal anti-gephyrin 3B11 (Synaptic Systems), high affinity 
rat monoclonal anti-HA 3F10 (Roche), rabbit polyclonal anti-NLG2 (Synaptic 
Systems), and rabbit polyclonal anti-NL1 (Synaptic Systems).  
Confocal Microscopy and Image Analysis 
Fluorescence images were acquired on a TCS-SP confocal laser scanning 
microscope (Leica, Bensheim, Germany) with a 40× 1.4 NA oil immersion 
objective, additionally magnified 2-fold with the pinhole set at 1 Airy unit. Stacks 
of z-sections with an interval of 0.4 μm were sequentially scanned twice for each 
emission line to improve the signal/noise ratio. Cluster analysis was carried out 
using MetaMorph Imaging System (Universal Imaging, Westchester, PA). First a 
binary template was created using the EGFP staining to identify transfected 
neurons, then cluster intensities in regions overlapping with the binary template 
were analyzed. Images were segmented to select immunofluorescent puncta 
over background labeling, and clusters were defined as >3 pixels as determined 
by visual inspection. Integrated Morphometry Analysis function of MetaMorph 
was used to quantify the number and size of clusters (four or five cells from at 
least four different experiments). For the rescue experiments, NLG2 staining was 
used to create the binary template for the NL2-HA/scFv-gephyrin and 
NL2Y770A-HA/scFv-gephyrin co-transfected cells. As excessive NLG2-HA 
expression masks the rescuing effect and results in an overall increase in 
synaptic staining (similar to NL2-HA overexpression alone), cells with a 
moderate amount of NL2-HA/NL2Y770A-HA expression (as identified by the 
unsaturated NL2 fluorescence signal) was selected for the analysis of the rescue 
effect. Representative figures were prepared using ImageJ software.  
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Electrophysiological recordings from hippocampal neurons in culture 
Spontaneous excitatory and inhibitory postsynaptic currents (EPSCs and IPSCs) 
were recorded at 9 days in vitro from cultured hippocampal neurons 
(transfected at 7 days in vitro with different constructs) at 22–24 °C using a 
Multiclamp 700A amplifier (Axon Instruments, Foster City, CA). In the case of 
transfected cells, mIPSCs or mEPSCs were recorded from single transfected cells 
surrounded by nontransfected ones. Patched cells were identified as putative 
principal cells on the basis of their passive membrane properties (Vrest and Rinput) 
which were similar to those described in identified pyramidal neurons in culture 
at the same days in vitro (Yang et al., 1993). No differences were found in these 
parameters between control and transfected neurons. Pooled data gave a mean 
Vrest value of −51 ± 1 mV and a mean Rinput value of 610 ± 43 MΩ (n = 47). Patch 
electrodes pulled from borosilicate glass capillaries (Hilgenberg, Malsfeld, 
Germany) had a resistance of 3–4 MΩ when filled with an intracellular solution 
containing 137 mM CsCl, 1 mM CaCl2, 2 mM MgCl2, 11 mMBAPTA, 2 mM ATP, and 
10 mM HEPES (the pH was adjusted to 7.3–7.4 with CsOH). IPSCs were recorded 
at a holding potential of −70 mV in the presence of 20 μM 6,7-dinitroquinoxaline-
2,3-dione (DNQX) and 50 μM d-2-amino-5-phosphonopentanoic acid (d-AP5) to 
block AMPA and NMDA receptors, respectively. EPSCs were recorded in the 
presence of 10 μm bicuculline and 50 μM d-AP5 to block GABAA and NMDA 
receptors, respectively. Miniature PSCs were recorded in the presence of 
tetrodotoxin (TTX, 1 μM) to block sodium currents and propagated action 
potentials and the respective GABAA or AMPA/NMDA receptor antagonists.  
For double patch recordings, pairs of action potentials (at 50-ms interval) were 
evoked in non transfected presynaptic neurons (in current clamp mode) by 
injecting depolarizing current pulses at a frequency of 0.1 Hz. IPSCs were 
detected from postsynaptic transfected (scFv-gephyrin) and non transfected 
(controls) neurons in voltage clamp mode at a holding potential of 0 mV (near 
the reversal potential for glutamate). In this case, the intracellular solutions 
contained 135 mM KMeSO4, 10 mM KCl, 10 mM HEPES, 1 mM MgCl2, 2 mM 
Na2ATP, and 0.4 mM Na2GTP (the pH was adjusted to 7.3 with KOH). It is worth 
noting that the probability of finding interconnected cells was 10–20%. Only 
∼6% of all neurons in a culture dish are GABAergic, and usually these cells are 
morphologically distinguishable (Benson et al., 1996). In all experiments, the 
cells were perfused with an external solution containing 137 mM NaCl, 5 mM 
KCl, 2 mM CaCl2, 1 mM MgCl2, 20 mM glucose, and 10 mM HEPES, pH 7.4, with 
NaOH. Data were sampled at 10 kHz and low pass-filtered at 3 kHz. The stability 
of the patch was checked by repetitively monitoring the input and series 
resistances during the experiments. Cells exhibiting 15–20% changes were 
excluded from the analysis. The series resistance was 10–15 MΩ. All drugs 
(except TTX, which was purchased from Latoxan, Valence, France) were obtained 
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from Tocris (Cookson Ltd., Bristol, UK). All drugs were dissolved in external 
solution, except DNQX, which was dissolved in dimethyl sulfoxide. The final 
concentration of dimethyl sulfoxide in the bathing solution was 0.1%. At this 
concentration, dimethyl sulfoxide alone did not modify the shape or the kinetics 
of synaptic currents. 
Hippocampal slice preparation. 
Transverse hippocampal slices (300 µM) were obtained from neonatal (postnatal 
day 4-9) young (postnatal day 11–15) and adult (postnatal day 27-35) mice 
using a standard protocol (Griguoli et al., 2010). Briefly, after being anesthetized 
with CO2, animals were decapitated. The brain was quickly removed from the 
skull and placed in ice-cold artificial cerebrospinal fluid (ACSF) containing (in 
mM): 130 NaCl, 25 glucose, 3.5 KCl, 1.2 NaH2PO4, 25 NaHCO3, 2 CaCl2, and 1.3 
MgCl2, saturated with 95% O2 and 5% CO2 (pH 7.3–7.4). Transverse 
hippocampal slices were cut with a vibratome and stored at room temperature 
(22–24°C) in a holding bath containing the same solution as above. After 
incubation for at least 45 min, an individual slice was transferred to a submerged 
recording chamber and continuously superfused at 33–34°C with oxygenated 
ACSF at a rate of 3–4 ml/min. 
 
Electrophysiological recordings in hippocampal slices. 
Recordings were made with a patch-clamp amplifier (Axopatch 1D amplifier, 
Molecular Devices) from CA3 pyramidal cells visualized with an upright 
microscope equipped with differential interference contrast optics and infrared 
video camera, using the whole cell configuration of the patch-clamp technique. 
Patch electrodes were pulled from borosilicate glass capillaries (Hingelberg, 
Malsfeld, Germany); when filled with an intracellular solution they had a 
resistance of 4-6 MΩ. The stability of the patch was checked by repetitively 
monitoring the input and series resistance during the experiments. Cells 
exhibiting changes of 15 % were excluded from the analysis. The series 
resistance was < 25 MΩ. 
Spontaneous glutamatergic and GABAergic postsynaptic currents were routinely 
recorded from a holding potential of -65, -70 mV in the presence of bicuculline 
(10 µM) and DNQX (20 µM), respectively. Miniature currents were recorded in 
the presence of TTX (1µM) to block sodium currents and propagated action 
potentials. For glutamatergic currents we used an intracellular solution 
containing (in mM):  125 Cs-methanesulphonate, 10 CsCl, 10 HEPES, 0.3 EGTA, 2 
MgATP, 0.3 NaGTP, (pH adjusted to ~ 7.3 with CsOH). For GABAergic currents 
we used an intracellular solution containing (in mM): CsCl 137, Hepes 10, BAPTA 
11, MgATP 2, MgCl2 2, CaCl2 1 and 5 QX-314 (pH adjusted to ~ 7.2-7.3 with 
CsOH).  
Concentric bipolar electrodes were used to stimulate granule cells in the dentate 
gyrus in order to elicit mossy fiber-excitatory postsynaptic currents (MF-EPSCs) 
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in CA3 pyramidal neurons (frequency of stimulation: 0.1 Hz; stimulus duration 
100-200 µs). Stimulus strength was adjusted to obtain at −65 mV stable 2-amino-
3-(5-methyl-3-oxo-1,2-oxazol-4-yl) propanoic acid (AMPA)-mediated responses 
of ~100 pA. The NMDA component was recorded from the same neuron at +40 
mV, using the same stimulus strength, after blocking the AMPA-mediated 
component with DNQX (20 µM).  
In some experiments, extracellular field potentials were recorded using 
conventional glass microelectrodes (tip diameter 5–10 μM) filled with ACSF and 
placed into the stratum pyramidale of the CA3 area.  
 
Data Analysis 
The analysis of spontaneous events was performed with Clampfit 10.1 software 
(Axon Instruments, Foster City, CA). This program uses a detection algorithm 
based on a sliding template. The template did not induce any bias in the sampling 
of events because it was moved along the data trace one point at a time and was 
optimally scaled to fit the data at each position. The detection criterion was 
calculated from the template-scaling factor and from how closely the scaled 
template fitted the data.  
For evoked IPSCs, transmission failures were identified visually. Mean IPSC 
amplitude was obtained by averaging successes and failures. The paired-pulse 
ratio (PPR), known to be inversely correlated to the initial release probability 
(Dobrunz and Stevens 1997), was calculated as the ratio between the mean 
amplitudes of IPSC2 over IPSC1. The coefficient of variation (CV−2) was 
calculated as the square root of the ratio between the standard deviation of 
IPSC1 and the mean amplitude of IPSC1 (Korn and Faber, 1991). 
The amplitude of the tonic current was estimated by the outward shift of the 
baseline current after the application of the GABAA receptor channel blocker 
picrotoxin (100 μM). Only current recordings that exhibited a stable baseline 
were included in the analysis. Baseline currents and their standard deviations 
were estimated by plotting 10 s periods of raw data in all point histograms. 
These were fitted with a Gaussian function. The peak of the fitted Gaussian was 
considered as the mean holding current (Glykys & Mody, 2007). 
NMDA/AMPA ratio was measured by averaging 15 to 30 sweeps for each holding 
potential. The AMPA-mediated component was measured at the peak of the 
current obtained at – 65 mV, while the  NMDA component was measured at the 
peak of the current obtained at +40 mV after blocking the AMPA component with 
DNQX. The weighted decay time constant for NMDA-mediated synaptic current 
was measured by dividing the area by its amplitude, independently of the fitting 
(Cathala et al., 2003). 
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Peak scaled non-stationary noise analysis was performed according to Traynelis 
et al., (1993) using the Mini Analysis program (version 6.0.1, Synaptosoft, Leonia, 
NJ). Miniature events were selected following the procedure described by 
Momiyama et al. (2003). Briefly, individual miniature events were analyzed by 
measuring the peak amplitude, the 10–90% rise time and the decay time 
constant. Measured parameters were then numbered according to the event 
number and tested by Spearman's rank order correlation test for time stability. 
After testing for correlation between rise time and amplitude and between rise 
time and decay time, miniature GABAergic events were used for noise analysis. 
Individual miniature events were aligned to the point of steepest rise time. The 
peak of the mean current response waveform was scaled to the response value at 
the corresponding point in time of each individual event before subtraction to 
generate the difference waveforms. The ensemble mean post synaptic current 
was binned into 50 bins of equal amplitude to assign similar weights to all 
phases of ensemble mean waveform. Variance was plotted against amplitude and 
individual points were fitted with the equation:  
σ2(I) = iI-I2/N + σb2  (1) 
where i is the unitary single-channel current, I is the mean current, N is the 
number of  channels open at the current peak and σb2 is the variance of the 
background noise. The single-channel chord conductance (ϒ) was calculated as:  
ϒ= i/(Em-Erev)  (2) 
 
from  the holding potential (Em) of −70 mV, assuming a reversal potential (Erev) of 
0 mV. 
 
Statistical analysis 
All values are presented as mean ± SEM of n experiments. Statistical comparison 
was performed using unpaired t-test or one-way analysis of variance (ANOVA). 
Probability distributions were examined using the Kolmogorov–Smirnov test. A 
p value < 0.05 was considered as statistically significant.  
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Gephyrin is a scaffold protein essential for stabilizing glycine
and GABAA receptors at inhibitory synapses. Here, recombi-
nant intrabodies against gephyrin (scFv-gephyrin) were used to
assess whether this protein exerts a transynaptic action on
GABA and glutamate release. Pair recordings from intercon-
nected hippocampal cells in culture revealed a reduced proba-
bility of GABA release in scFv-gephyrin-transfected neurons
compared with controls. This effect was associated with a
significant decrease in VGAT, the vesicular GABA transporter,
and in neuroligin 2 (NLG2), a protein that, interacting with
neurexins, ensures the cross-talk between the post- and presyn-
aptic sites. Interestingly, hampering gephyrin function also
produced a significant reduction in VGLUT, the vesicular glu-
tamate transporter, an effect accompanied by a significant
decrease in frequency of miniature excitatory postsynaptic cur-
rents. Overexpressing NLG2 in gephyrin-deprived neurons res-
cued GABAergic but not glutamatergic innervation, suggesting
that the observed changes in the latter were not due to a homeo-
static compensatory mechanism. Pulldown experiments dem-
onstrated that gephyrin interacts not only with NLG2 but also
with NLG1, the isoform enriched at excitatory synapses. These
results suggest a key role of gephyrin in regulating transynaptic
signaling at both inhibitory and excitatory synapses.
Speed and reliability of synaptic transmission are essential
for information coding and require the presence of clustered
neurotransmitter receptors at the plasmamembrane in precise
apposition to presynaptic release sites. The postsynaptic orga-
nization comprises a large number of proteins that ensure the
correct targeting, clustering, and stabilization of neurotrans-
mitter receptors. Among them, the tubulin-binding protein
gephyrin plays a crucial role in the functional organization of
inhibitory synapses (1). Through its self-oligomerizing proper-
ties, gephyrin can form a hexagonal lattice that traps glycine (2)
andGABAA receptors in the right place at postsynaptic sites (3,
4) by linking them to the cytoskeleton. Disruption of endoge-
nous gephyrin leads to reducedGABAA receptor clusters (3), an
effect that has been shown to be accompanied by a loss of
GABAergic innervation (5, 6). This observation suggests the
existence of cross-talk between the post- and presynaptic sites.
The retrograde control of presynaptic signaling may occur via
neuroligins (NLGs),3 postsynaptic cell adhesion molecules
known to transynaptically interact with presynaptic neurexins (7).
NLG1 is enriched at glutamatergic synapses (8, 9), whereas
NLG2 is preferentially associated withGABAergic connections
(10). Overexpression of NLGs has been shown to increase the
number of GABAergic and glutamatergic synaptic contacts
(11). Interestingly, increasing the expression level of PSD-95,
the scaffold molecule that directly binds NLG1, caused an
enhancement of the glutamatergic innervation at the expense
of the GABAergic one. This effect was accompanied by the
recruitment of NLG2 to glutamatergic synapses (11–13).
Moreover, the recent demonstration of a direct interaction
betweenNLG2and gephyrin (14) suggests a role for this protein
in regulating transynaptic signaling at inhibitory connections.
Altogether, these findings have led to the hypothesis that
scaffolding molecules can establish and maintain the proper
excitatory (E)/inhibitory (I) balance necessary for the correct
functioning of neuronal networks, by modulating neuroligin
localization and function at particular synapses (15–17).
Understanding the molecular mechanisms involved in the
maintenance of a proper E/I balance is a challenge as an alter-
ation of this parameter underlies several devastating forms of
neurological diseases including autism spectrum disorders
(18). Previous studies on cultured hippocampal neurons have
demonstrated that removal of gephyrin with single chain anti-
body fragments (scFv-gephyrin) (19) produces changes in the
gating properties of GABAA receptors associated with a
decrease in GABAergic innervation (6).
In the present study, scFv-gephyrin fragments were used to
characterize further the transynaptic contribution of gephyrin
to maintaining and stabilizing GABAergic synapses. Double
patch experiments from monosynaptically connected cells
revealed a reduction in the probability ofGABA release to scFv-
* This work was supported by a grant fromMinistero Istruzione, Universita` e
Ricerca (MIUR) (to E. C.).
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gephyrin-transfected cells. Moreover, transfection with scFv-
gephyrin affected not only GABA but also glutamate release as
demonstrated by the reduction in frequency of spontaneous
and miniature glutamatergic synaptic events. Immunocyto-
chemical data revealed a significant reduction in the number of
NLG2 clusters together with a decrease of VGAT and VGLUT,
the vesicular GABA and glutamate transporters, respectively.
Finally, biochemical experiments demonstrated that gephyrin
can form a complex not only with NLG2 but also with NLG1 in
the brain, suggesting a role of this scaffold protein in regulating
both excitatory and inhibitory synaptic transmission.
EXPERIMENTAL PROCEDURES
Neuronal and Cell Cultures—All experiments were carried
out in accordance with the European Community Council
Directive of 24 November 1986 (86/609 EEC) and were
approved by the local authority veterinary service. Primary cell
cultures were prepared as described previously (20). Briefly,
2–4-day-old (P2–P4) Wistar rats were decapitated after being
anesthetized with an intraperitoneal injection of urethane (2
mg/kg). Hippocampi were dissected free, sliced, and digested
with trypsin, mechanically triturated, centrifuged twice at 40
g, plated in Petri dishes, and cultured for up to 14 days. Exper-
iments were performed on cells cultured for at least 7 days. For
paired recording experiments, neurons were plated at low den-
sity (40,000 cells/ml).
HEK-293 cells were maintained in DMEM supplemented
with 10% fetal calf serum, penicillin (100 units/ml), and strep-
tomycin (100 mg/ml) and transiently transfected with various
plasmid constructs using the standard calcium phosphate
method. Cells were collected 24–48 h after transfection.
Construction of Plasmid Vectors, scFv-Gephyrin—Comple-
mentary DNAs encoding full-length FLAG-tagged gephyrin
have been described previously (21). The N-terminal truncated
gephyrin polypeptide (amino acids 2–188) fused to GFP is
described by Maas et al. (22). It acts as a dominant negative
protein due to its lack of dimerization motif and is able to
deplete endogenous gephyrin clusters in neurites within 24 h of
expression. The murine HA-tagged NLG1 and HA-tagged
NLG2 were constructed as reported elsewhere (23, 24). HA-
tagged NLG2Y770A point mutant was kindly provided by Dr.
Varoqueaux (14). NLG2-GFP was constructed by using PCR-
based mutagenesis. A PvuI restriction site was introduced 10
amino acids downstream of the sequence encoding for the
transmembrane domain of NLG2-HA. This restriction site was
then used to clone the EGFP coding sequence amplified using
oligonucleotides containing PvuI consensus sites.
The last 94 amino acids of the cytoplasmic domains of both
NLGs were inserted into pGEX4T1 vector for bacterial expres-
sions as glutathione S-transferase (GST)-NLGs 94-amino acid
fusion proteins. All PCR-amplified products were fully
sequenced to exclude the possibility of second site mutations.
The technique for isolating scFv-gephyrin has already been
reported (19).
Neuronal Transfection and Immunocytochemistry—Hip-
pocampal neurons in culture were transfectedwith EGFP alone
or co-transfected with EGFP and scFv-gephyrin using the cal-
cium phosphate transfection method. For each Petri dish, 3 g
of DNAwas transfected in total. Reliable co-transfection was
ensured by routinely transfecting 0.9 g of EGFP and 2.1 g
of scFv-gephyrin and identified by the increased EGFP signal
around the nucleus. For the rescue experiments, scFv-
gephyrin and the full-length HA-tagged NLG2 (NLG2-HA),
NLG2Y770A (NLG2Y770A-HA), and NLG1 (NLG1-HA)
were co-transfected at a ratio of 1:2.
Neurons were transfected at 7 days in vitro and used for
immunostaining 48 h later. All steps were carried out at room
temperature. After fixation with 4% paraformaldehyde in PBS
for 10min, neurons were quenched in 0.1 M glycine in PBS for 5
min and permeabilized with 0.1% Triton X-100 in PBS for 2
min. For the rescue experiments, cells were fixed with pre-
cooled 4%paraformaldehyde in PBS for 5min at 4 °C then 5min
at room temperature. They were then blocked in 0.2% BSA/1%
FCS or 10% FCS in PBS for 30 min. After incubation with pri-
mary antibodies for 1 h, cells were incubated with Alexa Fluo-
rophore-conjugated secondary antibodies (1:400) for 45min. In
the case of double-immunostaining, cells were incubated with
biotinylated secondary antibodies (1:100, 45 min) followed by
streptavidin-conjugated fluorophores (1:100, 30min). The cov-
erslips were washed in PBS, rinsed in water, and mounted with
VectaShield (Vector Laboratories).
The antibodies used were as follows: mouse monoclonal
anti-VGAT (1:200, Synaptic Systems), mousemonoclonal anti-
VGLUT1 (1:200, Synaptic Systems), rabbit polyclonal anti-
NGL2 (1:200, Synaptic Systems), biotinylated goat anti-mouse
IgG (Vector Laboratories). All secondary antibodies were
obtained from Invitrogen.
In Vitro Binding, Immunoprecipitation, and Western Blot
Analysis—Transfections were performed with the calcium
phosphate method. GST pulldown assays were performed as
described previously (21). For NLGs and gephyrin co-immuno-
precipitation, HEK 293 cells overexpressing NLG1-HA/
NLG2-HA and gephyrin-FLAG were lysed in 50 mM Tris-HCl,
pH 7.5, 100 mM NaCl, 0.1% Tween 20, 10% glycerol, 10 mM
EDTA, 2mMMgCl2, and protease inhibitormixture and immu-
noprecipitated by the anti-FLAG antibody. Analysis of NLG1/
NLG2-gephyrin interactions was performed on postnuclear
homogenates from neonatal rat brains using the following lysis
buffer: 50 mM-Tris HCl, pH 7.5, 150 mM NaCl, 0.5% CHAPS, 1
mM EDTA, 10% glycerol, and protease inhibitor mixture. After
a 2-h incubation with monoclonal anti-gephyrin antibody, an
immunoprecipitation experiment was performed according to
standard procedures. Primary antibodies were revealed by
HRP-conjugated secondary antibodies (Sigma) followed by
ECL (Amersham Biosciences). The following primary antibod-
ies were used: mouse monoclonal anti-FLAG M2 (Sigma),
mouse monoclonal anti-gephyrin 3B11 (Synaptic Systems),
high affinity ratmonoclonal anti-HA3F10 (Roche), rabbit poly-
clonal anti-NLG2 (Synaptic Systems), and rabbit polyclonal
anti-NLG1 (Synaptic Systems).
Confocal Microscopy and Image Analysis—Fluorescence
images were acquired on a TCS-SP confocal laser scanning
microscope (Leica, Bensheim, Germany) with a 40 1.4 NA oil
immersion objective, additionally magnified 2-fold with the
pinhole set at 1Airy unit. Stacks of z-sectionswith an interval of
0.4 m were sequentially scanned twice for each emission line
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to improve the signal/noise ratio. Cluster analysis was carried
out using MetaMorph Imaging System (Universal Imaging,
Westchester, PA). First a binary template was created using the
EGFP staining to identify transfected neurons, then cluster
intensities in regions overlappingwith the binary templatewere
analyzed. Images were segmented to select immunofluorescent
puncta over background labeling, and clusters were defined as
3 pixels as determined by visual inspection. Integrated Mor-
phometry Analysis function of MetaMorph was used to quan-
tify the number and size of clusters (four or five cells from at
least four different experiments). For the rescue experiments,
NLG2 staining was used to create the binary template for the
NLG2-HA/scFv-gephyrin and NLG2Y770A-HA/scFv-gephy-
rin co-transfected cells. As excessive NLG2-HA expression
masks the rescuing effect and results in an overall increase in
synaptic staining (similar to NLG2-HA overexpression alone),
cells with a moderate amount of NLG2-HA/NLG2Y770A-HA
expression (as identified by the unsaturatedNLG2 fluorescence
signal) was selected for the analysis of the rescue effect. Repre-
sentative figures were prepared using ImageJ software.
Electrophysiological Recordings—Spontaneous excitatory
and inhibitory postsynaptic currents (EPSCs and IPSCs) were
recorded at 9 days in vitro from cultured hippocampal neurons
(transfected at 7 days in vitro with different constructs) at
22–24 °C using a Multiclamp 700A amplifier (Axon Instru-
ments, Foster City, CA). In the case of transfected cells,mIPSCs
or mEPSCs were recorded from single transfected cells sur-
rounded by nontransfected ones. Patched cells were identified
as putative principal cells on the basis of their passive mem-
brane properties (Vrest and Rinput) which were similar to those
described in identified pyramidal neurons in culture at the
same days in vitro (25). No differences were found in these
parameters between control and transfected neurons. Pooled
data gave a mean Vrest value of51 1 mV and a mean Rinput
value of 610  43 megohms (n  47). Patch electrodes pulled
from borosilicate glass capillaries (Hilgenberg, Malsfeld, Ger-
many) had a resistance of 3–4 megohms when filled with an
intracellular solution containing 137 mM CsCl, 1 mM CaCl2, 2
mMMgCl2, 11 mM BAPTA, 2 mMATP, and 10 mMHEPES (the
pH was adjusted to 7.3–7.4 with CsOH). IPSCs were recorded
at a holding potential of 70 mV in the presence of 20 M
6,7-dinitroquinoxaline-2,3-dione (DNQX) and 50M d-2-ami-
no-5-phosphonopentanoic acid (D-AP5) to block AMPA and
NMDA receptors, respectively. EPSCs were recorded in the
presence of 10 M bicuculline and 50 M D-AP5 to block
GABAA and NMDA receptors, respectively. Miniature PSCs
were recorded in the presence of tetrodotoxin (TTX, 1 M) to
block sodium currents and propagated action potentials and
the respective GABAA or AMPA/NMDA receptor antagonists.
For double patch recordings, pairs of action potentials (at
50-ms interval) were evoked in nontransfected presynaptic
neurons (in current clampmode) by injecting depolarizing cur-
rent pulses at a frequency of 0.1 Hz. IPSCs were detected from
postsynaptic transfected (scFv-gephyrin) and nontransfected
(controls) neurons in voltage clampmode at a holding potential
of 0 mV (near the reversal potential for glutamate). In this case,
the intracellular solutions contained 135 mM KMeSO4, 10 mM
KCl, 10 mM HEPES, 1 mM MgCl2, 2 mM Na2ATP, and 0.4 mM
Na2GTP (the pH was adjusted to 7.3 with KOH). It is worth
noting that the probability of finding interconnected cells was
10–20%. Only6% of all neurons in a culture dish are GABAe-
rgic, and usually these cells aremorphologically distinguishable
(26). In all experiments, the cells were perfusedwith an external
solution containing 137mMNaCl, 5mMKCl, 2mMCaCl2, 1mM
MgCl2, 20mM glucose, and 10mMHEPES, pH 7.4, with NaOH.
Data were sampled at 10 kHz and low pass-filtered at 3 kHz.
The stability of the patch was checked by repetitively monitor-
ing the input and series resistances during the experiments.
Cells exhibiting 15–20% changes were excluded from the anal-
ysis. The series resistance was 10–15 megohms. All drugs
(except TTX, which was purchased from Latoxan, Valence,
France) were obtained fromTocris (Cookson Ltd., Bristol, UK).
All drugs were dissolved in external solution, except DNQX,
whichwas dissolved in dimethyl sulfoxide. The final concentra-
tion of dimethyl sulfoxide in the bathing solution was 0.1%. At
this concentration, dimethyl sulfoxide alone did notmodify the
shape or the kinetics of synaptic currents.
Data Analysis—The analysis of spontaneous events was per-
formed with Clampfit 10.1 software (Axon Instruments, Foster
City, CA). This program uses a detection algorithm based on a
sliding template. The template did not induce any bias in the
sampling of events because it was moved along the data trace
one point at a time and was optimally scaled to fit the data at
each position. The detection criterion was calculated from the
template-scaling factor and from how closely the scaled tem-
plate fitted the data.
For evoked IPSCs, transmission failures were identified visu-
ally.Mean IPSC amplitudewas obtained by averaging successes
and failures. The paired-pulse ratio (PPR), known to be
inversely correlated to the initial release probability (27), was
calculated as the ratio between the mean amplitudes of IPSC2
over IPSC1. The coefficient of variation (CV2) was calculated
as the square root of the ratio between the standard deviation of
IPSC1 and the mean amplitude of IPSC1 (28).
Values are given as mean  S.E. Unless otherwise stated,
significance of differences was assessed by Student’s t test. The
differences were considered significant when p 0.05.
RESULTS
Impairing Gephyrin Function with scFv-Gephyrin Reduces
the Probability of GABA Release—As recently reported (6),
transfecting cultured hippocampal neuronswith scFv-gephyrin
reduced the number of gephyrin and synaptic 2 subunit-con-
tainingGABAA receptor clusters. These effects were associated
with a severe impairment of both phasic and tonic GABAA
receptor-mediated inhibition. The mechanisms underlying
these effects relied on changes in GABAergic innervation as
suggested by the concomitant reduction in the number and size
of presynaptic VGAT clusters.
According to the quantal theory, the synaptic efficacy E, the
mean amplitude of unitary IPSCs, can be defined as E  mQ,
where m is the quantal content or mean number of quanta
released per presynaptic action potential and Q is the quantal
size or amplitude of the unitary IPSC (29). WhereasQ depends
on both pre- and postsynaptic mechanisms,m depends on pre-
synaptic factors, namely the number of release sites N and the
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probability of release (P). To see whether a decrease in quantal
content could account for the observed effects, simultaneous
recordingswere obtained frompairs of interconnected neurons
(the postsynaptic one expressing or not expressing scFv-gephy-
rin; see “Experimental Procedures”). As shown in Fig. 1, IPSCs
evoked in nontransfected cells by pairs of presynaptic action
potentials (50ms apart, delivered at a frequency of 0.1Hz, Con-
trol) were highly reliable and usually did not exhibit synaptic
failures. In contrast, with respect to control, IPSCs from scFv-
gephyrin-transfected cells (n 6) exhibited a significant reduc-
tion in amplitude (from 68.2  9.7 pA to 41.1  7.8 pA; p 
0.05, Mann-Whitney Rank test) and in successes rate (from
0.98 0.01 to 0.80 0.03; p 0.01, Mann-Whitney Rank test;
Fig. 1,A and B). These effects were associated with a significant
increase in the PPR (from 0.69 0.03 to 0.84 0.05; p 0.05;
Fig. 1C), which is considered an index of presynaptic release
probability (27, 28). Furthermore, the coefficient of variation
(CV2) was significantly increased (from0.37 0.007 to 0.61
0.05; p  0.01; Fig. 1C), indicating changes in quantal content
(28).
To assess further whether gephyrin depletion affects presyn-
aptic GABA release, as an additional approach we used 100 M
TPMPA, a weak competitive GABAA receptor antagonist that
has a very fast dissociation constant and competes with synap-
tically released GABA for the ligand binding site on GABAA
receptors (30, 31). The reduction of mIPSC amplitude by
TPMPA would therefore be influenced by relative changes in
synaptic GABA transient in the cleft (31). As shown in Fig. 2, in
scFv-gephyrin-transfected cells, the block of mIPSCs by
TPMPA was significantly (p  0.05) larger than controls
(30.4 1.3% versus 17.2 4.7%; n 6 for scFv-gephyrin and 7
for controls; p  0.5; Fig. 2, A and B), indicating that for scFv-
gephyrin-transfected cells, GABA concentration in the cleft
was lower than control.Overall, these data strongly suggest that
hampering gephyrin function with scFv-gephyrin reduces the
release of GABA from presynaptic terminals.
Gephyrin 2–188, a Dominant Negative Form of Gephyrin,
Mimics the Effect of scFv-Gephyrin on GABAergic Function—
To validate the results obtained with scFv-gephyrin, a trun-
cated gephyrin polypeptide comprising the N-terminal (amino
acids 2–188) of gephyrin fused with EGFP, known to act as a
dominant negative protein, was used (22). Due to the lack of
dimerization motif, this polypeptide interferes with the endog-
enous gephyrin lattice formation anddepletes gephyrin clusters
in neurites within 24 h of expression on cultured neurons.
Immunocytochemical experiments on hippocampal neurons
transfected with gephyrin 2–188 revealed a significant reduc-
tion in the number of VGAT clusters (without an effect on their
FIGURE 1.Hampering gephyrin function with scFv-gephyrin reduces the
probability ofGABA release.A, pair recordings obtained from two intercon-
nected neurons. The postsynaptic cell was transfected with scFv-gephyrin
(right). As control a neighboring nontransfected cell was used (left). Top traces
are pairs of actionpotentials evoked inpresynaptic cells at a 50-ms interval by
depolarizing current steps of variable amplitude every 10 s.Middle traces are
monosynaptic IPSCs (successes and failures) evoked at 0 mV (EGABA70mV)
by presynaptic action potentials. Bottom traces are averaged responses.
B, mean amplitude and successes rate obtained in monosynaptically con-
nected cells in control (white columns; n 7) and in scFv-transfected neurons
(black columns). C, PPR and CV2 of monosynaptically connected neurons
(n 6) recorded from control and scFv-transfected cells. *, p 0.05; **, p
0.01. Error bars, S.E.
FIGURE2.TheremovalofgephyrinwithscFv reducessynapticGABAtran-
sient in the cleft. A, representative traces of mIPSCs recorded at 70 mV
(dashed lines) from a control (left) and from a scFv-gephyrin-transfected cell
(right) in the absence (black) or in the presence of TPMPA 100 M (gray). In
both cases, mIPSC amplitudes are normalized to those obtained in pre-drug
conditions. Each trace is the average of 20–30 individual traces. B, each col-
umn representing the mean TPMPA-induced reduction in amplitude of
mIPSCs in control (white, n  7) and scFv-gephyrin-transfected cells (black,
n  6; *, p  0.05). Note the significantly larger TPMPA inhibition in trans-
fected cells. *, p 0.05. Error bars, S.E.
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size), indicating an effect on GABAergic innervation similar to
that observed for scFv-gephyrin (supplemental Fig. 1,A and B).
As with scFv-gephyrin, this effect was accompanied by a signif-
icant reduction in amplitude and frequency of spontaneous and
miniature IPSCs (in cells transfected with gephyrin 2–188 the
reduction in amplitude of sIPSCs andmIPSCs was 54 9% and
79 9% of controls, respectively; the reduction in frequency of
sIPSCs and mIPSCs was 32  7% and 37  1% of controls,
respectively; supplemental Fig. 1,C–E). These data further sup-
port the hypothesis that gephyrin not only regulates postsynap-
tic organization of synaptic GABAA receptors but also GABAe-
rgic innervation.
Gephyrin Removal Reduces theDensity and Size of Neuroligin
2 Clusters—How can gephyrin interfere with GABA release?
One possibility is that this protein interacts with cell adhesion
molecules such as neuroligins which, by binding neurexins,
ensure the cross-talk between the pre- and postsynaptic sites
(7). Of particular interest is NLG2, because this protein is
known to play a pivotal role in the organization of GABAergic
synapses (14). To verify whether disrupting gephyrin affects
NLG2 distribution, hippocampal neurons transfected with
scFv-gephyrin were immunostained for NLG2.
As shown in Fig. 3, A and B, scFv-gephyrin-transfected neu-
rons exhibited a significant reduction in the density of NLG2-
positive clusters compared with EGFP-transfected controls
(7.9 2.1 clusters/100m2 for scFv-gephyrin versus 27.2 4.8
clusters/100 m2 for EGFP; p  0.01; n  9). In addition, the
average size of these clusters was smaller for scFv-gephyrin-
than for EGFP-transfected neurons (4.9  0.2 m2 for scFv-
gephyrin versus 7.2 0.8m2 for EGFP; p 0.05;n 9).NLG2
did not relocalize to glutamatergic synapses because the synap-
tic fraction co-localized with VGLUT was barely detectable
(4.1 0.01% in control and 5.3 0.02% in scFv-gephyrin-trans-
fected cells, respectively; these values were not significantly dif-
ferent; p 0.05; data not shown).
Impairing Gephyrin Function with scFv-Gephyrin Reduces
Glutamatergic Innervation—The interaction of NLGs with
scaffolding proteins is crucial for ensuring the correct excitato-
ry/inhibitory balance, critical for the proper functioning of neu-
ronal networks. Therefore, the following experiments were
performed to assess whether disrupting gephyrin function with
scFv-gephyrin can affect not only GABAergic but also glutama-
tergic transmission.
To this aim, cultured hippocampal neurons transfected with
scFv-gephyrin were immunostained for VGLUT, a widely used
marker for presynaptic glutamatergic terminals (32). Com-
pared with controls (EGFP-transfected cells) in scFv-gephyrin-
transfected cells VGLUT-immunopositive clusters were signif-
FIGURE 3. scFv-gephyrin reduces the number and size of NLG2 andVGLUT clusters. A, neurons transfected (green) with EGFP (left) or EGFP/scFv-gephyrin
(right) and immunostained for NLG2 (red). Bottom panels are magnifications of thewhite boxesmarked on top. B, quantification of NLG2 clusters density (top)
and cluster size (bottom). C andD, as in A and B, but neurons were immunostained for the presynaptic glutamatergic marker VGLUT (red). Note the significant
reduction in the density and size of NLG2 and VGLUT clusters. *, p 0.05; **, p 0.01. Error bars, S.E.
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icantly reduced in density and size (Fig. 3, C and D). In
particular, the density of VGLUT clusters was reduced from
4.6  0.8 clusters/100 m2 in EGFP to 2.3  0.5 clusters/100
m2 in scFv-gephryin (p  0.05; n  12). The size of these
clusters was reduced from 9.3 0.5m2 to 7.5 0.6m2 (p
0.05). Furthermore, whole cell voltage clamp recordings per-
formed in the presence of bicuculline (10 M) and D-AP5 (50
M), to block GABAA and NMDA receptors, respectively,
revealed a significant reduction in frequency (but not in ampli-
tude) of spontaneous EPSCs (the frequency reached 40  8%;
p  0.05; n  12; the amplitude 95  13%; p  0.05; n  12)
recorded from scFv-gephyrin-transfected neurons compared
with controls (Fig. 4, A and C). Similarly, in scFv-gephyrin-
transfected cells, the frequency of miniature EPSCs recorded in
the presence of TTX was significantly reduced with respect to
controls (to 37 7%; p 0.05; from 0.78 0.14 Hz to 0.32
0.05 Hz; n  12) whereas the amplitude was unchanged (to
100 13%; p 0.05; from 34 6 pA to 34 5 pA; n 7; Fig.
4, B and C). Altogether, these results strongly support the
involvement of gephyrin in regulating not only GABAergic but
also glutamatergic synaptic transmission.
The Loss of GABAergic but Not Glutamatergic Innervation in
Gephyrin-deprived Neurons Can Be Rescued by Overexpressing
NLG2—To assess further the possibility that the reduced
GABAergic innervation in scFv-gephyrin-transfected cells is
mediated by NLG2 which may convey information in a retro-
grade way from post- to presynaptic sites, NLG2 was co-ex-
pressed with scFv-gephyrin. In immunocytochemical experi-
ments, co-expression of NLG2 with scFv-gephyrin induced a
significant increase in the density of VGAT-positive clusters
compared with cells transfected with scFv-gephyrin alone
(180  8%; from 10.6  0.7 clusters/100 m2 to 19.1  0.9
clusters/100 m2; p  0.01; n  11 and 8 for scFv and scFv/
NLG2, respectively), restoring VGAT cluster density to control
levels (Fig. 5, A and B). In line with previous studies (9), over-
expression of NLG2 alone led to a 2-fold increase in the density
of VGAT clusters compared with EGFP-transfected controls
(data not shown).
Parallel electrophysiological experiments from cultured neu-
rons revealed no changes in amplitude and frequency of spon-
taneousmIPSCs between cells co-transfectedwith scFv-gephy-
rin/NLG2 and controls (neighboring nontransfected cells). On
average, the frequency of mIPSCs was 0.211  0.040 Hz and
0.213 0.044 Hz (p 0.97) whereas the amplitude was55
4 pA and 53  6 pA (p  0.7) in control (n  7) and in
co-transfected neurons (n 8), respectively (Fig. 5B).
To see whether the observed rescue was gephyrin-depen-
dent, similar experiments were performed using the NLG2
mutant (NLG2Y770A-HA) which lacks gephyrin binding (14).
In this case, the number of VGAT-positive clusters/100 m2
was 19.8  1.7 (n  9), a value not significantly different from
that obtained with NLG2 (p 0.5; supplemental Fig. 2A).
In electrophysiological recordings, no changes in amplitude
or frequency of mIPSCs were detected between scFv-gephyrin/
NLG2Y770A-transfected cells and controls. The frequency of
mIPSCs was 0.22 0.07 Hz and 0.16 0.06 Hz in control (n
7) and in scFv-gephyrin/NLG2Y770A-transfected cells (n 6),
respectively (p  0.05; supplemental Fig. 2, B and C). The
amplitude of mIPSCs was 42  5 pA and 32  5 pA in the
absence or in the presence of scFv-gephyrin/NLG2Y770A,
respectively (supplemental Fig. 2, B and C).
Altogether, these experiments indicate that overexpres-
sion of NLG2 is able to rescue the loss of GABAergic inner-
vation induced by scFv-gephyrin. However, our data with
NLG2Y770A suggest that this effect only partially relies on
the direct recruitment of gephyrin by NLG2 at inhibitory
synapses (see “Discussion”).
It is possible that the observed reduction in glutamatergic
innervation following gephyrin depletion with scFv-gephyrin
represents a homeostatic compensatory mechanism to prevent
hyperexcitability and to maintain the right E/I balance within
the neuronal network (33). If this is the case, rescuing GABAe-
rgic innervation should lead to a concomitant change in gluta-
matergic transmission. However, this was not the case because
overexpressing NLG2 in gephyrin-depleted neurons failed to
restore VGLUT immunoreactive puncta (0.5  0.1 and 0.6 
0.1 clusters/100m2 for scFv and scFv/NLG2, respectively; p
0.5; Fig. 5C) as well as the frequency of mEPSCs to control
levels. The frequency ofmEPSCswas 0.64 0.16Hz and 0.26
FIGURE 4. scFv-gephyrin reduces the frequency but not the amplitude of
sEPSCs and mEPSCs. A, samples of spontaneous EPSCs recorded from con-
trols and scFv-gephyrin-transfected neurons at a holding potential of 70
mV in the presence of 10 M bicuculline and 50 M D-AP5. B, samples of
miniature EPSCs recorded from controls and scFv-gephyrin-transfected neu-
rons at a holding potential of 70 mV in the presence of 1 M TTX. C, each
column reprsents the reduction in amplitude (left) and in frequency (right) of
sIPSC (white) and mIPSCs (black) obtained from scFv-gephyrin-transfected
neurons (n  12) and expressed as percentage of controls (n  12; dashed
lines). *, p 0.05. Error bars, S.E.
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0.07 Hz in the absence or presence of NLG2 overexpression;
p 0.05; the amplitude of mEPSCs was 29 3 pA and 25 7
pA in the absence (n  8) or in the presence (n  9) of NLG2
overexpression (p 0.05; Fig. 5D).
However, the co-expression of NLG1 with scFv-gephyrin
was able to rescue the frequency of mEPSCs to control levels.
The frequency of mEPSCs was 0.55 0.35 Hz and 0.86 0.33
Hz in control (n  7) and in scFv-gephyrin/NLG1-transfected
cells (n  5), respectively (p  0.05; Fig. 6). No changes in
mEPSC amplitude were detected between control and scFv-
gephyrin/NLG1-transfected cells (27 6 pA in the absence and
17  8 pA in the presence of NLG1 overexpression; p  0.05;
Fig. 6). Overall, these data indicate that the observed NLG1-
induced rescue of glutamatergic function in gephyrin-deprived
neurons is at least partially dependent on gephyrin activity.
Gephyrin Interacts Directly with NLG1—It has been recently
reported that at inhibitory synaptic contacts gephyrin binds
NLG2 directly (14). The amino acid sequence identified as
gephyrin-binding motif on NLG2 is highly conserved in all
NLGs, and indeed gephyrin binds to all four NLGs in yeast
two-hybrid assays (14). To test whether gephyrin can form a
complex with NLG1 in mammalian cells, lysates of HEK-293
cells transfected with gephyrin-FLAG were subjected to a pull-
down assay with beads loaded with GST-NLG1 cytoplasmic
domain (NLG1CD), GST-NLG2CD, or with GST alone as a neg-
ative control. In agreement with previous observations (14),
NLG2CD was able to precipitate a consistent amount of gephy-
FIGURE 5. Co-expression of NLG2with scFv-gephyrin restores the loss of
GABAergic but not glutamatergic innervation. A, left, representative
images of neurons transfected with EGFP (top), scFv-gephyrin (middle) or co-
transfected with scFv-gephyrin and NLG2-HA (bottom). Dendrites were visu-
alized by EGFP signal or NLG2 staining (green). Neuronswere immunostained
for VGAT (red). Scale bars, 5m. Right, quantification of VGAT cluster densities
relative to the mean value obtained from EGFP-transfected neurons (dashed
line). **, p 0.01. C and D, as in A and B but for neurons immunostained for
VGLUT (red). Scale bars, 5 m. B, samples of spontaneous mIPSCs recorded
from cells co-transfected with scFv-gephyrin plus NLG2-HA and from
neighboring nontransfected cells (Control) at a holding potential of70 mV
in the presence of 1 M TTX, 20 M DNQX, and 50 M D-AP5. The columns
below the traces represent themean amplitude (left) and frequency (right) of
mIPSC from control (white; n  7) and from scFv-gephyrin-transfected cells
(gray;n 8).C, as inAbut for cells immunostained for VGLUT.D, as in Bbut for
mEPSCs. These were recorded from cells co-transfected with scFv-gephyrin
plus NLG2-HA (n  9) and from neighboring nontransfected cells (Control,
n 8) in the presence of 1 M TTX and 10 M bicuculline. Error bars, S.E.
FIGURE 6. Co-expression of NLG1 with scFv-gephyrin restores glutama-
tergic innervation. A, samples of spontaneous mIPSCs recorded from cells
co-transfected with scFv-gephyrin plus NLG1 and from neighboring non-
transfected cells (Control) at a holding potential of70mV in the presence of
1 M TTX and 10 M bicuculline are shown. B, each column represents the
mean amplitude (left) and frequency (right) ofmIPSC from control (white, n
7) and from scFv-gephyrin/NLG1-transfected cells (black, n 5).
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rin-FLAG (Fig. 7A, left). Interestingly, a small but significant
fraction of gephyrin-FLAG was also found in complex with
GST-NLG1CD (Fig. 7). Similar pulldown experiments were
then performed to assay the ability of endogenous gephyrin
present on neonatal rat brain homogenates to interact with
NLG1 and NLG2. Also in this case gephyrin was not only asso-
ciated with GST-NLG2CD fusion protein but also with GST-
NLG1CD (Fig. 7A, right). Here, the immunoblot analysis was
performed using a monoclonal antibody raised against the
C-terminal domain of gephyrin.
We then performed immunoprecipitation experiments to
investigate the presence of NLG1-HA/gephyrin-FLAG com-
plexes in vitro. HEK-293 cells were co-transfected with plas-
mids encoding for NLG1/2-HA and gephyrin-FLAG, orNLG1/
2-HA alone, and cell lysates were immunoprecipitated with the
anti-FLAG monoclonal antibody. The bound protein com-
plexes were analyzed by Western blotting using anti-HA and
anti-FLAG for NLG1 and gephyrin detection, respectively. As
shown in Fig. 7B (right), NLG1-HA was immunoprecipitated
only fromcells co-expressing gephyrin-FLAG.The same exper-
imental conditions were also applied to detect the expected
presence of NLG2-HA/gephyrin-FLAG complexes inmamma-
lian cells. Indeed, we found that a lower amount of gephyrin-
FLAG was able to precipitate a higher amount of NLG2-HA
compared with NLG1-HA, thus supporting previous in vitro
observations. Finally, endogenousNLG1 andNLG2were found
in native complexes with gephyrin upon co-immunoprecipita-
tion frommouse brain homogenates (Fig. 7C). These data sug-
gest that gephyrin, by interacting directly with NLG2 and to a
lesser extent with NLG1, may affect not only GABAergic but
also glutamatergic synaptic transmission.
DISCUSSION
The tubulin-binding protein gephyrin is a core protein of
inhibitory postsynaptic densities that interacts with the cyto-
skeleton to stabilize inhibitory receptors in precise apposition
to presynaptic active zones (1). In a previous study, we have
demonstrated that disrupting endogenous gephyrin with selec-
tive scFv-gephyrin altered the gating properties of GABAA
receptors, an effect that was found to be associated with modi-
fications of GABAergic innervation (6). In the present study we
hypothesized that hampering gephyrin function affects not
only the number of release sites (as suggested by the reduction
in VGAT clusters) but also the probability of GABA release. In
support of this view, in double patch experiments from inter-
connected neurons, we found that, with respect to controls,
scFv-gephyrin-expressing cells exhibited a significant decrease
in the amplitude of individual synaptic currents accompanied
by a clear increase in the number of transmitter failures and a
reduction in the PPR. Changes in transmitter failures and in
PPR are consistent with a decrease in release probability (27,
28). This would lead to a reduction in GABA concentration in
the synaptic cleft as suggested by the TPMPA experiments.
The role of gephyrin in ensuring a correct communication
between pre- and postsynaptic elements of synapses was fur-
ther validated by the experiments in which a truncated form of
gephyrin (gephyrin 2–188; 22) was used. This gephyrin mutant
lacks the dimerizationmotif, but it can still interactwith endog-
enous gephyrin molecules, producing dominant negative
effects on postsynaptic gephyrin clusters. Similar to scFv-
gephyrin, overexpression of gephyrin 2–188 caused a reduction
in GABAergic innervation and a decrease in frequency of spon-
taneous and miniature IPSCs, further confirming a key role of
gephyrin in maintaining the stability of GABAergic connec-
tions within the neuronal network. The ability of gephyrin to
influence presynaptic innervation was already suggested by Yu
et al., even though no mechanistic interpretation was provided
(5).
The presynaptic action of gephyrin on GABA release implies
the coordinated activity of other signalingmolecules that inter-
act directly or indirectly with gephyrin to ensure the corrected
cross-talk between the post- and presynaptic elements of the
synapse. Possible candidates are NLGs, specialized cell adhe-
sionmolecules that functionally couple the postsynaptic densi-
ties with the transmitter releasemachinery by forming transyn-
aptic complexes with their presynaptic binding partners,
neurexins (7). In particular, NLG2 is preferentially concen-
trated at inhibitory synapses (10) and binds gephyrin directly
through a conserved cytoplasmic domain (14). Consistent with
this finding, hampering gephyrin function with scFv-gephyrin
promoted a significant decrease in the total number and size of
NLG2 clusters upon scFv-induced gephyrin removal. It is inter-
esting to note that in a recent study (34), knocking down gephy-
rin with siRNA led to a shift of endogenous NLG2 from inhib-
itory to excitatory synapses, in the absence of any change in the
density of NLG2 clusters. In the present experiments instead
FIGURE 7. Gephyrin interacts with NLG2 and NLG1. A, GST-NLG1/2CD pull-
down assay using lysates of HEK-293 cells transfected with gephyrin-FLAG
(left) and rat brain lysates (right). B, lysates of HEK-293 cells transfected with
either NLG2-HA (left) or NLG1-HA (right) in the presence of gephyrin-FLAG or
with the vector alone (as anegative control) immunoprecipitatedwithmono-
clonal anti-FLAG antibodies. Immunoprecipitates were analyzed by Western
blotting using anti-HA and anti-FLAGmonoclonal antibodies. C, co-immuno-
precipitation experiments on rat brain lysates using a monoclonal anti-
gephyrin antibody and normal mouse serum (NMS) as negative control.
Immunoprecipitates were analyzed by Western blotting using a monoclonal
anti-gephyrin antibody and a polyclonal antibody against NLG2 and NLG1.
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we have observed a clear reduction in the density of NLG2
clusters without a detectable relocalization of this protein to
glutamatergic synapses. Because scFv-mediated removal of
gephyrin is associated with a significant reduction of synaptic
2-containing GABAA receptors (6) and evidence has been
provided for the reciprocal stabilization of NLG2 by GABAA
receptors (35), the reduction of NLG2 staining could be a con-
sequence of the loss of gephyrin-dependent GABAA receptor
clustering. We cannot exclude the possibility that scFv-gephy-
rin may affect the function of additional gephyrin-bound fac-
tors important for the efficient localization of NLG2 to and
from GABAergic terminals. Conventional kinesin (KIF5) and
the dynein motor complex have been shown to be involved in
microtubule-dependent transport of gephyrin, thus contribut-
ing to postsynaptic remodeling (22, 36). Because microtubule
motors transport and remodel a variety of transmembrane and
submembrane postsynaptic proteins (37, 38), similar mecha-
nisms may account for NLG2 transport.
The role ofNLG-neurexin complex as a coordinator between
postsynaptic and presynaptic sites has been investigated at
excitatory CA3-CA1 synapses in the hippocampus. This study
has revealed a retrograde modulation of neurotransmitter
release by PSD-95-NLG complex (39). The authors found that
overexpression of the glutamatergic scaffold protein PSD-95
enhanced release probability via a mechanism involving the
NLG-neurexin complex.
Along the same line, at GABAergic synapses, evidence has
been provided that knocking downNLG2 produces a reduction
in quantal content associated with a decrease in quantal size of
unitary responses (40). In agreement with our electrophysi-
ological data, these findings suggest a crucial role of gephyrin-
NLG2 interaction on GABA release.
In our experiments, the reduction in the probability ofGABA
release after scFv-gephyrin transfection seems to involve a
mechanism that only partially relies on the directNLG2-gephy-
rin interaction. Hence, the NLG2 point mutant, NLG2Y770A,
unable to bind gephyrinwas as effective as thewild-type protein
in rescuing GABAergic transmission in scFv-gephyrin-de-
prived neurons. Two possible hypotheses, which are not mutu-
ally exclusive, can be put forward to explain our results.
First, although the NLG2Y770A mutant is impaired in
gephyrin binding activity it still maintains the ability to induce
the activation of collybistin (14), a gephyrin partner known to
promote its synaptic targeting in vivo (14). Interestingly, in col-
lybistin knock-out mice, a reduction in frequency of mIPSCs
similar to that detected in the present experiments was
observed (41), thus suggesting a possible involvement of colly-
bistin in transynaptic signaling.
Second, NLGs form homomultimers through the extracellu-
lar acetylcholinesterase-homologous domain (42). Therefore, it
is possible that overexpressing NLG2Y770A in hippocampal
neurons containing endogenous NLG2 allows the formation of
multimers. As a consequence this mutant recruited at inhibi-
tory synapses would act in concert with endogenous NLG2 to
rescue GABAergic transmission.
Unexpectedly, hampering gephyrin function with scFv-
gephyrin produced a significant reduction not only of GABAe-
rgic but also of glutamatergic innervation as assessed by the
significant decrease in density of VGLUT-positive puncta asso-
ciated with a significant reduction in frequency, but not in
amplitude, of spontaneous andminiature glutamatergic events.
This effect was not due to a homeostatic plasticity mechanism
because overexpressing NLG2 in gephyrin-depleted neurons
failed to reestablish glutamatergic innervation. However, a res-
cue was obtained by co-expressing NLG1 with scFv-gephyrin.
Because the overexpression of NLG1 alone has been shown to
enhance glutamatergic innervation by severalfold (9) the fact
that this does not occur in gephyrin-deprived neurons suggests
that the scaffold protein contributes tomodulateNLG1-depen-
dent transynaptic signaling. In support of this observation, co-
immunoprecipitation experiments revealed the existence of
native complexes not only between gephyrin and NLG2 but
also with NLG1, which is localized primarily at excitatory syn-
apses (8), thus confirming and extending previous data
obtained with the yeast two-hybrid system (14). Moreover, in
favor of the possible involvement of gephyrin in regulating
transynaptic signaling at excitatory synapses is the observation
that, at least in immature hippocampal neurons in vitro (as
those used in the present study), this protein has been found
localized opposite to glutamatergic release sites (43, 44). The
presence of gephyrin at both GABAergic and glutamatergic
synapses may be relevant for neuronal development. Alto-
gether, these results show that gephyrin interacts, at least in
immature neurons, with bothNLG2 andNLG1 to regulate both
excitatory and inhibitory inputs converging on the same neu-
ron thus controlling the E/I balance at the network level.
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Key points summary 
 
• Autism spectrum disorders (ASDs) are often associated with single mutations of genes 
involved in synaptic organization, including those encoding for neuroligins which bridge 
the cleft and ensure the cross-talk between the pre and postsynaptic elements of the 
synapse.  
• Here, transgenic mice carrying the human R451C mutation of Nlgn3, have been used to 
investigate whether changes in synaptic signaling occur in the CA3 hippocampal region 
at early stages of postnatal development.  
• An enhancement of correlated network activity such as Giant Depolarizing Potentials, a 
hallmark of developmental networks, was observed at birth.  
• This depended on the increased GABAergic drive to CA3 principal cells, since it was 
associated with an enhanced frequency of miniature GABAergic (but not glutamatergic) 
synaptic currents.   
• An early alteration in the excitatory/inhibitory balance, thought to be crucial for the 
refinement of neuronal circuits, may account for the behavioral deficits observed in 
children with ASDs. 
 
Abstract  
Autism Spectrum Disorders (ASDs) comprise an heterogeneous group of neuro-developmental 
abnormalities, mainly of genetic origin, characterized by impaired social interactions, 
communications deficits and stereotyped behaviors. In a small percentage of cases, ASDs have 
been found to be associated with single mutations in genes involved in synaptic function. One of 
these involves the postsynaptic cell adhesion molecule neuroligin (NL) 3. NLs interact with 
presynaptic neurexins (Nrxs) to ensure a correct cross talk between post and presynaptic 
specializations. Here, transgenic mice carrying the human R451C mutation of Nlgn3, were used 
to study GABAergic signaling in the hippocampus early in postnatal life. Whole cell recordings 
from CA3 pyramidal neurons in slices from NL3 R451C knock-in mice revealed an enhanced 
frequency of Giant Depolarizing Potentials, as compared to controls. This effect was probably 
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dependent on an increased GABAergic drive to principal cells as demonstrated by the enhanced 
frequency of miniature GABAA-mediated (GPSCs), but not AMPA-mediated postsynaptic 
currents (EPSCs). Change in frequency were associated with an acceleration of mGPSCs decays 
possibly of postsynaptic origin. However, peak scaled non-stationary fluctuation analysis  did not 
reveal any change in unitary synaptic conductance or in the number of GABAA receptor 
channels. The increased frequency of mEPSCs detected  in adult NL3 R451C mice may represent a 
late form of compensatory homeostatic correction to counter the excessive GABAA-mediated 
inhibition. Therefore, it is reasonable to assume that alterations in the excitatory/inhibitory 
balance, crucial for the refinement of neuronal circuits early in postnatal development, accounts 
for the behavioral deficits observed in ASDs patients. 
 
Abbreviations  
ASD, Autism Spectrum Disorders; DNQX, 6,7-Dinitroquinoxaline-2,3-dione; EPSCs, excitatory 
postsynaptic currents; GDPs, Giant depolarizing Potentials; GPSCs, GABAA-mediated 
postsynaptic currents; KI, knock-in; KO, knock-out; K-S, Kolmogorov-Smirnov; MF, mossy 
fibers; NL, neuroligin; NO-711, 1-[2-[[(Diphenylmethylene)imino]oxy]ethyl]-1,2,5,6-tetrahydro-
3-pyridinecarboxylic acid hydrochloride hydrochloride; Nrx, neuroexin; P, postnatal; SR 95531, 
6-Imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic acid; TPMPA, (1,2,5,6-
Tetrahydropyridin-4-yl) methylphosphinic acid; TTX, tetrodotoxin; WT, wild type. 
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Introduction 
ASDs comprise a heterogeneous group of pathological conditions characterized by impaired 
social interactions, deficits in verbal and non verbal communication, limited interest in the 
surrounding environment associated with stereotyped and repetitive behavior (American 
Psychiatric Association, 2000). ASDs are among the most heritable neuro-developmental 
disorders with a high incidence in infancy and early childhood (Weintraub, 2011). It is believed 
that the genetic predisposition together with environmental factors contribute to alter normal 
brain development leading to an impaired connectivity between brain regions, ultimately 
weakening the specialized functions of cortical areas (Geschwind & Levitt, 2007). 
Interestingly, a small percentage of cases with idiopathic ASD have been found to be associated 
with single mutations in genes involved in synapses organization, pointing to synaptic 
dysfunction as one possible cause of autism (Südhof, 2008). Among these, mutations of genes 
encoding for cell adhesion molecules of the neuroligin (NL; Jamain et al., 2003; Laumonnier et 
al., 2004; Yan et al., 2005), neurexin (Nrx; Kim et al,.  2008) families or for SHANK3, a scaffold 
protein involved in the structural organization of dendritic spines and a binding partner of NLs 
(Durand et al., 2007), have received particular attention. Nrxs and NLs bridge the cleft thus 
providing the functional link between pre- and post-synaptic elements of the synapse.  Over-
expression of NLs in non-neuronal cells co-cultured with neurons induces structural 
differentiation of both excitatory and inhibitory presynaptic terminals in contacting axons 
(Scheiffele et al., 2000; Fu et al., 2003; Graf et al., 2004; Sara et al., 2005). Conversely, Nrxs 
trigger postsynaptic differentiation by aggregating NLs and neurotransmitter receptors on the 
dendritic surface (Graf et al., 2004). The bidirectional signaling through the NL-Nrx is crucial 
for synapse development and stabilization (Scheiffele et al., 2000; Varoqueaux et al., 2006; 
Chubykin et al., 2007; Poulopoulus et al., 2009; Ko et al., 2009).  
Interestingly, one missense mutation causing R451C substitution within a highly conserved 
region of the extracellular esterase-homology domain of the Nlgn3 gene was detected in two 
male siblings, one with autism, severe intellectual disabilities and seizures and the other with 
Asperger syndrome (Jamain et al., 2003). To gain insights into the possible mechanisms of ASD, 
this mutation has been introduced into the endogenous Nlgn3 in mice by gene targeting (Tabuchi 
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et al., 2007). Previous work from juvenile and adult NL3R451C knock-in mice have revealed 
deficits in social interaction, reminiscent of those found in ASD patients, associated with  
modifications in GABAergic (Tabuchi et al., 2007) and glutamatergic (Etherton et al., 2011) 
synaptic transmission. 
These studies however, did not address the question whether the R451C mutation of NL3 affects 
GABAergic signaling at early developmental stages when GABA exerts a critical role in synapse 
formation and stabilization (Pizzarelli & Cherubini, 2011). This information is important because 
developmental disorders such as ASDs can be diagnosed early in infancy when an immediate 
therapeutic intervention may maximize potential benefits.  
We examined synaptic transmission in the CA3 hippocampal area during the first two weeks of 
postnatal life when rapid morphological changes occur at both pre and postsynaptic levels 
Amaral & Dent, 1981) and in adulthood. We found that the R451C mutation selectively affects 
GABAergic signaling and correlated network activity from birth.    
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Methods 
Ethical approval 
All experiments were performed in accordance with the European Community Council Directive 
of November 24, 1986 (86/609EEC) and were approved by the local authority veterinary service 
and by SISSA ethical committee. All efforts were made to minimize animal suffering and to 
reduce the number of animal used. 
 
Animals  
NL3R451C mice (Tabuchi et al., 2007) were purchased from Jackson Laboratories (Maine, USA). 
Experiments were performed on off-spring male derived from heterozygous mating. 
Electrophysiological experiments were performed and analyzed blind before genotyping. This 
was carried out on tail biopsy DNA by PCR using a standard protocol. At least three mice for 
each genotype were used in a given experiment.   
 
Hippocampal slice preparation.  
Transverse hippocampal slices (300 µM) were obtained from neonatal (postnatal day 4-9) young 
(postnatal day 11–15) and adult (postnatal day 27-35) mice using a standard protocol (Griguoli et 
al., 2010). Briefly, after being anesthetized with CO2, animals were decapitated. The brain was 
quickly removed from the skull and placed in ice-cold artificial cerebrospinal fluid (ACSF) 
containing (in mM): 130 NaCl, 25 glucose, 3.5 KCl, 1.2 NaH2PO4, 25 NaHCO3, 2 CaCl2, and 1.3 
MgCl2, saturated with 95% O2 and 5% CO2 (pH 7.3–7.4). Transverse hippocampal slices were 
cut with a vibratome and stored at room temperature (22–24°C) in a holding bath containing the 
same solution as above. After incubation for at least 45 min, an individual slice was transferred 
to a submerged recording chamber and continuously superfused at 33–34°C with oxygenated 
ACSF at a rate of 3–4 ml/min. 
 
Electrophysiological recordings.  
Recordings were made with a patch-clamp amplifier (Axopatch 1D amplifier, Molecular 
Devices) from CA3 pyramidal cells visualized with an upright microscope equipped with 
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differential interference contrast optics and infrared video camera, using the whole cell 
configuration of the patch-clamp technique. Patch electrodes were pulled from borosilicate glass 
capillaries (Hingelberg, Malsfeld, Germany); when filled with an intracellular solution they had a 
resistance of 4-6 MΩ. The stability of the patch was checked by repetitively monitoring the input 
and series resistance during the experiments. Cells exhibiting 15% changes were excluded from 
the analysis. The series resistance was < 25 MΩ.  
Spontaneous glutamatergic and GABAergic postsynaptic currents were routinely recorded from 
a holding potential of -65, -70 mV in the presence of bicuculline (10 µM) and DNQX (20 µM), 
respectively. Miniature currents were recorded in the presence of TTX (1µM) to block sodium 
currents and propagated action potentials. For glutamatergic currents we used an intracellular 
solution containing (in mM):  125 Cs-methanesulphonate, 10 CsCl, 10 HEPES, 0.3 EGTA, 2 
MgATP, 0.3 NaGTP, (pH adjusted to ~ 7.3 with CsOH). For GABAergic currents we used an 
intracellular solution containing (in mM): CsCl 137, Hepes 10, BAPTA 11, MgATP 2, MgCl2 2, 
CaCl2 1 and 5 QX-314 (pH adjusted to ~ 7.3 with CsOH).  
Concentric bipolar electrodes were used to stimulate granule cells in the dentate gyrus in order to 
elicit 2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl) propanoic acid (AMPA)-mediated excitatory 
postsynaptic currents (EPSCs) in CA3 pyramidal neurons (frequency of stimulation: 0.1 Hz; 
stimulus duration 100-200 µs). Stimulus strength was adjusted to obtain at −65 mV stable EPSCs 
of ~100 pA amplitude. The NMDA component was recorded from the same neuron at +40 mV, 
using the same stimulus strength, after blocking the AMPA-mediated component with DNQX 
(20 µM). While AMPA-mediated EPSCs were recorded close to the reversal potential of GABA, 
NMDA currents were elicited in the presence of DNQX (20 µM) and bicuculline (10 µM) to 
block AMPA and GABAA receptors, respectively.  
In some experiments, extracellular field potentials were recorded using conventional glass 
microelectrodes (tip diameter 5–10 µM) filled with ACSF and placed into the stratum pyramidale 
of the CA3 area.  
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Drugs 
The following drugs were used: 6,7-Dinitroquinoxaline-2,3-dione (DNQX), 6-Imino-3-(4-
methoxyphenyl)-1(6H)-pyridazinebutanoic acid (SR 95531) hydrobromide, picrotoxin and 
bicuculline, purchased from Ascent Scientific; (1,2,5,6-Tetrahydropyridin-4-yl)met 
hylphosphinic acid (TPMPA) and N-(2,6-Dimethylphenylcarbamoylmethyl) triethylammonium 
bromide (QX 314), purchased from Tocris Bioscence; tetrodotoxin (TTX) from Latoxan. 
Bumetanide and 1-[2-[[(Diphenylmethylene)imino]oxy]ethyl]-1,2,5,6-tetrahydro-3-
pyridinecarboxylic acid hydrochloride hydrochloride (NO-711), from Sigma-Aldrich. Zolpidem 
was a gift of Dr. A. Barberis (Italian Institute of Technology, Genova). Stock solutions were 
made in distilled water and then aliquoted and frozen at −20°C. DNQX and picrotoxin were 
dissolved in dimethylsulfoxide (DMSO). The final concentration of DMSO in the bathing 
solution was 0.1%. At this concentration, DMSO alone did not modify the membrane potential, 
input resistance, or the firing properties of CA3 pyramidal neurons. Drugs were applied in the 
bath by gravity by changing the superfusion solution to one differing only in its content of 
drug(s). The ratio of flow rate to bath volume ensured complete exchange within 2-3 min. 
Data analysis 
Data were acquired at 20 kHz , filtered with a cut-off frequency of 2 kHz and stored on computer 
in order to perform off-line analysis. Miniature AMPA and GABAA-mediated postsynaptic 
currents were  analyzed using Clampfit 10.0 (Axon Instruments). This program uses a detection 
algorithm based on a sliding template. The template did not induce any bias in the sampling of 
events because it was moved along the data trace by one point at a time and was optimally scaled 
to fit the data at each position. The detection criterion was calculated from the template-scaling 
factor and from how closely the scaled template fitted the data. To minimize the contribution of 
the unquantifiable effects of cable filtering, detailed kinetic analysis of miniature synaptic 
currents was limited to events with a rise time ≤ 1 ms. The rise time was estimated as the 10–
90% time needed to reach the peak of the synaptic current. The weighted decay was obtained by 
dividing miniatures charge transfer by their amplitude.  
The amplitude of the tonic current was estimated by the outward shift of the baseline current 
after the application of the GABAA receptor channel blocker picrotoxin (100 µM). Only current 
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recordings that exhibited a stable baseline were included in the analysis. Baseline currents and 
their standard deviations were estimated by plotting 10 s periods of raw data in all point 
histograms. These were fitted with a Gaussian function. The peak of the fitted Gaussian was 
considered as the mean holding current (Glykys & Mody, 2007).  
NMDA/AMPA ratio was measured by averaging 15 to 30 sweeps for each holding potential. The 
AMPA-mediated component was measured at the peak of the current obtained at – 65 mV, while 
the  NMDA component was measured at the peak of the current obtained at +40 mV after 
blocking the AMPA component with DNQX. The weighted decay time constant for NMDA-
mediated synaptic current was measured by dividing the area by its amplitude, independently of 
the fitting (Cathala et al., 2003). 
Peak scaled non-stationary noise analysis was performed according to Traynelis et al., (1993) 
using the Mini Analysis program (version 6.0.1, Synaptosoft, Leonia, NJ). Miniature events were 
selected following the procedure described by Momiyama et al. (2003). Briefly, individual 
events were analyzed by measuring the peak amplitude, the 10–90% rise time and the decay time 
constant. Measured parameters were then numbered according to the event number and tested by 
Spearman's rank order correlation test for time stability. After testing for correlation between rise 
time and amplitude and between rise time and decay time, miniature GABAergic events were 
used for noise analysis. Individual events were aligned to the point of steepest rise time. The 
peak of the mean current response waveform was scaled to the response value at the 
corresponding point in time of each individual event before subtraction to generate the difference 
waveforms. The ensemble mean post synaptic current was binned into 50 bins of equal 
amplitude to assign similar weights to all phases of ensemble mean waveform. Variance was 
plotted against amplitude and individual points were fitted with the equation:  
σ
2(I) = iI-I2/N + σb2  (1) 
where i is the unitary single-channel current, I is the mean current, N is the number of  channels 
open at the current peak and σb2 is the variance of the background noise. The single-channel 
chord conductance (ϒ) was calculated as:  
ϒ= i/(Em-Erev)  (2) 
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from  the holding potential (Em) of −70 mV, assuming a reversal potential (Erev) of 0 mV. 
 
Statistical analysis 
All values are presented as mean ± SEM of n experiments. Statistical comparison was performed 
using unpaired t-test or one-way analysis of variance (ANOVA). Probability distributions were 
examined using the Kolmogorov–Smirnov test. A p value < 0.05 was considered as statistically 
significant.  
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Results 
Spontaneous network-driven events are enhanced  in NL3R451C mice  
As ASDs are neurodevelopmental disorders, we first verified whether the NL3R451C mutation  
alters correlated network activity, the so-called Giant Depolarizing Potentials (GDPs), a hallmark 
of developmental networks (Ben-Ari et al., 1989; Ben-Ari et al., 2007). GDPs which represent a 
primordial form of synchrony between neurons, thought to be essential for proper circuit 
maturation (Ben-Ari et al., 2007; Blankenship & Feller, 2010), are generated by the synergistic 
action of glutamate and GABA, both of which are depolarizing and excitatory at early 
development stages (Cherubini et al., 1991).  
We focused on the CA3 region of the hippocampus where GABAergic interneurons are centrally 
involved in GDPs generation (Allene et al., 2012). GDPs were recorded simultaneously from 
single cells and from population of neurons as extracellular field potentials (Figure 1A and B).  
GDPs occurred more frequently in NL3R451C knock-in mice respect to WT (0.69 ± 0.009  Hz, 
n=17, and 0.046 ± 0.006  Hz, n=24 in knock-in and control mice, respectively; p=0.043; 
unpaired t-test). As shown in the cumulative inter-event-interval plot of Figure 1C, the curve 
obtained from NL3R451C knock-in mice was shifted to the left respect to that obtained from WT 
animals (p<0.05; K-S test). In addition,  as illustrated in Figure 1C, in NL3R451C knock-in mice 
the cumulative probability curve related to charge transfers through the currents underlying 
GDPs was shifted to the right respect to controls and was significantly different from that 
obtained from WT animals (p<0.01 ; K-S test).  
 
Enhanced basal GABAergic but not glutamatergic transmission in young NL3R451C knock-
in mice  
Since GDPs are generated by the synergistic action of GABA and glutamate we next examined 
whether changes in spontaneous miniature synaptic currents could account for the observed 
effects. Miniature GABAA- and AMPA-mediated postsynaptic currents (mGPSCs and mEPSCs, 
respectively) were recorded at three different postnatal ages (P4-P9, P11-P15, P27-P35) in the 
presence of TTX (1 µM) and bicuculline or DNQX, respectively. As shown in the cumulative 
distribution plots of Figure 2, significant differences in the inter-event intervals distributions but 
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not amplitude of mGPSCs were observed in all groups examined (p<0.05 for all three groups; K-
S test). However due to the large variability between individual neurons, the mean frequency 
values from knock-in mice were significantly larger than those obtained from WT animals only 
at P11-P15. Mean frequency values were: P4-P9 (WT, 0.8 ± 0.1 Hz, n=19; NL3R451C, 0.97 ± 0.18 Hz 
n=18 ; p>0.05; unpaired t-test). P11-P15 ( WT, 4.47 ± 0.4 Hz n=18;  NL3R451C, 6.48 ± 0.75 Hz; 
n=20; p<0.05; unpaired t-test);  P27-P35 (WT, 11.9 ± 2 Hz, n=9; NL3R451C, 14.4 ± 1.44 Hz, n=12  
p>0.05; unpaired t-test). Respective amplitude values were: P4-P9 ( WT, 39.8 ± 2.8 pA n=2 ; 
NL3R451C, 41.9 ± 2.4 pA; n=18); P11-P15 (WT, 42.9 ± 2.1 pA; n=18; NL3R451C, 45.9 ± 2.4 pA; n=20 ) 
P27-P35 (WT, 48.5 ± 4.5 pA; n=9; NL3R451C, 49.3 ± 4.8 pA n=12); p>0.05 for all three groups. 
 In contrast, cumulative distribution plots of inter-event-intervals of mEPSCs recorded from 
NL3R451C and WT mice were significantly different only at P28-P35 (p<0.05; K-S test; Figure 3). 
No significant differences in cumulative amplitude distributions were observed between 
NL3R451C and WT mice (p>0.05; K-S test). Mean frequency values were: P4-P9 (WT,  0.76 ± 
0.12 Hz; n=9; NL3R451C, 0.6 ± 0.12; Hz n=11); P11-P15 (WT, 0.97 ± 0.19 Hz;  n=11; NL3R451C, 
0.91 ± 0.13 Hz; n=12); P27-P35 (WT, 2.7 ± 0.8 Hz; n=9; NL3R451C, 3.8 ± 0.6 Hz; n=17). Mean  
amplitude values were P4-P9 (WT, 23.5 ± 3 pA; n=9; NL3R451C, 21.9 ± 1.7 pA; n=11);  P11-P15 
(WT, 25.7 ± 1.7 pA; n=11; NL3R451C, 24.8 ± 1 pA; n=12); P27-P35 (WT, 23.5 ± 2.9 pA, n=9; 
NL3R451C, 25.5 ± 1.3 pA;n=17); p>0.05 for all three groups).  
Altogether, these results strongly support the involvement of the NL3R451C mutation in the 
enhancement of GABAergic transmission at early stages of postnatal development. 
Furthermore, to assess whether the NL3R451C mutation differentially affects AMPA- and NMDA-
mediated synaptic transmission, AMPA- and NMDA-mediated postsynaptic currents evoked by 
granule cell stimulation were examined at P4-P9 from CA3 principal cells at -65 mV and +40 
mV, respectively. While AMPA-mediated EPSCs were recorded close to the reversal potential of 
GABA, NMDA currents were elicited in the presence of DNQX (20 µM) and bicuculline (10 
µM) to block AMPA and GABAA receptors, respectively. As illustrated in Figure S1, no 
significant differences were observed in the NMDA/AMPA ratio (WT 0.24 ± 0.06, n=6 ; KI 0.28 
± 0.04 n=4 ; p>0.05) between the two different genotypes.  
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In addition, similar decay time values of NMDA-mediated EPSCs were detected in both 
genotypes (WT 88.17 ± 6 ms, n=6; NL3R451C 85.1 ± 20 ms; n=4; p>0.05; Supplementary Figure 
1), indicating that at MF-CA3 synapses the NL3R451C mutation does not alter glutamatergic 
synaptic transmission and the postsynaptic expression of NMDA receptor subunits. As the 
stronger effect of the NL3R451C mutation on GABAergic synaptic transmission was observed 
during the second postnatal week we concentrated our attention on this developmental stage 
(P11-P15) 
 
The NL3R451C knock-in mutation affects GABA release 
According to the quantal theory, the synaptic efficacy E, the mean amplitude of unitary GPSCs, 
can be defined as E=mQ, where m is the quantal content or the mean number of quanta released 
per presynaptic action potential and Q is the quantal size or amplitude of the unitary postsynaptic 
current (Katz, 1969). While Q depends on both pre (GABA content in synaptic vesicles) and 
postsynaptic (GABAA receptors) mechanisms, m depends on presynaptic factors, namely the 
number of release sites N and the probability of release (P) at each individual site. Therefore, 
presynaptic changes in GABA release may be related to modifications either in Q or m or both. 
To assess whether the increase in frequency of mGPSCs observed in NL3R451C mice is due to 
changes in GABA release, we analyzed GABA transients in the cleft. We took advantage of the 
weak competitive GABAA receptor antagonist TPMPA which has a very fast dissociation 
constant and competes with synaptically released GABA for the same ligand binding site on 
GABAA receptors (Jones et al., 2001; Barberis et al., 2004).  A different blocking effect of 
TPMPA on mGPSCs in WT and in NL3R451C mice would reflect relative changes in synaptic 
GABA transients since the fast dissociation time constant of TPMPA is comparable with the 
duration of GABA synaptic transient in the cleft (Mozrzymas et al., 1999; Barberis et al., 2000; 
Jones et al., 2001). Bath application of TPMPA (200 µM) caused a more pronounced reduction 
of mGPSCs amplitude in WT than in NL3R451C mice (30.5 ± 2.2 %; n=8 and 18.4 ± 3.7 %; n=7 in 
WT and NL3R451C mice, respectively, p<0.05; one-way ANOVA), suggesting an increased 
GABA transient in the synaptic cleft of NL3R451C mice respect to controls (Figure 4).  
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To test whether this effects was associated with an increased number of available GABAA 
receptors on the postsynaptic membrane (opened by a single GABA quantum, on the assumption 
that GABAA receptors are not saturated by the content of a single vesicle, Barberis et al., 2004), 
we used the peak-scaled non-stationary fluctuation analysis (see methods; Traynelis et al., 1993). 
We used only stable recordings of mGPSCs with no time-dependent changes in either peak 
amplitude, 10-90% rise time and decay time (electrotonic filtering was excluded on the basis of 
no correlation between the 10-90% rise time and the decay time; Momyiama et al., 2003).  
For each cell a parabolic variance versus mean curve was obtained (see individual samples in 
Figure 5A and B). By fitting data points with equation 1 gave an estimated unitary currents of 2 
± 0.27 pA and 2.6 ± 0.25 pA in WT and NL3R451C mice, respectively, corresponding to a 
weighted mean channel conductance of 29.2 ± 3.8 pS (n=8) and 37 ± 3.5 pS (n=9). These values 
were not significantly different (p > 0.05; Figure 5C). In addition, no significant differences in 
the number of GABAA receptor channels were found between WT and knock-in mice (25.7 ± 
4.8, n=8 and  22.4 ± 2.1, n=9, in WT and NL3R451C mice, respectively; p>0.05; Figure 5C) 
indicating that changes in frequency of mGPSCs could not be attributed to modifications in the 
number of receptor channels opened at the peak of a spontaneous miniature GABAergic events. 
 
The NL3R451C knock-in mutation alters the decay kinetic of GABAA receptors 
Next, we examined the kinetic properties of miniature events. As shown in Figure 6A, respect to 
WT animals, synaptic currents obtained from NL3R451C KI mice at P9-P11 displayed a 
significantly faster decay time (the weighted decay time was 9.14 ± 0.4 ms;  n=9; and 7.43 ± 0.5 
ms; n=9; in WT and NL3R451C mice, respectively; p<0.05) in the absence of any change in the 
rise time ( 0.53 ± 0.02  ms;  n=9 ; and 0.47 ±0.02  ms; n= 9; in WT and NL3R451C mice, 
respectively; p>0.05). This led to a leftward shift of the cumulative probability curve obtained 
from NL3R451C respect to WT mice (the two cumulative curves were significantly different; 
p<0.05, K-S test; Figure 6B).   
The faster decay time of mGPSCs observed in NL3R451C mice may result from a differential 
expression of GABAA receptor subunits in the postsynaptic membrane. One possibility is that the 
NL3R451C KI mutation accelerates the developmental switch from α2 to α1 subunits of GABAA 
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receptors, known to produce currents with faster decay kinetics (Laurie et al. 1992; Cherubini & 
Conti, 2001). To elucidate whether in NL3R451C mice more α1 containing GABAA receptors are 
recruited at synapses respect to α2, we examined the prolongation of current decay induced by 
zolpidem, known to selectively enhance the activity of α1 subunit-containing receptors (Pritchett 
& Seeburg, 1990). Since the effects of zolpidem on miniature GABAergic currents reflects the 
degree of receptor occupancy (Perrais & Ropert, 1999), we analyzed only mGPSCs duration. 
Application of zolpidem (100 nM) prolonged the decay time of  mGPSCs in both WT and 
NL3R451C mice. As shown in Figure 6C and D, in comparison with WT animals, the prolongation 
of synaptic decay was more pronounced in NL3R451C KI mice (WT, 14 ± 2%, n=6; NL3R451C, 23 
± 4 %, n=7). However the difference between the two genotypes did not reach a significant level 
(p>0.05, one-way ANOVA ).  
Recent studies have shown that intracellular chloride concentration may interfere with the gating 
properties and the expression of GABAA receptors thus regulating the shape of GABAA-
mediated postsynaptic currents (Houston et al., 2009; Succol et al., 2012). In particular, in the 
cerebellum, the developmental shift from α3 to α1 containing GABAA receptor subunits 
responsible for the faster decay of synaptic events has been attributed to changes in polarity of 
GABA action from the depolarizing to the hyperpolarizing direction (Succol et al., 2012). 
Therefore, the following experiments were undertaken to assess whether a different GABAergic 
drive (due to changes in [Cl-]in) could differentially affect network activity in the two genotypes 
at P11-P15. To this aim spontaneous EPSCs were recorded at -65 mV (close to the reversal of 
GABA, see methods) from WT and NL3R451C KI mice, before and after application of gabazine 
(10 µM; a selective GABAA receptor antagonist) or bumetanide (10 µM; a selective blocker of 
the chloride importer NKCC1). In percentage these drugs produced a similar reduction in 
frequency (but not in amplitude) of spontaneous glutamatergic events (gabazine: 59.8 ± 12.2 %; 
n=6; 61.6 ± 12.3 %; n=9; bumetanide: 52.2 ± 10.8 %; n=9; 51.2 % ± 11.7; n=7; in WT and in 
NL3R451C  knock-in mice, respectively; p>0.05; Supplementary Figure 2).  
The similar reduction in frequency of spontaneous EPSCs induced by gabazine- and bumatanide- 
detected in WT and NL3R451C  KI mice suggests comparable changes in GABAergic drive and 
[Cl-]in in the two genotypes and possibly reflects the action of gabazine and bumetanide on 
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presynaptic GABAA receptors (Jang et al., 2006; Nakamura et al., 2007; Trigo et al., 2008; 
Beltran & Gutierrez, 2012) and NKCC1 chloride importer on axon initial segments (Khiroug et 
al., 2008), respectively. 
 
The NL3R451C KI mutation does not alter the tonic GABAA-mediated conductance  
Once released, GABA rapidly diffuses across the synaptic cleft to occupy synaptic GABAA 
receptors. Part of the neurotransmitter escapes the cleft and invades the extracellular space to 
occupy extrasynaptic high affinity receptors and to generate a persistent GABAA-mediated 
conductance (Farrant & Nusser, 2005) which is involved in a number of physiological and 
pathological processes (Brickley & Mody, 2012). Recent studies have demonstrated a down-
regulation of GABAA-mediated tonic conductance in an animal model of X Fragile syndrome, a 
common inherited cause of mental retardation with language deficit and autistic behavior (Curia 
et al., 2008; Olmos-Serrano et al., 2010). Therefore, in the following experiments we searched 
for differences in GABAA-mediated tonic conductance between WT and NL3R451C mice. The 
tonic conductance was obtained by measuring the shift in the holding current following the 
application of the GABAA receptor channel blocker picrotoxin (100 µM). This drug caused a 
similar shift in holding current in WT and in NL3R451C mice (54 ± 11 pA, n=11, and 49 ± 15 pA, 
n=6, in WT  and in NL3R451C mice, respectively; p=0.8; Figure 7).  
Furthermore, to test whether GABA transporters differentially affect ambient GABA in WT and 
NL3R451C mice, we applied NO-711, which selectively blocks the neuronal and glial GABA 
transporter GAT-1 (Borden, 1996; Semyanov et al., 2004). NO-711 (10 µM) produced a similar 
inward shift of the baseline current in both WT and NL3R451C mice (41.5 ± 12.8 pA and 42 ± 7.5 
pA in WT, n=6, and knock-in animals, respectively; n=7; p=0.7 in both; Figure 8 A-C). Addition 
of picrotoxin caused in the two genotypes a similar outward shift in baseline currents (71 ± 20 
pA; n= 6 and 71 ± 12 pA; n=7; in WT and in NL3R451C mice, respectively, p=0.98). These data 
indicate that the NL3R451C mutation does not affect GABA transporters and the tonic GABAA-
mediated conductance. 
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Discussion 
The present results provide evidence that the NL3R451C mutation selectively affects correlated 
network activity and GABAergic signaling already at birth. A previous study from layer 2/3 
pyramidal neurons in acute slices of somatosensory cortex obtained from juvenile (P13-P16) 
NL3R451C KI mice has revealed an increased inhibitory synaptic transmission. These animals 
exhibited enhanced spatial learning abilities associated with deficits in social interaction 
(Tabuchi et al., 2007; but see Chadman et al., 2008 for the behavioral phenotype), similarly to 
those found in some forms of ASDs. The authors suggested that the NL3 mutation enhances 
GABAergic transmission without changing the release probability since they failed, at least in 
the barrel cortex, to detect major modifications in short-term synaptic plasticity.  
Our data on GDPs indicate that the NL3R451C mutation affects GABA release. During the first 
week of postnatal life, GDPs are generated by the interplay between GABA and glutamate, both 
of them depolarizing and excitatory. Therefore changes in frequency and shape of spontaneous 
giant events can be attributed to modifications in the GABAergic, in the glutamatergic drive to 
principal cells or in both. A close examination of spontaneous miniature events, occurring during 
the first week of postnatal life, revealed an increased frequency, but not in amplitude of 
mGPSCs, suggesting a presynaptic type of action. This was further supported by TPMPA 
experiments  that, as expected for an enhanced GABA transient in the cleft, showed a reduced 
blocking effect of the fast-off GABAA antagonist on miniature events in NL3R451C KI mice. 
Although an increased number of available postsynaptic GABAA receptors, if these are not 
saturated by the content of a single GABA containing vesicle (Barberis et al., 2004; Hartman et 
al., 2006) may account for these results, this was not the case since a similar number of receptor 
channels were revealed with peak-scaled non-stationary fluctuation analysis in both WT and 
NL3R451C knock-in mice, indicating that the observed effects were not postsynaptic in origin.  
Presynaptic changes in GABA release can be attributed to modifications in the probability of 
GABA release, in the number of release sites or in the content of GABA in single synaptic 
vesicles. Changes in probability of GABA release seem unlikely considering that we examined 
miniature events generated by the release of a single quantum. Our data do not allow 
distinguishing  between the other two possibilities (changes in the number of release sites or in 
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vesicle GABA content). However, in agreement with previous data from Südhof group showing 
an enhancement of presynaptic GABAergic marker VGAT (but not VGlut1) in the hippocampus 
of NL3R451C KI mice (Tabuchi et al., 2007), it is likely that an GABAergic innervation may 
contribute to the enhancement of GABA release.  
In the present experiments we did not characterize which subtype of GABAergic interneuron is 
involved in the observed effects. However, several lines of evidence suggest the involvement of 
parvalbumin-positive cells: i. highly interconnected, parvalbumin positive hub neurons, essential 
for triggering network oscillations in the form of GDPs in the immature hippocampus (Bonifazi 
et al., 2009) have been found to be occasionally parvalbumin-positive (Picardo et al. 2011). 
These cells which persist in adulthood (Picardo et al., 2011), retain the capacity of coordinating 
the timing of neuronal activity, thus contributing to generate theta and gamma rhythms (Bartos et 
al., 2007; Klausberger & Somogyi, 2008; Wulff et al., 2009), known to be involved in high 
cognitive functions (Singer, 1993). ii. In ASD mouse models (NL3R451C knock-in mice and in 
animals prenatally exposed to the histone deacetylase inhibitor, valproate) an asymmetric 
reduced expression of parvalbumin-positive interneurons was found  across hemispheres in 
parietal and occipital cortices (Gogolla et al., 2009). Since parvalbumin-positive neurons 
normally drive experience-dependent circuit development (Fagiolini et al., 2004; Hensch, 2005), 
the selective disruption of these cells may alter neuronal networks during a critical period of 
postnatal development (Pizzarelli & Cherubini, 2011). Whatever is the subtype of GABAergic 
interneuron involved, the present data unveil an alteration of the excitatory/inhibitory (E/I) 
balance, known to exert a key role in the refinement of cortical circuits early in postnatal life (Le 
Blanc & Fagiolini, 2011).  
The increased frequency (but not amplitude) of spontaneous miniature glutamatergic events 
detected in adult (but not in neonatal or juvenile NL3R451C mice) may represent a late form of 
compensatory homeostatic correction, developed to counter the excessive GABAA-mediated 
inhibition. In this respect, the possibility that changes in the expression of AMPA- and NMDA 
receptors containing the NR2B subunits, observed in the CA1 region of adult NL3R451C mice 
may underlie  the same phenomenon, cannot be excluded (Etherton et al., 2011). 
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Interestingly, as compared to WT animals, NL3R451C knock-in mice exhibited mGPSCs with 
faster decay kinetics. The speed-up of mGPSCs kinetics may depend  on different pre, 
postsynaptic mechanisms or both  (Barberis et al., 2011). At the postsynaptic level, this can be 
attributed to different expression of GABAA receptors containing subunits. In particular, 
receptors containing the α1 or α2 subunits (along with β and γ2 subunits) exhibit synaptic 
currents with fast and slow kinetics, respectively (Cherubini & Conti, 2001) and the tendency of 
zolpidem to prolong  more the synaptic decay in mGPSCs from NL3R451C respect to WT, 
strongly suggest an increased recruitment of α1 respect to α2 subunits at synapses. GABAA 
receptor subunits expression may be altered by activity-dependent changes of intracellular 
chloride (Succol et al., 2012). However, no differences in intracellular chloride levels were 
detected between WT and NL3R451C mice making this possibility unlikely. At presynaptic level, 
the spatio-temporal profile of GABA concentration in the synaptic cleft may affect agonist 
binding as well as the gating properties of GABAA receptors resulting in modifications of the 
shape  of synaptic signals.  However, in contrast with the present observations, in these cases 
changes in the decay kinetics should be associated with changes in amplitude and in the rise time 
of synaptic currents (Barberis et al., 2011). Finally, the similar values of GABAA-mediated tonic 
conductance measured in WT and NL3R451C mice, allow excluding the involvement of 
extrasynaptic receptors in the observed kinetics modifications. 
How the E/I balance regulates brain functions ? Recent studies have highlighted the role of 
transynaptic signaling via NLs and Nrxs in assembling and stabilizing pre and postsynaptic 
components (Südhof, 2008). In particular, the NLs which in vertebrate are encoded by four genes 
(Nlgn1-4 with various splice variants) form homo-dimers through their extracellular domains 
(Missler et al., 2012). While NL1 is preferentially associated with glutamatergic synapses (Song 
et al., 1999), NL2 and NL4 with GABAergic synapses (Varoqueaux et al., 2004; Graf et al., 
2004; Dong et al., 2007; Hoon et al., 2011). Interestingly, we have recently found that gephyrin, 
a core protein of inhibitory postsynaptic densities that interacts with the cytoskeleton to stabilize 
inhibitory receptors in precise opposition to presynaptic active zones, transynaptically acts via 
NL2 on GABA release, thus directly contributing to maintain an appropriate E/I balance 
(Marchionni et al., 2009; Varley et al., 2011). Hampering gephyrin function not only alters 
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GABAA receptors clusterization and their  gating properties but also the probability of GABA 
release, an effect mediated by NL2 since it could be rescued by over expressing this protein in 
gephyrin-deprived neurons (Varley et al., 2011). Although NL3 is highly expressed in the brain 
where is localized at both excitatory and inhibitory synapses (Budreck & Scheiffele, 2007), its 
functional role remains to be elucidated. However, the developmental pattern of NL3 expression, 
whose peak is coincident with that of synaptogenesis strongly suggests the involvement of this 
protein in synapse formation and stabilization.  
As already outlined by Tabuchi et al., (2007), the NL3R451C mutation results in a gain of function 
since no effects on miniature GABAergic currents were detected in NL3 KO mice. It is worth 
noting that although mutated NL genes or associated proteins have been found only in a small 
number of young patients, they provide crucial information on the synaptic abnormalities which 
possibly affect ASDs. 
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Figure 1 
 
 
 
The NL3R451C knock-in  mutation enhances correlated network activity in the immature 
hippocampus. A. Whole cell voltage-clamp (upper traces) and extracellular field recordings 
(lower traces) of GDPs in hippocampal slices obtained from WT (black) and NL3R451C mice 
(grey). B. GDPs from the traces in A shown on an expanded time scale. C. Cumulative 
probability plots of inter-event intervals and areas of inward currents underlying GDPs  recorded 
from WT (n=24) and NL3R451C mice (n=17). Curves in the plots referring to WT and R451C KI 
mice are significantly different (p<0.01 ; p<0.01; K-S test). 
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Figure 2 
 
 
 
The NL3R451C knock-in mutation enhances the frequency of mGPSCs. Samples traces of 
mGPSCs recorded from CA3 principal cells at P4-P9 (A), P11-P15 (B) and P27-P35 (C) from 
WT (black) and in NL3R451C knock-in mice (grey). Below, cumulative probability plots of inter-
event intervals (left) and amplitude (right) of obtained from WT and  NL3R451C knock-in mice. 
Changes in inter-event-interval (p<0.05; K-S test)  but not in amplitude (p>0.05; K-S test)    were 
significantly different at all developmental stages examined . 
 
 
 
 32 
 
Figure 3 
 
 
 
The NL3R451C knock-in mutation does not affect spontaneous miniature glutamatergic 
events. A. Samples traces of mEPSCs recorded from CA3 principal cells at P4-P9 from WT 
(black) and in NL3R451C knock-in mice (grey). Below, cumulative probability plots of inter-event 
intervals (left) and amplitude (right) of obtained from P4-P9 (A), P11-P15 (B) and P27-P35 (C) 
WT and NL3R451C knock-in mice. B. and C. as A but for later developmental stages. Note 
changes in frequency (but not amplitude of miniature events at P27-P35 (the two curves are 
significantly different; p<0.05; K-S test). 
 33 
 
  
Figure 4 
 
 
 
Increased synaptic GABA transient in NL3R451C knock-in mutant mice. A. Sample traces of 
mGPSCs recorded from NL3R451C mutants (grey) and littermate (black), in the absence (tick 
line, Control) and in the presence of TPMPA (200 µM; thin line). The amplitudes of mGPSCs 
from NL3R451C knock-in mice were normalized to those obtained from  WT animals. B. Each 
column represents the mean TPMPA-induced reduction in amplitude of mGPSCs in WT (black: 
n= 8) and NL3R451C mice (grey; n= 7). * p<0.05. 
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Figure 5 
 
 
 
The NL3R451C knock-in mutation does not affect single channel conductance and/or the 
number of GABAA receptor channels. A. Individual mGPSCs (dotted lines) are shown with 
the average currents (thick lines) in WT and R451C mice. B. Current/variance relationships for 
mGPSCs shown in A. C. Summary plots of weighted mean channel conductance   and number of 
GABAA receptor channels in WT (black; n=8 ) and in NL3R451C knock-in mice (grey; n=9 ).  
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Figure 6 
 
 
 
Faster decay of mGPSCs in NL3R451C knock-in mice. A. Sample traces of mGPSCs (each  
trace is the average of > 50 individual traces) obtained from NL3R451C knock-in mice (grey) and 
control littermates (WT, black). On the right the two traces are superposed. B. Cumulative 
probability plot of decay times from WT (black; n= 9) and NL3R451C knock-in mice (grey; n= 8). 
The two curves are significantly different (p<0.01 ; K-S test). C. Sample traces of mGPSCs from 
NL3R451C (grey) and WT mice (black), before (Control) and during application of zolpidem (100 
nM). D. Summary plots of normalized changes in mGPSCs decays induced by zolpidem in WT 
(black, n= 6) and in NL3R451C (grey, n= 7) mice. 
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Figure 7 
 
 
 
The NL3R451C knock-in mutation does not alter tonic GABAA-mediated conductance. A. 
Left: representative trace of spontaneous GPSCs recorded from a P11 pyramidal neurons in 
hippocampal slices obtained from a WT (black) and NL3R451C KI mice (grey) before (Control) 
and during bath application of picrotoxin (PTX; 100 µM). Right: all-point histogram of 10 ms 
traces from the cell recorded on the left in control conditions and in the presence of picrotoxin. 
B. Summary data obtained from WT (black; n= 11) and NL3R451C KI mutant mice (grey; n=6).  
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Figure 8 
 
 
 
The NL3R451C knock-in mutation does not alter tonic GABAA-mediated inhibition. A. Left: 
representative traces of spontaneous GPSCs recorded in a P 12 pyramidal cell in hippocampal 
slice obtained from a WT animal before (Control), during application of the GAT-1 blocker NO-
711 (10 µM) and NO-711 plus picrotoxin (100 µM). Right: all-point histogram of 10 ms traces 
from the cell recorded on the left in control conditions, in the presence of NO-711 and NO-711 
plus picrotoxin. B. As in A but from NL3R451C KI mutant mouse. C. Summary data obtained from 
WT (black; n= 6) and NL3R451C knock-in mutant mice (grey; n= 7).  
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Supplementary Figure 1  
 
 
 
 
 
The NL3R451C knock-in mutation does not affect excitatory glutamatergic responses at 
immature MF-CA3 synapses.  A. Sample traces of measurements of the ratio of NMDA versus 
AMPA receptor-mediated synaptic currents in NL3R451C mutants (grey) and in littermate controls 
(black).B. summary graphs of NMDA/AMPA ratio (WT 0.24 ±0.06, n=6 ; KI 0.28 ±0.04 n=4 ; 
p> 0.05)  and NMDA decay times  (WT 88.17± 6 ms, n=6; KI 85.1± 20 ms, n=4, p>0.05). 
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Supplementary Figure 2 
 
 
 
Gabazine and bumetanide similarly reduce spontaneous glutamatergic activity in WT and 
in NL3R451C  knock-in mice. A. Sample traces of  AMPA-mediated spontaneous EPSCs 
recorded at P11-P15 from WT (black) and NL3R451C  knock-in mice (grey) in control and in the 
presence of gabazine (10 µM) from a holding potential of -65 mV. B. Each column represents 
the normalized reduction in frequency of spontaneous EPSCs in WT (black; n=6  ) and in 
NL3R451C  knock-in mice (grey; n=9  ). C-D. As in A-B but in the presence of bumetanide (WT 
n=9; KI n=7. Note similar gabazine- and bumetanide-induced reduction in frequency of 
spontaneous glutamatergic events in both genotypes. 
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Autism spectrum disorders (ASDs) comprise a heterogeneous group of pathological conditions, mainly of genetic origin, char-
acterized by stereotyped behavior, marked impairment in verbal and nonverbal communication, social skills, and cognition.
Interestingly, in a small number of cases, ASDs are associated with single mutations in genes encoding for neuroligin-
neurexin families. These are adhesion molecules which, by regulating transsynaptic signaling, contribute to maintain a proper
excitatory/inhibitory (E/I) balance at the network level. Furthermore, GABA, the main inhibitory neurotransmitter in adult life,
at late embryonic/early postnatal stages has been shown to depolarize and excite targeted cell through an outwardly directed flux
of chloride. The depolarizing action of GABA and associated calcium influx regulate a variety of developmental processes from
cell migration and diﬀerentiation to synapse formation. Here, we summarize recent data concerning the functional role of GABA
in building up and refining neuronal circuits early in development and the molecular mechanisms regulating the E/I balance.
A dysfunction of the GABAergic signaling early in development leads to a severe E/I unbalance in neuronal circuits, a condition
that may account for some of the behavioral deficits observed in ASD patients.
1. Introduction
Autism spectrum disorders (ASDs) comprise a complex and
heterogeneous group of pathological conditions including
autism, Rett and Asperger syndromes, and pervasive devel-
opmental disorder-otherwise nonspecified, characterized by
impaired social interactions, deficits in verbal and nonverbal
communication, and a limited interest in the surrounding
environment associated with stereotyped and repetitive
behaviors [1]. The incidence of these disorders, which varies
between 10 and 20 per 10000 children, has risen dramatically
over the past two decades mainly because of the use of
broader diagnostic criteria and the increased attention of the
medical community [2]. Clinical signs are usually present at
the age of 3 years, but prospective studies of infants at risk
have demonstrated that deficits in social responsiveness,
communication, and play could be present already at the age
of 6–12 months.
ASDs are the most heritable neurodevelopmental dis-
orders of early childhood. Genetic factors are thought to
account for ∼80% of autism cases, and since autism is
a spectrum of disorders, it is conceivable that in most cases
diﬀerent genes act in combination in diﬀerent individuals
[3]. Genes, interacting with epigenetic factors, may influence
neuronal migration, axon pathfinding, dendritic develop-
ment, synaptogenesis, and pruning, thus contributing to
alter neuronal connectivity and information processing [4].
Interestingly, a small percentage of ASDs patients carry
single mutations in genes encoding for synaptic cell adhe-
sion molecules of the neurexin (NRXN)-neuroligin (NLG)
families [5]. These include mutations in genes encoding for
NRXN1 [6, 7], for NLG3, NLG4 [8–10], and for Shank3 [11].
Although rare, these mutations provide crucial information
on the synaptic abnormalities which possibly aﬀect ASDs
patients and point to synapses dysfunction as a possible
site of autism origin. Synapses are specialized intercellular
junctions which transfer information from a neuron to a
target cell, usually another neuron.
Several lines of evidence suggest that an impairment
of GABAergic transmission contributes to the development
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of ASDs. GABA, the main inhibitory neurotransmitter in
adulthood is released by interneurons which contain the
GABA synthesizing enzymes glutamic acid decarboxylase
(GAD)65 and GAD67. GABAergic interneurons, which con-
stitute a heterogeneous group of cells, diﬀerently classified
in virtue of their anatomical, physiological, and molecular
features [12], represent only 10%–15% of the total neuronal
population. Nevertheless, they provide the functional bal-
ance, complexity, and computational architecture of neu-
ronal circuits [13]. They play a key role in regulating neu-
ronal excitability via feedback and feed-forward inhibition.
Axons of diﬀerent inhibitory cells target diﬀerent postsynap-
tic subcellular compartments, allowing them to selectively
control the output of pyramidal cells [14], thus providing
the temporal structure that orchestrates the activity of
neuronal ensembles leading to coherent network oscillations
[15].
While in the mature brain GABA acts as an inhibitory
transmitter, during the embryonic and the perinatal period,
this neurotransmitter depolarizes targeted cells and triggers
calcium influx. GABA-mediated calcium signaling regulates
a variety of diﬀerent developmental processes from cell pro-
liferation migration, diﬀerentiation, synapse maturation,
and cell death [16]. Although the geometry and the cellular
and subcellular selectivity of GABAergic axons are mainly
genetically determined, axonal branching and arborization
are regulated by activity and experience and often require
brain-derived neurotropic factor (BDNF, [17]). Thus, sen-
sory stimulation contributes to shape neuronal circuits,
whereas sensory deprivation significantly retards their mat-
uration [18–20].
Considering the multifacet of GABA activities particu-
larly during development, it is not surprising that distur-
bance of GABAergic signaling can result in aberrant informa-
tion processing, as found in neurodevelopmental disorders
such as ASDs. In particular, it has been hypothesized that at
least some forms of autism result from an imbalance between
excitation and inhibition in local circuits involved in sensory,
mnemonic, social, and emotional processes. The resulting
hyperexcitability could disrupt the normal formation of
cortical maps leading to a relatively unstable state [21]. The
cortex is organized in vertical mini columns of functionally
related glutamatergic and GABAergic neurons that process
thalamic inputs. Local GABAergic circuits contribute to
control the functional integrity of minicolumns via lateral
inhibition. Interestingly, analysis of postmortem tissues from
ASDs patients has revealed alterations in the number of mini
columns, in the horizontal spacing separating cell columns,
and in their internal structure [22]. The abnormal cytoar-
chitecture is often associated with an increased expression of
calbindin-, calretinin- and parvalbumin-positive GABAergic
interneurons [23]. In addition, changes in GAD65 and
GAD67 [24], in the mRNA encoding for these enzymes
[25–27], in GABAA [28, 29] and GABAB receptors [30]
have been found in brain samples from ASDs patients. The
altered GABAergic function may reduce the threshold for
developing seizures as demonstrated by the high comorbidity
of ASDs with epilepsy (one third of ASDs patients have
seizures [31]). This further strengthens the hypothesis that
an unbalance between excitation and inhibition contributes
to these devastating neurological disorders.
This paper will focus on the functional role of GABA
in regulating developmental processes, their experience-
dependent refinement and, at the network level, the balance
between excitation and inhibition. In addition, the implica-
tions that an altered GABAergic signaling may have in neu-
rodevelopmental disorders such as ASDs will be discussed
taking into account diﬀerent animal models.
2. GABA, a Pioneer Neurotransmitter in
Neuronal Circuits Formation
The construction of the brain relies on a series of well-
defined genetically and environmentally driven factors whose
disruption leads to pathological disorders including ASDs.
During central nervous system development, a sequence
of temporally related events during which neurons prolif-
erate, migrate, diﬀerentiate, and establish proper synaptic
connections occurs [16]. Further refinement of immature
networks needs adaptive processes involving experience- or
activity-dependent mechanisms, which lead to the formation
of new synapses and elimination of others. Using imag-
ing techniques and electrophysiological approaches, several
patterns of coherent activity have been characterized early
in development [32]. Uncorrelated spontaneous activity
consisting of calcium action potentials has been suggested
to play a crucial role in regulation of cortical neurogenesis
at late embryonic stages [16, 33]. At birth, synchronous
neuronal activity can be detected in the hippocampus and in
the neocortex. This relies firstly on the activation of intrinsic
conductances and gap junctions and later on synapse-driven
events. Thus, small cell assemblies coupled to gap junctions
generate nonsynaptic spontaneous plateau assemblies (SPAs,
[32], Figure 1).
These involve small groups of neurons and are associated
with sustained intrinsic membrane potential oscillations.
SPAs are modulated by oxytocin, a maternal hormone
essential for labour induction, which transiently converts
GABA action from excitatory to inhibitory [34]. As the
network matures and the density of functional synapses
increases, synaptic-driven network oscillations replace SPAs.
A downregulation in the expression of connexins via CREB
signalling, following activation of NMDA receptors, may lead
to SPAs silencing [35]. Two diﬀerent patterns of network-
driven synaptic oscillations have been described: the giant
depolarizing potentials or GDPs [36] and early network
oscillations or ENOs [37]. These are reminiscent of “long
oscillations” and “spindle bursts”, respectively, recorded from
the rat somatosensory cortex in vivo [38] or of discontinue
activity patterns observed in the EEG of preterm babies [39].
While ENOs (which usually precede GDPs) were initially
thought to constitute the cortical counterpart of hippocam-
pal GDPs, they have been shown to coexist with GDPs in
the neocortex [32]. In the neocortex, ENOs critically depend
on the activation of NMDA receptors [37]. In addition,
evidence has been provided that extrasynaptic NMDA
receptors activated by ambient glutamate generate a tonic
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Figure 1: Patterns of electrical activity observed at late embryonic/early postnatal stages in the cortex. E20: uncorrelated calcium spikes; P0:
Spontaneous Plateau Assemblies (SPAs) synchronized by gap junctions. P3–P5: early network oscillations (ENOs) mediated by glutamate.
P6–P8: giant depolarizing potentials (GDPs) mediated by GABA and glutamate. (Modified from [32]).
current, which contributes to depolarize the membrane, to
enhance cell excitability and to convert silent synapses into
functional ones [40]. The activation of NMDA receptors by
“ambient” glutamate would be facilitated by changes in
subunits composition [41], in voltage dependence of the
magnesium block [42] and in the high aﬃnity for glutamate
of extrasynaptic NMDA receptors.
In the hippocampus, GDPs are generated by the synergis-
tic action of glutamate and GABA, which in the immediate
postnatal period, orchestrates neuronal ensembles via its
depolarizing and excitatory action [43]. Before synapses for-
mation, GABA depolarizes targeted neurons via a paracrine
type of action. GABA released in a calcium- and SNARE-
independent way by nonconventional release sites such as
growth cones and astrocytes diﬀuses away to activate extrasy-
naptic receptors [44]. The absence of an eﬃcient uptake
system will enable GABA to accumulate in the extracellular
space and to reach a concentration suﬃcient to exert its distal
action. The depolarizing action of GABA would activate
voltage-dependent calcium channels and would facilitate
the relief of the voltage-dependent magnesium block from
NMDA receptors, thus allowing calcium entry and activation
of second messengers.
Using network dynamics imaging, online reconstruction
of functional connectivity and targeted whole-cell record-
ings, it has been recently demonstrated that, in immature
hippocampal slices, functional hubs composed of subpop-
ulations of GABAergic interneurons with large axonal
arborizations are able to synchronize large neuronal ensem-
bles [45]. The depolarizing action of GABA in immature
neurons results from an outwardly directed flux of chloride.
Chloride homeostasis is controlled by the Na-K-2Cl cotrans-
porter NKCC1 and by the K-Cl cotransporter KCC2 that
enhance and lower [Cl−]i, respectively [46]. Due to the
low expression of the KCC2 extruder at birth, chloride
accumulates inside the neuron via NKCC1. The progressive
increase in the expression of KCC2 is responsible for the
developmental shift of GABA from the depolarizing to the
hyperpolarizing direction. KCC2 extrudes K+ and Cl− using
the electrochemical gradient for K+. Cl− extrusion is weak in
immature neurons and increases with neuronal maturation.
The functional role of the depolarizing action of GABA
on early circuits development has been assessed by manip-
ulating the expression levels of KCC2 and NKCC1, respec-
tively. Thus, the premature expression of KCC2, has been
shown to convert the action of GABA from excitatory to
inhibitory and to impair the morphological maturation
of cortical cells, without altering their radial migration
[47]. This eﬀect can be mimicked by overexpressing the
inwardly rectifying K+ channel which lowers the membrane
potential and reduces cell excitability, strongly suggesting
that membrane depolarization caused by the early GABA
excitation is essential for the functional maturation of cor-
tical circuits in vivo. On the other hand, knocking down
the expression of NKCC1 to abolish GABAA-mediated
excitation, leads to a significant reduction in AMPA receptor-
mediated synaptic transmission associated with a disrup-
tion of dendritic arborization and spines density further
indicating that the depolarizing and excitatory action of
GABA plays a permissive role in the formation of excitatory
synapses [48]. Interestingly, these eﬀects could be rescued
by over expressing a mutant form of voltage-independent
NMDA receptors, indicating that GABA depolarization
cooperates with NMDA receptor to regulate the formation
of excitatory synapses. It is worth noting that GDPs and
associated calcium transients act as coincidence detectors for
enhancing, in an associative type of manner, synaptic eﬃcacy
at emerging GABAergic [49], and glutamatergic synapses
[50]. Using a “pairing” procedure, consisting of correlating
GDPs-associated calcium rise with stimulation of mossy
fibers or Schaﬀer collaterals, in the CA3 and CA1 region,
respectively, we found that this procedure produced a strong
and persistent potentiation of synaptic responses (Figure 2).
In the absence of pairing, no significant changes in synap-
tic eﬃcacy could be detected. Similar results were obtained
by progressively increasing the interval between GDPs and
mossy fiber/Schaﬀer collateral stimulation. Pairing-induced
potentiation was prevented when the cells were loaded with
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Figure 2: Pairing GABA-mediated GDPs with Schaﬀer collateral stimulation persistently enhances synaptic strength at glutamatergic CA3-
CA1 connections. (a) Experimental paradigm. (b) The rising phase of GDPs (between the dashed lines) was used to trigger synaptic
stimulation (stim) (c) EPSCs evoked in CA1 principal cells by minimal stimulation of Schaﬀer collateral, before and after pairing (average of
19 responses). (d) Each bar represents the mean peak amplitude of synaptic responses including failures (n = 8) and the paired pulse ratio
(PPR; n = 8), obtained before (open) and after (closed) pairing. (Modified from [50]).
the calcium chelator BAPTA or when nifedipine (but not
the NMDA receptor antagonist D-(-)-2-amino-5-phospho-
nopentanoic acid) was added to the extracellular medium,
suggesting that activity-dependent changes in synaptic eﬃ-
cacy depend on calcium rise through voltage-dependent
calcium channels and not via NMDA receptors.
Immature neurons are characterized by an elevated num-
ber of “silent” synapses [40]. These are synapses that do not
conduct at rest either, because the neurotransmitter is not
released when the presynaptic terminal is invaded by an
action potential (presynaptically silent), or because they are
unable to detect the release of the neurotransmitter due
to the lack of the respective receptors on the subsynaptic
membrane (postsynaptically silent). Silent synapses can be
converted into active ones by activity-dependent processes
and this represents the most common mechanism for LTP
induction, not only during development but also in the
mature brain [51]. Interestingly, the pairing procedure was
able to convert silent synapses into active ones. In particular,
in double pulse experiments, pairing caused the appearance
of responses to the first stimulus and increased the number
of successes to the second one, indicating that an increased
probability of transmitter release accounts for long-term
increase in synaptic strength. Therefore, calcium entry
through voltage-dependent calcium channels, activated by
the depolarizing action of GABA during GDPs, is instrumen-
tal in enhancing the number of functional GABAergic and
glutamatergic synapses and/or the probability of GABA and
glutamate release in a Hebbian way. This may contribute to
refine neuronal connectivity before the establishment of the
adult neuronal circuit.
3. Molecular Determinants of
GABAergic Synapses Formation
In the adult brain, information processing relies on the inte-
gration of excitatory and inhibitory circuits which use glu-
tamate and GABA/glycine as neurotransmitters, respectively.
The so-called excitatory/inhibitory (E/I) balance represents
a critical condition for the correct functioning of neuronal
networks and it is essential for nearly all brain func-
tions, including representation of sensory information and
cognitive processes. The E/I balance is maintained via
highly regulated homeostatic mechanisms [52]. Neurons
are able to compensate for experimental perturbations by
modulating ion channels, receptors, signaling pathways, and
neurotransmitters. At the molecular level, these processes
require chromatin remodeling, changes in gene expression
and repression, changes in protein synthesis, turnover and
cytoskeleton rearrangement [53]. A disruption of the home-
ostatic control, due to the lack of compensatory changes,
leads to an imbalanced E/I ratio and to the developmental
of neuropsychiatric disorders including mental retardation,
epilepsy and ASDs [21].
During brain maturation, the development of a proper
E/I balance is achieved with the shift of GABA action from
the depolarizing to the hyperpolarizing direction, a process
that in rodents starts appearing toward the end of the first,
beginning of the second postnatal week [54]. Disturbances
in the E/I balance may also occur when the formation or
maintenance of one class of synapses prevails over the others.
The selective loss of excitatory or inhibitory synapses can
take place during the initial period of synapse formation
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and consolidation or late in development during activity-
dependent refinement of neuronal circuits and may involve
mutations in genes encoding for ion channels or GABAA
receptor subunits. These would lead to circuits with abnor-
mal activity and prone to seizures [55]. For example, the
disruption in mice of the gabrb3 gene, which encodes for
β3 subunits of GABAA receptors, highly expressed during
development, is suﬃcient to cause phenotypic traits which
parallel those present in the Angelman syndrome [56]. Thus,
mice lacking the β3 subunits exhibit a major reduction
of GABAA receptors, thalamic disinhibition and seizures
associated with learning and memory deficits, poor motor
skills on a repetitive task, hyperactivity, and a disturbed rest-
activity cycle, all features characteristic of children aﬀected
by this neurological disorder. The cellular and molecular
mechanisms underlying these phenomena are still poorly
understood and their comprehension is further complicated
by intrinsic diﬀerences among neuronal types, experimental
conditions and the developmental stage of neurons [57].
During neuronal circuit assembly, GABA signaling pre-
cedes and promotes the formation of glutamatergic synapses
[58]. The sequential development of GABA- and glutamate-
mediated connections is independent on the arrival of aﬀer-
ent inputs but is related to the degree of maturation of tar-
geted cells including changes in dendritic length, in somatic
size and capacitance [58]. While functional GABAergic
synapses require the presence of small apical dendrites in
stratum radiatum of the hippocampus, glutamatergic con-
nections require the presence of dendrites in stratum lacuno-
sum moleculare.
The refinement of GABAergic connections and their
translation into a potent inhibitory network is a protracted
process which extends well beyond the first two postnatal
weeks into the adolescent period and is regulated by
neuronal activity and experience. In the visual cortex, for
instance, experience-dependent regulation of the GABAergic
innervation controls the onset of critical periods [59] during
which neuronal circuits display a heightened sensitivity to
environmental stimuli and are greatly shaped by sensory
experience. Thus, a delayed and an accelerated onset in visual
plasticity can be obtained by negatively or positively interfer-
ing with the GABAergic function, respectively [59]. GABA
signaling itself would be responsible for the development of
inhibitory connections as demonstrated by the observation
that, knocking down GAD67 in basket interneurons severely
impairs GABAergic innervation [20]. These eﬀects may be
attributed to the activity-dependent reduction in GABA
synthesis and signaling following down regulation of GAD67
levels and/or enzyme activity [20].
To be highly eﬃcient, synaptic transmission requires the
presence of clustered postsynaptic receptors localized in pre-
cise apposition to presynaptic release sites. At inhibitory con-
nections, this task is accomplished by gephyrin, a tubulin-
binding protein which traps glycine and GABAA receptors in
the right place anchoring them to the cytoskeleton [60].
Interestingly, a recent study has demonstrated that
gephyrin directly interacts with adhesion molecules of the
NLGs family [61] which in turn bind to their presynaptic
partners NRXNs to regulate transmitter release (Figure 3).
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Figure 3: Structural organization of GABAergic synapses. The
postsynaptic organization comprises a large number of proteins that
allow the correct targeting, clustering and stabilization of GABAA
receptors. Among them gephyrin forms hexagonal lattices that
trap GABAA receptors in precise apposition to presynaptic release
sites. Cell adhesion molecules of the neuroligin-neurexin families
bridge the cleft and ensure transsynaptic signaling, essential for the
maintenance of a proper E/I balance.
Therefore, gephyrin plays a key role not only in stabiliz-
ing GABAA receptors but also in regulating transsynaptic
signaling and in maintaining an appropriate E/I balance.
The NLG-NRXN complexes possess a potent “synaptogenic”
or synapses organizing activities as demonstrated by their
ability to induce presynaptic diﬀerentiation of contact-
ing neuritis when expressed in heterologous nonneuronal
cells. Postsynaptic NLGs promote the assembly of func-
tional presynaptic specializations in axons while presynaptic
NRXNs recruit postsynaptic scaﬀolding proteins and neu-
rotransmitter receptors in dendrites via their interaction
with NLGs [62]. By functionally coupling synaptic calcium
channels with the release machinery, NRXNs are thought to
play an essential role in calcium-triggered neurotransmitters
release [63]. The NLGs family comprises five diﬀerent
genes (NLG1-NLG5 with various splice variants), which
form homodimers through the extracellular domain. Among
these, NLG2 is preferentially associated with GABAergic
synapses, while NLG1 with glutamatergic synapses [64, 65].
The NRXN family includes α- and β-NRXN. Initially, β-
NRXN was considered the main partner for NLG, but
recently, also α-NRXN was found to bind NLG [66].
Unlike β-NRXN that participates in the formation of both
glutamatergic and GABAergic synapses, α-NRXN seems to
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be specific for GABAergic synapses [67]. Therefore, it is clear
that within a neuronal network, the NLG-NRXN interaction
controls the formation of both glutamatergic and GABAergic
synapses [68]. At inhibitory synapses, GABAA receptors
are firstly assembled in the endoplasmic reticulum from
appropriate subunits and then delivered to the plasma
membrane. Targeting and clustering GABAA receptors at
synaptic and extrasynaptic sites is dynamically regulated by
neuronal activity [69] and requires the precise interplay of
various proteins and active transport processes along the
cytoskeleton [60, 70].
Disrupting endogenous gephyrin with selective antibod-
ies led to a reduction of GABAA receptor clusters [71], an
eﬀect that was associated with a decrease in the density
and size of NLG2 clusters and with a loss of GABAergic
innervation (Kasap, personal communication). Thus, pair
recordings from interconnected cells demonstrated that,
respect to controls, neurons transfected with recombinant
antibodies against gephyrin exhibited a lower probability of
GABA release. This reduction likely involves NLG2 which
is preferentially concentrated at inhibitory synapses and
directly binds gephyrin through a conserved cytoplasmatic
domain [61]. Similarly, at glutamatergic synapses, the NLG-
NRXN complex has been shown to act as a coordinator
between postsynaptic and presynaptic sites [72]. Hence,
overexpressing the glutamatergic scaﬀold protein PSD-95 on
the postsynaptic site enhanced the probability of glutamate
release via a retrograde modulation of neurotransmitter
release which probably involves the NLG-NRXN complex.
From the reported data, it is not surprising that single muta-
tions in genes encoding for adhesion molecules belonging to
the NLG-NRXN families, such as those found in few cases
of ASDs [73], lead to defective architectural structuring of
synaptic connections, molecular assembly of synapses and an
E/I unbalance.
As outlined in the next section, the use of animal models
of ASDs has enabled to investigate the mechanistic basis
of the E/I imbalance for a range of neurodevelopmental
disorders.
4. Altered GABAergic Signaling in
Animal Models of ASDs
A dysfunction of GABAergic signaling mediates autism-
like stereotypes in the majority of animal models of ASDs
obtained by experimentally manipulating candidate genes
for autism susceptibility or environmental risk factors. The
characteristic ASDs phenotype is often associated with either
a loss or a gain of the GABAergic function. Consistent with
postmortem studies from brain tissues obtained from ASDs
patients [74] alterations in GABA synthesising enzymes
GAD65 and GAD67, in GABA release, in the expression of
particular subtypes of GABAA receptors have been described.
A presynaptic reduction in glutamic acid decarboxylase
1 (Gad1) and glutamic acid decarboxylase 2 (Gad2) mRNA
encoding for GAD67 and GAD65, respectively, has been
recently found in mice lacking the Mecp2 gene in GABA
releasing neurons (Viaat-Mecp2−/y , [75]). Mutations in the
X-linked Mecp2 gene, which encodes the transcriptional reg-
ulator methyl-CpG-binding protein 2 (MeCP2), cause the
majority of Rett syndrome cases [76–78] which is character-
ized by an apparently normal early development followed by
loss of language skill, motor abnormalities, cognitive deficits,
stereotyped behavior, respiratory dysrhythmias, and seizures
leading sometimes to premature death. Viaat-Mecp2−/y mice
exhibit a significant reduction in amplitude (but not in
frequency) of miniature inhibitory postsynaptic currents
(mIPSCs) an eﬀect which occurs in the absence of any
alteration in amplitude or frequency of miniature excitatory
postsynaptic currents (mEPSCs), indicating that MeCP2
deficiency in GABAergic neurons has a cell-autonomous
impact on quantal release from glutamatergic neurons [75].
The reduction in GABA content and inhibitory neuro-
transmission aﬀects synaptic plasticity processes as sug-
gested by the impairment of long-term potentiation (LTP)
induced by theta burst stimulation of Schaﬀer collateral
[75]. Previous electrophysiological studies using Mecp2 null
mice, revealed a significant reduction in spontaneous firing
associated with a decrease in amplitude of mEPSCs in layer
5 pyramidal neurons as compared to WT control animals
at early presymptomatic and symptomatic stages [79]. In
the hippocampus of Mecp2 null mice, the diminished level
of basal excitatory drive has been shown to contribute,
at the network level, to slow down spontaneous rhythmic
field potentials activity, generated by the interplay between
excitation and inhibition [80]. This condition paradoxically
makes the hippocampal network overresponsive to excitatory
stimuli.
An imbalance between excitation and inhibition has been
found also in individuals aﬀected by Tuberous sclerosis, a
genetic multisystem disorder characterized by widespread
hamartomas in several organs, including the brain, heart,
skin, eyes, kidney, lung, and liver [81]. Tuberous sclerosis
patients exhibit a variety of neurological disorders including
epilepsy and autism-like disorders. The aﬀected genes are
Tsc1 and Tsc2 encoding hamartin and tuberin, respectively.
The hamartin-tuberin complex inhibits the mammalian-
target-of-rapamycin pathway that controls cell growth and
proliferation [81].
Interestingly, a loss of GABAergic function accounts for
the hyper excitability observed in an animal model of fragile
X syndrome (FXS), a common inherited cause of mental
retardation with language deficits, hyperactivity, autistic
behavior and seizures. FXS is caused by a trinucleotide
expansion of fragile X mental retardation 1 (fmr1) gene
which prevents the expression of the encoded protein called
Fragile X mental retardation protein (FMRP, [82]). As the
Mecp2 gene, the fmr1 gene is located in chromosome X
(Xq27.3). The lack of FMRP in animal models of FXS (the
Fmr1-null mouse) leads to an E/I imbalance in favor of
excitation. Among the factors contributing to enhance cell
excitability in Fmr1 KO animals an impairment of GABAer-
gic circuitry [83] and a decreased expression of GABAA
receptor subunits have been reported [84–87]. In subicu-
lar neurons, for example, a down regulation of GABAA-
mediated tonic (but not phasic) inhibition associated with
a reduced expression of α5 and δ GABAA receptors subunits
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has been found [88]. These alterations may contribute
to deficits in cognitive functions and to epileptic activity
observed in FXS patients. In contrast, electrophysiological
recordings from spiny neurons in the striatum, involved
in motor control and in specific aspects of cognition and
motivation, have revealed a selective increase in frequency
of sIPSCs and mIPSCs, probably secondary to an enhanced
probability of transmitter release from GABAergic terminals,
suggesting that modifications in GABAergic function in
Fmr1 KO mice are region-specific [89].
Relevant inhibitory synaptic abnormalities (involving
both phasic and tonic GABAA-mediated inhibition), which
may contribute to the abnormal social behavior of Fmr1 null
mice, are present in the basolateral nucleus of the amygdala
[90], which regulates fear and anxiety behaviors.
Linkage and association studies have revealed that the
chromosomal region 15q11-q13 is strongly implicated in
ASDs [91]. Maternal duplications of this region remain one
of the most common cytogenetic abnormalities found in
cases of idiopathic ASDs, which account for 1-2% of cases.
Deletion of this region results in either Angelman or Prader-
Willi syndrome, depending from which parent the deletion
has been inherited [92]. Interestingly, within this chromoso-
mal region, exists a gene cluster of GABAA receptors, Gabrb3,
Gabra5, and Gabrg3, encoding for β3, α5, and γ3 sub-
units, respectively. GABAA receptors are hetero-oligomeric
proteins spanning the membrane to form anion-permeable
channels. Assembled from eight classes of subunits exhibiting
diﬀerent degrees of homology a large variety of functional
receptors with diﬀerent biophysical and pharmacological
properties are expressed in mammalian brain. GABAA
receptors play a crucial role in proliferation, migration, and
diﬀerentiation of precursor cells thus contributing to the
establishment of neuronal circuits [93]. A developmental
deficit of GABAA receptors function would aﬀect neuroge-
nesis and maturation of neuronal network. Among diﬀerent
GABAA receptor genes, the targeted deletion of Gabrb3 gene
encoding for the β3 subunit, which is highly expressed during
brain development [94], leads to abnormalities in social
behavior, cognitive deficits, motor stereotypes and seizures,
reminiscent of the ASDs phenotype [56, 92, 95, 96].
Other mutations that aﬀect the GABAergic system con-
cern the homeobox genes Dlx1 and Dlx2, involved in the
development of most telencephalic GABAergic neurons [97].
Interestingly, the human locus with the highest LOD score
for autism susceptibility (D2S2188 on chromosome 2q)
maps very close to the gene encoding for the GABA synthe-
sized enzyme GAD65 and to Dlx1 and Dlx2. Furthermore,
the autism susceptibility locus D7S477 on chromosome 7q
maps within about six megabases of Dlx5 and Dlx6 which
are implicated in the regulation of forebrain GABAergic
neurons [98]. This region hosts the gene encoding for
Reelin, a protein expressed in cortical GABAergic neurons
[99]. Reelin is a signaling protein that plays a pivotal role
in the migration of several neuronal cell types and in the
development of neuronal connections [100, 101]. Reeler
mice, devoid of Reelin, exhibit cytoarchitectonic alterations
in their brain similar to those found in autistic patients [102]
associated with decrease GABA turnover [103].
Interestingly, the removal of the homeobox containing
transcription factors Engrailed-2 (EN2), known to be in-
volved in the regionalization pattering and neuronal diﬀer-
entiation of the midbrain and hindbrain [104] in mice
(En2−/−mice) leads to behavioral abnormalities similar to
those observed in ASDs patients [105]. In addition, these
mice exhibit a reduced expression of parvalbumin and som-
atostatin positive interneurons in the hippocampus, an eﬀect
associated with an increased susceptibility to seizures [105,
Table 1].
While the majority of animal models so far examined
exhibits a loss of GABAergic function, mice carrying the
human R415C mutation in the Nlgn3 gene display a gain
of function. Neuroligins (NLGs) are specialized cell adhesion
molecules that functionally couple the postsynaptic densities
with the transmitter release machinery by forming transsy-
naptic complexes with their presynaptic-binding partners,
neurexins [73]. NLG3 R451C KI mice bear a striking
phenotype with mimics in many aspects that found in ASDs
patients ([106] but see [107]). Functional characterization
of these mice has revealed (in contrast with NLG3 KO
mice) a loss of NLG3 in the forebrain associated with
impaired social interactions and a 50% increase in the
frequency of spontaneous inhibitory events with apparent
no eﬀects on excitatory synaptic transmission [106]. Inter-
estingly, in NLG3 R451C KI mice, the gain of function
is accompanied with a significant increase in the level of
the vesicular transporter for GABA, VGAT, and gephyrin, a
postsynaptic scaﬀolding protein, crucial for recruiting and
maintaining neurotransmitter receptors in the right place
and for ensuring a correct E/I balance.Whether the increased
release of GABA selectively aﬀects only a subset of GABAer-
gic interneurons is still unclear. In addition, this animal
model exhibits an asymmetric reduction of parvalbumin-
positive basket cells across the two hemispheres [108]. How-
ever, immunocytochemical data from postmortem material
obtained from ASDs patients have revealed an increased
density of calbindin-, calretinin-, and parvalbumin-positive
interneurons in the hippocampus [23], a condition that
would alter neuronal signaling and synchronization leading
to cognitive dysfunctions [109]. The enhanced GABAergic
innervation may cause a compensatory downregulation of
GABAA receptors. The reduction in benzodiazepine-binding
sites on GABAA receptors observed in the hippocampus of
autistic patients supports this hypothesis [110].
Among autism risk factors, prenatal or neonatal envi-
ronmental challenges, including early exposure to valproic
acid (VPA), a histone deacetylases inhibitor, are widely used
as animal models of ASDs [111]. The VPA model has been
developed on the basis of the observation that treatment of
epilepsy or bipolar disorders in pregnant women (20–24 days
after conception) with VPA leads to an increased incidence
of ASDs in their children [112]. A unifying hypothesis
where the core pathology of the autistic brain consists in
hyper-functionality and excessive neuronal processing in
local neuronal microcircuits in prefrontal, somatosensory
cortex, and amygdala, leading to social and environmental
withdrawal has been proposed [113, 114]. Interestingly, as
the neuroligin-3 model, the VPA model of ASDs exhibits an
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Table 1: Main alterations of GABAergic signaling present in diﬀerent animal models of ASDs. For the Rett syndrome, diﬀerent genotypes
are expressed in brackets.
Mouse model Alterations in GABAergic signaling Ref.
Reduced levels of GAD65 and GAD67 (Viaat-Mecp2−/y) [75]
Reduced inhibitory quantal size in layer 2/3 pyramidal neurons of the somatosensory
cortex
Mecp 2-KO
(Rett syndrome)
The E/I balance is shifted to favor inhibition over excitation in cortical networks
(Mecp22lox/x, Nestin-Cre)
[79]
Reduced frequency of IPSC-based spontaneous rhythmic field potentials in the
hippocampus (Mecp2tm1.1Bird)
[80]
Fmr 1-KO
(X fragile)
Down regulation of GABAA-mediated tonic inhibition in the subiculum [88]
Reduced expression of α5 and δ GABAA receptor subunits in the subiculum
Increased frequency of sIPSCs and mIPSCs in the striatum [89]
Reduction in amplitude and frequency of sIPSCs and mIPSCs [90]
Reduced GABAA-mediated tonic inhibition
[84–87]Reduced GABAergic innervation in the amygdala
Reduced expression of GABAA receptor subunits
Gabrb 3 KO
The E/I balance is shifted to favor excitation over inhibition in cortical networks
(EEG recordings)
[56]
Dlx1/Dlx2 KO
Abnormal cell migration
Reduction in the number of GABAergic interneurons in the cortex, olfactory bulb
and hippocampus
[97]
Reln-KO
Reduced level of GAD67 [103]
Decreased GABA turnover
Reduced expression of parvalbumin- and somatostatin-
En2-KO positive GABAergic interneurons in the hippocampus [115]
Increased susceptibility to seizures
Increased frequency of mIPSC
Nlg3 R451C KI Increased level of VGAT and gephyrin [106]
Asymmetric reduction of PV positive basket cells across cortical hemispheres [108]
valproic acid
The E/I balance is shifted to favor excitation over inhibition in the lateral amygdala
(multi electrode arrays)
[114]
Asymmetric reduction of PV positive basket cells across cortical hemispheres [108]
asymmetric reduction of parvalbumin-positive cells across
the two hemispheres [108]. The disruption of inhibitory
circuits may delay critical periods in specific ASDs brain
regions [59], thus perturbing γ-oscillations implicated in
high cognitive functions.
5. Future Perspectives
Although much more work is required to understand the
cellular and molecular mechanisms regulating the E/I bal-
ance at synapses, it is clear from the reviewed data that
GABAergic signaling plays a key role in the construction
of neuronal networks and that disruption of GABAergic
circuits accounts for several neurodevelopmental disorders
including ASDs. A significant progress has been made in
characterizing genes involved in synapses formation and
maintenance but their role in the organization of neuronal
circuits is still limited. From a clinical perspective, a
challenged task will be to identify, in animal models of
ASDs, the cellular substrates of microcircuits implicated in
diﬀerent cognitive and behavioral deficits associated with
ASDs. This can be accomplished by using new optogenetic
tools that would allow to selectively activate or silence specific
interneuronal populations and to study their functional
consequences [116]. With this technique, GFP fusions of
channelrhodopsin-related proteins and halorhodopsin, can
be delivered into the brain via viral infection. In response
to diﬀerent wavelengths of light, label cells and axons can
be either depolarized (in the case of channelrhodopsin,
[117]) or hyperpolarized (in the case of halorhodopsin),
thus allowing to switch on and oﬀ selective groups of
genetically targeted interneurons and to study the neural
basis of diﬀerent behaviors [118]. This will allow better
understanding the mechanistic bases of ASDs and to develop
new selectively targeted therapeutic tools for most eﬀective
interventions.
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Conclusions and future perspectives 
 
To be highly efficient, synaptic transmission requires the presence of clustered 
postsynaptic receptors localized in precise apposition to presynaptic release 
sites. The molecular mechanisms which accomplish this level of organization 
along with the functional role of different synaptic proteins are not fully 
understood. 
At inhibitory synapses, the interplay of different proteins including gephyrin, 
collybistin and neuroligin 2 and 3 seems to have a major role in recruiting and 
stabilizing receptors at GABAergic synapses. In the first study, I have 
demonstrated that the scaffold protein gephyrin not only stabilizes GABAA 
receptors at subsynaptic membranes but via a transynaptic action involving the 
neuroligin-neurexin  complex regulates GABA release. This could be of particular 
relevance as it has been proposed that the interaction between scaffold and 
adhesion molecules of the neuroligin-neurexin families contributes to set the 
balance between excitation and inhibition in local networks. An altered E/I 
balance may account for several behavioral and cognitive deficits observed in 
patients affected by neuropsychiatric disorders, including ASDs. To date the 
etiology of ASDs remains largely unknown, however, recent genetic findings 
together with emerging anatomical and functional imaging studies suggest a 
potential unifying model in which the unbalance between excitation and 
inhibition may be responsible for high order association areas disconnection in 
the brain.  
Taking advantage of the mouse model of autism carrying the human R451C 
mutation of the Nlgn3 gene, found in two families of autistic patients I have 
observed an increased GABAergic but not glutamatergic signaling  in the 
hippocampus already at early stages of postnatal development. The early 
alteration in the excitatory/inhibitory balance, may account for behavioral 
deficits observed in children with ASDs. Although my experiments have revealed 
postsynaptic GABAA receptors modifications associated with alterations in 
transmitter release, they have not addressed the mechanisms responsible for the 
observed phenotype, including the type of interneurons involved and networks 
function. To gain more details about the mechanisms responsible for the 
observed effects, we are planning to investigate: 
1. The mechanisms underlying  the gain-of-function phenotype; 
2. The role of a subset of GABAergic interneurons in regulating the activity of 
local networks. 
 
The mechanisms underlies  the gain-of-function phenotype 
 
In vitro experiments have demonstrated that the NL3R451C mutant shows 
defective trafficking with retention of up to 90 % of the NL3 protein in the 
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endoplasmic reticulum with only a 10 % delivered to the synapses  (Tabuchi et 
al. 2007). At GABAergic and glutamatergic synapses, scaffold molecules such as 
gephyrin and PSD-95, certainly contribute to proper receptors targeting. 
However, their contribution to the localization of NL3 at GABAergic and 
glutamatergic synapses is still unknown. Co-immunoprecipitation experiments 
following ectopic expression of gephyrin, PSD-95 with a truncated versions of 
NL3 (NL3 lacking the PDZ-binding domain or NL3 lacking the gephyrin binding 
motif etc.) in HEK293 cells could shed light on the mechanisms of protein-
protein interaction and cellular localization of NL3. The interaction of NL3 with 
collybistin will be also tested. Quantitative western blot and 
immunofluorescence approaches (both on brain tissues and on cultured 
hippocampal neurons) would allow to assess whether the truncated mutants and 
the  NL3R451C mutation alters the expression/distribution of inhibitory proteins 
like gephyrin, NL2, collybistin and GABAA receptor subunits. A redistribution of 
NLs at inhibitory synapses may explain the gain of function found in the present 
experiments.   
In addition, over-expression of NL3 mutants in hippocampal cell cultures 
obtained from NL3 KO mice may provide functional insights into the 
mechanisms of NL3 function.  
 
The role of a subset of GABAergic interneurons in regulating the activity of 
local networks  
 
From a clinical point of view, it would be extremely important to identify the 
dynamics of GABAergic microcircuits implicated in network abnormalities 
responsible for cognitive and behavioral deficits associated with ASDs. Post-
mortem analysis of brain tissue from autistic patients, have revealed an 
increased expression of calbindin-, calretinin- and parvalbumin-positive 
GABAergic interneurons (Lawrence et al., 2010). In particular, several lines of 
evidences suggest a major role of parvalbumin positive (PV+) interneurons in 
neuropsychiatric disorders including schizophrenia and ASDs. These 
interneurons not only contribute to synchronize neuronal ensembles but exert a 
powerful control on spike timing and synaptic integration. To unveil possible 
dysfunctions in local inhibitory circuits involving   PV+ interneurons, we plan to 
cross NL3R451C knock-in mice with GAD67-GFP mice (selectively expressing the 
EGFP in PV+ interneurons). Pair recordings will be performed from 
interconnected PV+ or PV- basket cells and pyramidal cells in the CA1 
hippocampal region. PV+ and PV- interneurons will be characterized on the basis 
of their different firing patters, membrane time constants, input resistances and 
on their ability to exhibit Depolarization-induced Suppression of Inhibition (DSI) 
upon membrane depolarization of their pyramidal target neuron. In contrast to 
PV+, PV- interneurons exhibit CB1-sensitive DSI (Glickfeld and Scanziani, 2006). 
The relative amount of excitation received by the PV+ and PV- basket cells will be 
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measured in control and upon repetitive stimulation of Schaffer collateral (in 
controls EPSCs evoked in PV- cells respond poorly to the repetitive activation of a 
single pathway as compared to PV+ cells). Changes in short-term plasticity may 
underline differences in the recruitment of the two types of interneurons during 
ongoing hippocampal activity. Furthermore, the magnitude of feed-back and 
feed-forward inhibition and their ability to integrate and summate consecutive 
inputs will be compared in the same way as in Glickfeld and Scanziani, (2006). In 
particular changes in feedback inhibition could be of interest for their 
importance in gamma oscillations (Wang, 2010). 
EEG gamma (γ) oscillations have received particular attention because of their 
putative role in higher brain function (Bartos et al., 2007). In autistic patients, 
alterations of high cognitive functions including sensory integration, have been 
found to be associated with modifications of gamma-band oscillations in the 
electroencephalogram (Orekhova et al., 2012; Stroganova et al., 2012). Similarly, 
animal models of ASD show a decreased synchrony in the gamma frequency 
range (Gibson et al., 2008; Gandal et al., 2010). γ oscillations which are strongly 
dependent on excitatory/ inhibitory (E/I) balance (Wang, 2010) prevail in the 
hippocampus and in the somato-sensory cortex. Principal cells in the somato-
sensory cortex receive excitatory inputs directly from the thalamus, but the same 
thalamic fibers innervate also fast spiking, PV+ basket cells, which mediate the 
feed-forward inhibition. Thus, principal cells receive excitatory inputs directly 
from the thalamus and inhibitory ones, from PV+ interneurons, that are excited 
by the same thalamic fibers (Agmon & Connors, 1991). Therefore, we plan to 
investigate whether also in our model, an altered E/I balance at the level of the 
local circuit involving layer IV spiny neurons may account for oscillatory 
dysfunction in the gamma frequency range. 
Finally, in cultured hippocampal neurons from mice obtained by crossing 
NL3R451C knock-in with GAD67-GFP we will studied whether GABAergic 
innervation is segregated along the somato-dendritic compartment of a given 
cell. Segregation associated with a selective loss of perisomatic but not dendritic 
GABAergic synapses has been demonstrated in NL-2 KO mice, a condition that 
alters the E/I balance (Poulopoulos et al, 2009). To this aim, individual 
glutamatergic and GABAergic currents will be evoked in principal cells by 
directly un-caging glutamate and GABA, onto individual glutamatergic and 
GABAergic synapses. In this way the dendritic filtering will similarly affect both 
the GABAergic and the glutamatergic components. Synapses will be 
simultaneously visualized with VGLUT and VGAT, respectively, coupled to 
different fluorescent dyes. Individual neurons will be visualized by fluorescent 
dye injection through the recording pipette. Amplitudes and kinetics of 
glutamatergic and GABAergic currents recorded from different regions will be 
compared with those obtained from KO or WT animals.  
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